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Proteins are inherently anisotropic macromolecules due to the variation in the 
surface-exposed amino acid side-chains on the protein surface. Protein phase 
diagrams describe the solution conditions where phase transitions, such as liquid-
solid and liquid-liquid, occur. The position of these phase boundaries is dependent on 
both the intrinsic characteristics of the protein and on its environment. As a result, 
changes to the protein or its environment can significantly alter its phase diagram. 
Human γD-crystallin (HGD) is a protein found in the eye lens and is remarkably 
stable at high concentrations. HGD exhibits short-ranged attractive interactions, i.e. 
shorter than a quarter of the protein diameter. As a result, HGD undergoes liquid-
liquid phase separation (LLPS). The temperature (Tph) at which LLPS occurs can be 
used as a measure of the strength of attractive interactions between proteins in 
solution.  
The effects of chemically modifying specific amino acids (Lys-2 and Cys-110) on 
the surface of HGD with a (hydrophobic) small molecule fluorescent label were 
examined using both experiments and simulations. By measuring the LLPS 
temperature for modified proteins in mixtures with native protein, it was possible to 
determine how surface anisotropy and the chemical properties of the modifier 
changed the protein’s phase behaviour. Very low modified protein compositions (as 
low as xm = 0.0001) were sufficient to increase Tph significantly (~14 K), but both the 
position and type of fluorescent dye used influenced Tph.  A numerical model was 
designed to explain the experimental observations and revealed that the increase in 
LLPS in the presence of modified protein was due to a new increase in attraction in 
the system. 
The effects of chemical modification were further examined by modifying HGD with 
PEGylated biotin at both the Cys and Lys positions on the protein surface. Even at 
high modified protein compositions (xm ~ 0.9), there was little change in Tph relative 
to unmodified HGD when the modification was performed at the Lys position. 
However, Tph increased significantly for thiol modified protein at a similar modified 
protein composition (~10 K). Neither modification had any impact on the structure of 
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the protein relative to unmodified HGD. This study further highlighted how both the 
specific chemical modification and its position on the protein surface can change the 
impact to a phase boundary.   
Finally, the nucleation and growth of protein aggregates in solution and in cells was 
probed using double mutants of HGD. For solution based measurements of the 
P23VR58H mutant of HGD, it appears that aggregate growth produces monodisperse 
particle sizes, which appear to grow via monomer addition. When measurements are 
made in smaller volumes, surface effects lead to heterogeneous nucleation and 
polydisperse aggregates emerge. However, heterogeneous nucleation can be 
suppressed by surface treatments. Aggregate growth in cells was demonstrated for 
the P23TR36S mutant of HGD. Heterogeneous aggregates of GFP labelled protein 
were observed in cells for up to 4 days and these particles sizes were predominantly 
1-2 µm in size. While some larger particle sizes were observed, these were very few 
in number. Significant cell death was associated with later particle growth stages, 
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cDNA – Complementary 
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CGM – Complete growth medium 
Cys – Cysteine 
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DMEM – Dulbecco’s modified 
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DOS – Degree of substitution 
dsDNA – Double-stranded 
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DSC – Differential scanning 
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emGFP – Emerald green fluorescent 
protein 
ES – Electrostatic 
ESI-MS – Electrospray ionisation 
mass spectrometry 
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h – Planck’s constant 
HbC – C haemoglobin 
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HPLC – High performance liquid 
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thiogalactopyranoside 
Kd – Dissociation constant 
kT – Thermal energy 
LB – Lysogeny broth 
Lys – Lysine 
M – Molar 
MWCO – Molecular weight cut off 
NaCl – Sodium Chloride 
NaOH – Sodium Hydroxide 
NHS – N-hydroxysuccinimide 
OD – Optical density 
P23T – Pro-23 to Thr mutant 
P23V – Pro-23 to Val mutant 
PAGE – Polyacrylamide gel 
electrophoresis 
PBS – Phosphate buffered saline 
PCR – Polymerase chain reaction 
PDL – Poly-D-lysine 
PEG – Polyethylene glycol 
Phe – Phenylalanine 
pI – Isoelectric point 
PLL – Poly-L-lysine 
POI – Protein of interest 
Pro – Proline 
PrP – Prion protein 
PTM – Post translational modification 
R36S – Arg-36 to Ser mutant 
R58H – Arg-58 to His mutant 
RP-HPLC – Reverse phase high 
performance liquid chromatography 
RPM – Revolutions per minute 
SDS – Sodium dodecyl sulphate 
SE-HPLC – Size exclusion high 
performance liquid chromatography 
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Ser – Serine 
sfDMEM – Serum free Dulbecco’s 
modified Eagle’s medium 
SLS – Static light scattering 
S/N – Signal-to-noise ratio 
S/V – Surface-to-volume ratio 
SP – Sulphopropyl 
T – Temperature 
Tc – Critical temperature 
Tclear  – Clearing temperature 
Tcloud – Clouding temperature  
TEMED – 
Tetramethylethylenediamine  
Thr – Threonine 
Tph – Phase transition temperature 
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Trp – Tryptophan 
Tyr – Tyrosine 
UV – Ultraviolet 
UV/Vis – Ultraviolet/Visible 
Val – Valine 
VDW – van der Waals 
v/v – volume per volume 
w/v – weight per volume 
xL – Fraction of labelled protein 
xm – Fraction of modified protein 
ε – Extinction co-efficient 
ϕ – Volume fraction 
ϕc – Critical volume fraction 
λ – Wavelength 
λex – Excitation wavelength 
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Self-assembly can be defined as “the autonomous organization of components into 
patterns or structures without human intervention” and is a ubiquitous process 
throughout nature and technology (Whitesides and Boncheva 2002; Whitesides and 
Grzybowski 2002). There are two types of self-assembly: static self-assembly 
involving systems at equilibrium and dynamic self-assembly which requires 
dissipation of energy within the system (Whitesides and Grzybowski 2002). The 
ability of components in a system to self-assemble arises from the characteristics of 
the components as well as their environment (Whitesides and Grzybowski 2002). 
Protein self-assembly plays a crucial biological role and understanding the 
mechanisms underlying the self-assembly of proteins is of considerable importance 
for many biological and industrial processes (McManus, Charbonneau et al. 2016). 
1.2 Thermodynamics of self-assembly 
Thermodynamic constraints are the driving forces leading to self-assembly 
(Grzybowski, Wilmer et al. 2009). Thermodynamics is the study of transformations 
of energy, the basic concepts of which are work, heat and energy (Atkins 1988). The 
First Law of Thermodynamics states that the energy of an isolated system is constant 
and is defined mathematically in equation 1.1: 
 ΔU = q + w 1.1 
where ΔU is the change in internal energy of a closed system, q is the heat supplied 
to a system and w is work done on a system. At constant volume, ΔU and q are 
equal.  
Enthalpy (H) pertains to systems where heat (q) is supplied to a system at a constant 
pressure and no other work is being done on the system. H is defined mathematically 
in equation 1.2: 
 H =U + pV 1.2 
where H is the enthalpy, U is the internal energy and p is pressure and V the volume 




Entropy (S) is a term denoting the disorder of a system and is defined by equation 
1.3: 
 S = kB log W 
 
1.3 




 and W denotes the 
number of microstates in the system.  
Free energy is related to H and S through the Gibbs function (G) at constant 
temperature (T) given in equation 1.5: 
 ΔG = ΔH – TΔS 1.4 
If ΔG is negative, a reaction has a tendency to convert reactants into products and is 
said to be spontaneous. Conversely, when ΔG is positive, the reaction is not 
spontaneous. When ΔG is zero, a system is said to be in thermodynamic equilibrium. 
The chemical potential of a sample is uniform when ΔG is zero regardless of the 
number of phases present (Atkins 1988). 
1.3 Proteins 
Proteins are polymers composed of chains of amino acids which, in many cases, fold 
into a unique three-dimensional structure. Proteins are synthesised in ribosomes and 
are generally divided into two distinct classes: globular and transmembrane. Globular 
proteins are water-soluble and are found in the cytosol of the cell as well as in 
intracellular and bodily fluids (Whitford 2005). Transmembrane proteins are found in 
the cellular membrane and contain a hydrophobic core region that interacts with the 
hydrophobic tails of the lipid bilayer which is flanked by two hydrophilic caps 
(Alberts, Johnson et al. 2002). Both classes of protein have functionalities that are 
derived from their folding and self-assembly. 
1.3.1 Protein structure and folding  
Amino acids are the building blocks of proteins. There are over 300 naturally 
occurring amino acids but proteins are comprised of only 22 (Rodwell, Botham et al. 
2015), all of which consist of a central carbon atom (known as the α-carbon) 
connected to an amino functional group, a carboxyl functional group, a hydrogen and 
a side chain (R-group) (figure 1.1).  Selenocysteine (Sec) and pyrolysine (Pyl) are 
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 amino acids and, though found in all three domains of life 
(archae, prokaryotes and eukaryotes), are extremely rare (Zhang and Gladyshev 
2007). Amino acids are zwitterionic and differ only in the chemical make-up of their 
side-chains which vary in complexity but can only contain carbon, hydrogen, 
nitrogen, oxygen and sulphur (figure 1.1). Although amino acids (excluding Glycine) 
can have L and D forms, the vast majority of proteins contain amino acids in the L 
enantiomer. Amino acids can be classed according the chemical properties of their 
side chains as acidic, basic, hydrophobic, hydrophilic and neutral. 
 
Figure 1.1: An amino acid showing the amino group, carboxyl group and R group. 
Amino acids are covalently bonded via a peptide (amide) bond after a condensation 
reaction forming polypeptides and proteins (figure 1.2). The unique sequence of the 
amino acids between the N- and C- terminals in a protein is called its primary 
structure.  
 
Figure 1.2: Condensation of water to form a peptide bond between two amino acids. 
The regular repeating local structures arising from the amino acids in the primary 
structure in a protein give rise to its secondary structure. There are two main 
classifications of secondary structure: α-helices (figure 1.3) and β-sheets (figure 1.4). 
The α-helix is a right-handed helix with 3.6 amino acid residues per turn and a 
distance (known as a translation distance) of 0.15 nm between amino acids resulting 
in a pitch of 0.54 nm. It is the most common secondary structure motif. The 




Figure 1.3: Right handed α-helix. Taken from Whitford 2005. 
β-sheets are formed from β-strands which are elongated helical arrangements with 
two residues per turn, a translation distance of 0.34 nm and a pitch of 0.7 nm. These 
strands interact to form a sheet-like arrangement which is stabilised by hydrogen 
bonding.  
 
Figure 1.4: Two adjacent β-strands interacting via hydrogen bonds.  
Taken from Whitford 2005. 
Protein tertiary structure arises from the folded polypeptide chain and is stabilised by 
hydrogen bonds (as for the secondary structure) in addition to disulphide bridges 
(formed by the oxidation of the thiol side chains in Cys residues), hydrophobic 
interactions between the non-polar residues, electrostatic interactions between 
charged residues and van der Waals interactions arising between dipoles. Predicting 
a protein’s tertiary structure from its amino acid sequence is extremely difficult and, 
in general, protein structures are determined experimentally rather than being 
inferred or calculated on the basis of their sequence (Dill and MacCallum 2012). 
Protein folding is reversible but the native folded state is more stable than the 
unfolded state due to the decrease in free energy associated with protein folding. The 
theoretical time for a protein to explore all of the possible conformations during 
folding is in the region of 10
73
 years (Cooper 2011). However, proteins fold in 
timescales of between microseconds to minutes. This is known as the Levinthal 
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Paradox (Levinthal 1968). When a protein’s secondary or tertiary structure is 
disrupted, the protein is said to be ‘denatured’ and protein functionality is 
diminished. Denaturation can occur either reversibly or irreversibly as a result of 
extremes of heating or pH or by the addition of denaturants such as chaotropes, 
solvents, cross-linkers or reducing agents (Whitford 2005).  
 Protein quaternary structure arises when proteins containing more than one 
polypeptide chain (also known as subunits) are held together by disulphide bonds, 
hydrophobic interactions, hydrogen bonds and salt bridges. For some proteins such 
as haemoglobin, the formation of its tetrameric quaternary structure is essential for 
its function (Gunton, Shiryayev et al. 2007).  
1.4 Protein condensation  
1.4.1 Background 
Protein condensation can refer to the native or non-native assembly of proteins that 
results in the formation of condensed states such as amorphous solids, crystals, dense 
protein liquids, gels or polymer fibres (Gunton, Shiryayev et al. 2007). These 
assemblies can form either by design, which is seen with the self-assembly of viral 
capsids, or when something goes wrong, which is seen with the polymerization of 
haemoglobin S (HbS) (Eaton and Hofrichter 1990; Hagan 2014; McManus, 
Charbonneau et al. 2016). Understanding protein condensation is of considerable 
importance for both biological and industrial processes (McManus, Charbonneau et 
al. 2016). Protein condensation is also implicated in the pathogenesis of several 
diseases which are described in section 1.4.2.  
1.4.2 Protein condensation diseases 
The main pathological feature of protein condensation diseases, which include sickle 
cell anaemia, Alzheimer’s disease and cataract, is the loss of protein solubility that 
leads to a condensed protein phase (Annunziata, Ogun et al. 2003; Chen, Vekilov et 
al. 2004). The insoluble protein condensates formed as a feature of the pathogenesis 
of these diseases have impaired biological function. The pathologies of some of these 
condensation diseases are discussed below. 
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Sickle cell disease is one of the oldest known protein condensation diseases and was 
first diagnosed over a century ago (Ferrone 2016). Individuals suffering from sickle 
cell disease have inherited two mutated genes while those who have inherited only 
one mutated gene are said to have sickle cell trait (Gunton, Shiryayev et al. 2007). 
Normal haemoglobin (HbA) is a tetrameric globular protein consisting of two α and 
two β subunits. Sickle haemoglobin (HbS) is a mutant of HbA associated with sickle 
cell anaemia. HbS accounts for over half of the haemoglobin in patients suffering 
from sickle cell anaemia (Steinberg 1999). Red blood cells in individuals suffering 
from sickle cell anaemia are distorted, with some resembling a sickle as opposed to 
being disc-shaped. The distortion in cell shape associated with sickle cell anaemia is 
caused by a two-step homogeneous/heterogeneous nucleation process that leads to 
polymerization of deoxygenated HbS to form rigid linear fibers that distort the shape 
of the cell (figure 1.5). The polymerization of HbS is a result of a single mutation of 
a negatively charged Glu to a hydrophobic Val at position 6 on the surface of the β 
subunits of HbS that, in turn, leads to its polymerization. The binodal for HbS is 
unusual in the sense that it has a critical point that represents the lowest temperature 
at which LLPS occurs as opposed to the highest (Serrano, Galkin et al. 2001; Galkin, 




Figure 1.5: The pathophysiology of sickle cell disease (left) and the structure of sickle cell fibers 
(right). Taken from Steinberg 1999 and Ferrone 2016. 
Homozygous haemoglobin C (CC) disease is a form of anaemia involving 
condensed protein states and is also due to a mutation at site 6 in the β subunit of the 
haemoglobin tetramer involving the replacement of a Glu with a positively charged 
Lys which leads to a decreased solubility (Hunt and Ingram 1958; Tokumasu, 
Nardone et al. 2009). HbC forms crystals in oxygenated red blood cells of patients 
presenting with CC disease as well as in patients with SC disease who are 
heterozygous and produce HbS and HbC (Feeling-Taylor, Yau et al. 2004). The latter 
is considerably more severe than the former and is potentially life threatening (Nagel 
and Lawrence 1991). In patients suffering from CC and SC disease, crystallization 
occurs due to an increase in hydrophobic interactions as a result of a conformational 
change which arises from the mutation at site 6 (Feeling-Taylor, Yau et al. 2004). 
The solubility line for HbC indicates that it has a retrograde temperature dependence 
i.e. the solubility decreases as temperature increases (Feeling-Taylor, Banish et al. 
1999; Vekilov, Feeling-Taylor et al. 2002). 
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Alzheimer’s disease (AD) is the most prevalent form of age-related dementia with 
the majority of cases occurring in individuals aged 65 or over (Williamson, Goldman 
et al. 2009). Amyloid β (Aβ) is a globular protein associated with AD (Gunton, 
Shiryayev et al. 2007). There are two major forms of Aβ: Aβ40 and Aβ42 (Gu and 
Guo 2013). Proteolysis of amyloid precursor protein (APP) by γ-secretase at the C-
terminus results in peptides of varying lengths (Blennow, de Leon et al. 2006). The 
sole difference between Aβ40 and Aβ42 is their length, which differ by two 
hydrophobic residues to produce peptides which are 40 and 42 residues long 
respectively (Gu and Guo 2013; Cukalevski, Yang et al. 2015). The two hydrophobic 
residues in Aβ42 make it more prone to aggregation than its more abundant Aβ40 
counterpart and thus it is more commonly associated with AD (Cukalevski, Yang et 
al. 2015). Amyloid plaques are compacted deposits of Aβ fibrils and are a key 
characteristic of AD (figure 1.6) (Selkoe and Podlisny 2002). Abnormally hyper-
phosphorylated tau proteins, which are associated with AD as well as other 
neurodegenerative diseases known as ‘taupathies’, form neurofibrillary tangles and 
also contribute to the pathology of AD (figure 1.6) (Iqbal, Liu et al. 2010; Iqbal, Liu 
et al. 2016).  
 
Figure 1.6: A photomicrograph of a section of the amygdala of a patient with AD showing two 
amyloid plaques and numerous neurofibrillary tangles. Taken from Selkoe and Podlisny 2002. 
There are two types of AD: early onset familial AD and late onset sporadic AD. 
Familial AD is extremely rare and is as result of mutations in APP and presenilin 
genes (Blennow, de Leon et al. 2006). The more common sporadic AD is thought to 
occur as a result of an age-induced imbalance between the production and clearance 
of Aβ (Blennow, de Leon et al. 2006).  
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Other condensed protein diseases that result in a loss of proper protein function that 
in turn lead to neurological disorders include Parkinson’s Disease (PD, caused by 
aggregation of a protein called α-synuclein (α-syn) into amyloid fibrils (Galvagnion, 
Buell et al. 2015)) and Huntington’s Disease (HD, which involves the formation of 
aggregates of huntingtin protein (HTT) (Ross and Tabrizi 2011)).  
Cataract, which is the leading cause of blindness worldwide, can arise due to aging 
which leads to modifications such as deamidation, methylation or disulphide bond 
formation, damage from UV radiation, an altered environment due to chronic 
conditions such as diabetes or be genetic in origin (Banerjee, Pande et al. 2011; 
Rivillas-Acevedo, Fernández-Silva et al. 2015). Cataract is defined as any opacity of 
the crystallin lens (Hejtmancik 2008) (figure 1.7). Lens opacity arises as a result of 
substantial variations in the refractive index over distances that are comparable to the 
wavelength of visible light (Benedek 1971; Delaye and Tardieu 1983) due to the 
formation of aggregates with high molecular weights within the ocular lens which 
scatter light and impair vision (Thurston, Hayden et al. 1997).  
 
Figure 1.7: A cataractous lens showing opacity. Taken from Messina-Bass et al. 2006.  
The high molecular weight aggregates that cause light scattering are held together by 
various attractive forces which include covalent interactions arising from disulphide 
or glycosidic linkages or non-covalent interactions arising from hydrophilic, 
electrostatic and van der Waals interactions (Benedek, Pande et al. 1999). Cataract 
can be categorized based on the age of onset: congenital cataract usually occurs in 
the first year of life; juvenile cataract usually occurs in the first decade of life; pre-
senile cataract occurs before the age of 45 and age-related cataract occurs after this 
time (Shiels and Hejtmancik 2013). Congenital (or hereditary) cataract arises due to a 
decrease in protein solubility as a result of single mutations in the amino acid 
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sequence of proteins found in the eye lens (Rivillas-Acevedo, Fernández-Silva et al. 
2015). Some of these mutations are discussed in section 1.9.2. 
1.5 Protein interactions 
The macroscopic thermodynamic properties and phase behaviour of proteins in 
solution that are critical to their function are determined by intermolecular protein-
protein interactions (Quang, Sandler et al. 2014). The intermolecular forces between 
proteins that govern its behaviour are no different from those between any other 
types of molecules (Leckband and Israelachvili 2001). Non-covalent protein 
interactions can be either specific or non-specific. Specific protein interactions (also 
known as complementary, lock-and-key and ligand-receptor and recognition 
interactions) arise synergistically from geometric, steric, ionic and directional forces 
to give a strong bond e.g. the avidin-biotin complex which boasts the strongest 
known non-covalent bond with a dissociation constant Kd = 10
-15
 M (which translates 
to a binding energy of ~35 kT or ~20 kcal mol
-1
 at room temperature) (Leckband and 
Israelachvili 2001; General, Dragomirova et al. 2012). In general, the sum of the 
non-covalent attractive and repulsive interactions between proteins gives rise to a 
protein interaction potential. Attractive interactions arise from the hydrophobic 
effect, van der Waals interactions and hydrogen bonding, while repulsive interactions 
are due to electrostatics and hydration interactions. These are outlined below (table 
1.1 and figure 1.8). Protein-protein interactions arising from non-covalent forces 
release substantially less energy than for the formation of a typical covalent bond (1–
5 kcal mol
-1
 for a non-covalent interaction versus ~50–200 kcal mol
-1
 for covalent 
bond formation) and, so, protein-protein interactions are mediated by weak 
intermolecular forces at room and physiological temperatures (Lodish, Berk et al. 
2000). However, multiple non-covalent interactions can work together to stabilise a 
protein and are also essential in mediating the binding of enzymes with substrates 
and antibodies with antigens (Lodish, Berk et al. 2000). The sum of the attractive and 
repulsive contributions arising from the amino acid side chains of a protein gives rise 
to its net interaction potential which is also known as the potential of mean force 
(PMF) (Israelachvili 1992). The energy (E) of the interaction potential is distance (D) 


















van der Waals – Weak Short → long 
Hydration + Strong Short 
Hydrophobic – Strong Long 
Steric + Strong Short 
Hydrogen bonding – Weak Short 
Electrostatic +/ – Weak → strong Short → long 
 
 
Figure 1.8: Generic attractive and repulsive interaction potentials between two protein molecules. 
Taken from Leckband and Israelachvili 2001. 
van der Waals (VDW) forces act between all atoms and molecules and arise due to 
fluctuations in the electric dipole moments of molecules which give rise to an 
attractive force as the atoms or molecules approach one another (Israelachvili 1992; 
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Leckband and Israelachvili 2001). The strength of VDW forces has a power law 
dependence on the separation distance (D) between the two bodies on which it is 





  1.6 
where CVDW is dependent on the optical properties and geometries of the acting 
bodies (Leckband and Israelachvili 2001).  
The hydrophobic effect is a strong, long-range, entropy-driven attractive force 
between non-polar molecules, the strength of which is dependent on the 
hydrophobicity of the interacting non-polar molecules (Leckband and Israelachvili 
2001). When a hydrophobic molecule comes into contact with water (or another 
polar solvent), it forces the water molecules to form a rigid cage-like structure 
around the hydrophobic molecule (Lodish, Berk et al. 2000). The restricted motion of 
the polar solvent surrounding non-polar molecules is energetically unfavourable 
(Israelachvili 1992). The long-range attraction that exists between non-polar 
molecules causes them to come together and this leads to an increase in entropy by 
releasing the rigid polar molecules in the solvent, thereby reducing free energy 
(Israelachvili 1992). The hydrophobic effect is important for protein stability and 
contributes to the tendency of proteins to bury non-polar amino acid side-chains in 
the proteins core and thus exclude water (General, Dragomirova et al. 2012). 
Hydration forces (also known as solvation forces) are repulsive interactions arising 
between molecules with surfaces that have water tightly bound to chemical groups 
with hydrophilic nature (Israelachvili 1992). The repulsive nature of these forces is 
two-fold and is energetically driven in terms of both entropy and enthalpy (Leckband 
and Israelachvili 2001). An increased excluded volume around the hydrated molecule 
as a result of the surface-bound water is an entropy driven process while a decrease 
in the adhesion strength of the surface is enthalpy driven (Leckband and Israelachvili 
2001). 
Steric interactions are repulsive forces that exist between molecules that contain a 
hydrophilic polymer (e.g. PEG) bound to the surface as they approach one another in 
solution (Leckband and Israelachvili 2001). However, if the attached polymer 
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contains functional groups that can attractively interact with another molecule at 
once within range, bridging is said to occur (Leckband and Israelachvili 2001). 
When polymers are free in solution they can cause a depletion force which is an 
entropy driven event that leads to an attractive force between proteins that interact 
via a depletion zone that is free of the hydrophilic polymer as water is driven out into 
the bulk solution which decreases the free energy of the system (Leckband and 
Israelachvili 2001; Thurston 2006). 
Hydrogen bonding is a type of weak electrostatic attraction that occurs between a 
hydrogen atom (H) that is covalently bonded to an electronegative atom (known as a 
donor atom (D)) to give a polar molecule that forms a weak attraction with an 
electronegative acceptor atom (A) (figure 1.9) (Lodish, Berk et al. 2000; Leckband 
and Israelachvili 2001). 
: :D H A D H A                   
Figure 1.9: Attractive interaction between a covalently bound hydrogen and a polar molecule. 
The strength of the hydrogen bond in water is in the region of 4 to 5 kcal mol
-1
 and 
between 1 and 2 kcal mol
-1
 for biomolecules (Lodish, Berk et al. 2000). Hydrogen 
bonding between amino acids is responsible for stabilising the alpha helix and beta 
sheet components of protein secondary structure and is one of the major contributors 
to a protein stability (Pace, Scholtz et al. 2014) 
Electrostatic (ES) interactions can be both attractive and repulsive and arise due to 
an interaction between a negatively charged atom/molecule (anion) and a positively 
charged atom/molecule (cation) where atoms/molecules of opposite charge attract 
one another and atoms/molecules of the same charge repel one another. In an ionic 
species, bonding electrons are never shared. A salt-bridge (or ion pair) contributes to 
protein stability and is formed between side-chain groups in a protein that are of 
opposite charge and within 5 Å of each other (General, Dragomirova et al. 2012). 
Zeta potential (also known as electrokinetic potential) is a measure of the effective 
electrostatic interaction between two charged surfaces (such as in a protein). A 
charged particle in buffer will form an adsorbed layer called an electric double layer 
(EDL) around itself (figure 1.10). The inner layer, known as the Stern layer, consists 
of particles with an opposite charge to that of the particle surface. A diffuse, variable 
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outer layer comprising of charged atoms/molecules of both signs surrounds the Stern 
layer and is separated from the bulk solution by a hypothetical interface known as the 
slipping plane. The Zeta potential is the potential at this interface (Bhattacharjee 
2016; An, Huang et al. 2017).  
 
Figure 1.10: Schematic representation of electric double layer. Taken from An, Huang et al. 2017. 
Despite these individual non-covalent interactions being well characterised, their 
collective contribution to protein stability and self-assembly is far less well 
understood (Israelachvili 1992; Vekilov and Chernov 2003; Gunton, Shiryayev et al. 
2007; Fusco and Charbonneau 2016). Protein stability and self-assembly are 
discussed in more detail in section 1.7. 
1.6 Colloids  
1.6.1 Colloid systems 
While there is no defined distinction between colloidal and non-colloidal systems, 
the term ‘colloid science’ refers to systems where one or more of the components has 
at least one dimension that is between a nanometre and a micron in length scale 
(Shaw 1992). There are three unique classes of colloidal system: colloidal 
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dispersions, colloidal solutions and association colloids. Colloidal dispersions are 
subsequently classified according to the two phases involved. A sol is a dispersion of 
a solid in a liquid or a solid in a solid; An aerosol is a dispersion of liquid or a solid 
in a gas; An emulsion describes a dispersion of a liquid in a liquid; A foam is a 
dispersion of a gas in a liquid. Colloids can be further classified according to how 
well they attract (lyophilic or hydrophilic) or repel (lyophobic or hydrophobic) a 
solvent or water (Atkins 1988).  
1.6.2 Isotropic colloids 
The hard sphere (HS) model was initially developed by theorists to understand 
liquids (Jones 2002).  Hard spheres are thought of as perfect spheres with an 
interparticle potential equal to zero unless they overlap in which case the potential 
becomes infinite (Jones 2002). Hard sphere (HS) systems are one of the simplest 
forms of interacting systems and neither repel nor attract at distances greater than the 
particle diameter (Royall, Poon et al. 2013). Theoretically, the particle volume 
fraction (ϕ) is the only parameter that determines the behaviour of a HS system. In 
reality, however, colloids will display a degree of ‘softness’ (Pusey and van Megen 1986; 
Royall, Poon et al. 2013).  
1.6.3 Anisotropic colloids 
Patchy particles are colloids that exhibit anisotropy in their shape and/or surface 
properties. The self-assembly of patchy particles, designed to interact in an 
anisotropic manner is of great interest in the field of soft matter (Bianchi, Largo et al. 
2006; Bianchi, Blaak et al. 2011). In addition, patchy particle models have been 
developed where an isotropic interaction potential has been replaced with an 
anisotropic one to explain their behaviour (Glotzer and Solomon 2007; Pellicane, 
Smith et al. 2008; Fusco, Headd et al. 2014).  
1.6.4 Colloidal interactions 
The net interaction potential between atoms or molecules in a system is given by the 
sum of its attractive and repulsive contributions (Everett 1988). However, forces 
between particles have a much longer interaction range than atoms or molecules 
which must be taken into account (Everett 1988). In a colloidal system, there are 
several physicochemical factors that account for the behaviour of the system: colloid 
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size, colloid shape, surface properties, colloid-colloid interactions and colloid-solvent 
interactions (Shaw 1992). Colloids also display phase transitions between gas, liquid, 
solid and liquid crystalline phases depending on the range of the inter-particle 
attraction (figure 1.10) (Anderson and Lekkerkerker 2002). These phase transitions 
have been observed for globular protein solutions (Rosenbaum, Zamora et al. 1996; 
Asherie 2004). These properties allow for direct parallels to be drawn between 
colloids and proteins. Indeed, the tuneable electrostatic interactions of proteins made 
possible by varying pH and ionic strength as well as the monodisperse size 
distribution of a single protein system make proteins ideal candidates to understand 
equilibrium and non-equilibrium phase behaviour of colloidal solutions (Dorsaz, 
Thurston et al. 2008). Since protein solutions can be classed as  colloidal fluids due 
to the their submicron size, colloidal systems with defined regions of attraction have 
been successfully used as a means of gaining insights into protein phase behaviour 
(Dorsaz, Thurston et al. 2008).  
 
Figure 1.10: Phase diagrams for (a) hard-sphere system showing fluid (F) and crystal (C) phases, (b) 
hard-spheres with long range attraction showing gas (G), liquid and fluid phases and (c) a system 
incorporating short-range attraction. Taken from Anderson and Lekkerkerker 2002. 
1.6.5 Modelling colloidal interactions 
Simplified coarse-grained models that are representative of protein-protein 
interactions are the preferred simulation method because direct molecular 
simulations are computationally demanding (Quang, Sandler et al. 2014). Several 
potentials such as adhesive hard sphere (Rosenbaum, Zamora et al. 1996), square-
well (Liu, Garde et al. 2005), modified Lennard-Jones (Wolde and Frenkel 1997), 
Yukawa (Foffi, McCullagh et al. 2002) and Derjaguin, Verway, Landau and 
Overbeek (DVLO) (Pellicane, Costa et al. 2004) potentials treat protein molecules as 
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hard spheres with an implicit solvent potential and parameters for interaction 
strength, interaction range and particle diameter (Quang, Sandler et al. 2014) and can 
qualitatively predict certain features of the phase diagram. However, to quantitatively 
reproduce the phase diagram for a protein, it is imperative to account for the 
anisotropy of the protein surface. Proteins are inherently anisotropic as a result of 
their unique surface, varying charge distribution and, to a lesser extent, their non-
spherical shape (Quang, Sandler et al. 2014; McManus, Charbonneau et al. 2016). 
This anisotropy affects the way a protein behaves in solution. The chemical 
anisotropy of the surface plays a more crucial role in determining  phase behaviour 
than the  shape anisotropy (McManus, Charbonneau et al. 2016). The seminal work 
of Lomakin, Asherie et al. (1999) incorporated an anisotropic (or aeolotopic) 
potential into a simple model and accurately reproduced the liquidus and binodal 
lines (discussed in more detail in 1.7.4) of the experimental phase diagram for bovine 
γIIIb crystallin. Other models have been developed since then that also account for the 
anisotropy dependent phase behaviour of globular proteins (Sear 1999; Romano, 
Sanz et al. 2011; Dorsaz, Filion et al. 2012; Quinn, Gnan et al. 2015). 
1.7 Protein stability, phase transitions and phase diagrams 
1.7.1 Protein stability 
Aggregation can be defined as the aberrant assembly of two or more protein 
monomers (either folded or partially/fully unfolded or a combination of both). 
Aggregates may be reversible (which tends to be thermodynamically driven or 
irreversible which tends to be kinetically driven (Roberts 2014) and can range in size 
between nanometres and micrometres in size (figure 1.11) (McManus, Charbonneau 




Figure 1.11: Various protein and peptide self-assemblies.  
Taken from McManus, Charbonneau et al. 2016. 
One way to think about protein stability is the ability of a protein to maintain its 
native state after folding and is of considerable importance in the biopharmaceutical 
and food industries since proteins in solution need to remain soluble during 
production, transport and storage (Amin, Barnett et al. 2014). Structural stability is 
the ability of a protein to resist denaturation and solution (or colloidal) stability is the 
resistance of the protein to self-associate in solution (James and McManus 2012; 
Blumlein and McManus 2013; Quigley and Williams 2015). Both the structural and 
solution stability of a protein  can depend on the solution conditions (such as ionic 
strength, temperature, pH, salt type and concentration, and the presence of 
excipients, ligands and cosolutes, etc.) as well as the inherent properties of the 
protein itself (James and McManus 2012; Blumlein and McManus 2013; Wang, 
Latypov et al. 2014). Protein aggregation can occur as a result of either colloidal or 
thermal instability and is a major biopharmaceutical regulatory concern since the 
formation of aggregates in a biotherapeutic can impact efficacy as well as patient 
safety and minimizing the rate of aggregation is of particular interest in the 
development of biotherapeutics (Wang and Roberts 2010).  
1.7.1.1 Aggregate morphology 
Protein aggregates are usually categorised as amorphous or fibrillar. Amorphous 
aggregates lack long range order and are composed of native and/or unfolded protein 
(Wang and Roberts 2010). Fibrillar aggregates, so called due to their long fibrous 
20 
 
shape, have long range order and have been shown to contain mainly β-sheet 
structure (Wang and Roberts 2010).  
1.7.1.2 Mechanisms of protein aggregation 
There are five common mechanisms associated with protein aggregation. Although 
these mechanisms are distinct, they are not mutually exclusive and can occur 
simultaneously within the same system (Philo and Arakawa 2009). Understanding 
these mechanisms can help to develop methods to prevent or diminish the 
undesirable formation of aggregates (Philo and Arakawa 2009). 
1.7.1.2.1 Mechanism 1: Reversible association of the native monomer 
Reversible association of native monomer (i.e. monomer in its natively folded state) 
to form oligomers occurs due to the inherent patchiness and resulting 
complementarity of the protein surface (Fink 1998; Philo and Arakawa 2009). 
Irreversible aggregation can be mediated by inter-protein disulphide bridges. As 
protein concentration increases and larger oligomers are formed, these aggregates 
may become irreversible over time (Philo and Arakawa 2009).   
1.7.1.2.2 Mechanism 2: Aggregation of conformationally altered 
monomer 
Proteins that are conformationally altered (i.e. partially unfolded) due to heat or shear 
stress can form strong oligomers in a manner similar to the mechanisms associated 
with reversible association of native monomer (Roberts 2007; Philo and Arakawa 
2009). Proteins that associate via Mechanism 2 have a low propensity to aggregate in 
their native states and the principal difference between these two mechanisms is the 
state of the associating protein (i.e. folded or unfolded) (Philo and Arakawa 2009). 
1.7.1.2.3 Mechanism 3: Aggregation of chemically modified product 
Mechanism 3 is similar to mechanism 2 in the sense that a conformational change is 
required to induce aggregation. The origin of the structural change is usually 
chemical degradation caused by oxidation, deamidation, photo-decomposition or 
proteolysis which change the interaction potential of the protein (Philo and Arakawa 
2009; Wang, Nema et al. 2010). Aggregates formed via Mechanism 3 can consist of 
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both chemically modified monomer as well as native monomer (Philo and Arakawa 
2009). 
1.7.1.2.4 Mechanism 4: Nucleation controlled aggregation 
Nucleation controlled aggregation involves monomer addition of native protein and 
can proceed either homogeneously via monomer addition to a critical nucleus 
composed of the native monomer or heterogeneously where an impurity or 
contaminant has acted as a critical nucleus (Philo and Arakawa 2009; Wang and 
Roberts 2010).  
1.7.1.2.5 Mechanism 5: Surface induced aggregation 
Surface induced aggregation begins with reversible binding of native monomer to a 
surface which then triggers a conformational change in the protein that in turn drives 
aggregation via a mechanism similar to Mechanism 2 (Philo and Arakawa 2009; 
Wang, Nema et al. 2010). Mechanism 4 can be considered a special case of 
Mechanism 5 since the surface of the critical nucleus is driving aggregation (Philo 
and Arakawa 2009). 
1.7.2 Protein phase transitions and phase diagrams 
Thermodynamically-driven protein phase transitions proceed without a change in 
protein structure and can give rise to a number of condensed protein phases and 
states such as crystals, concentrated liquids via liquid-liquid phase separation (LLPS) 
and gels (Dumetz, Chockla et al. 2008; Vekilov 2010). For a phase transition to 
occur, the change in Gibbs free energy in the system (ΔG = ΔH – TΔS) must be 
negative (Wentzel and Gunton 2008; Haaga, Pemberton et al. 2016). A system is said 
to be in thermodynamic equilibrium when ΔG is zero (Vekilov 2010).  
The second virial coefficient B22 (also known as B2 and A22) is a measure the strength 
of a two body (e.g. protein-protein) interaction in a dilute solution and has been used 
as a means of measuring the tendency of a protein-protein to self-associate i.e. its 
colloidal stability (Gunton, Shiryayev et al. 2007). It is related to the interaction 
potential W(r) by equation 1.7:  
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where M is the molecular mass, NA is Avogadro’s Number, W(r) is the interaction 
potential, kB is Boltzmann’s constant, T is the temperature and r is the centre to 
centre separation. A positive B22 value indicates that interactions between the protein 
and solvent are favoured so a repulsive protein-protein interaction dominates and the 
solvent is said to be a “good solvent”. A negative B22 value indicates that an 
attractive protein-protein interaction dominates and the solvent is said to be a “bad 
solvent”. A “theta solvent” is said to be an ideal solvent and is one where the B22 
value is zero (George and Wilson 1994). George and Wilson (1994) found that 
crystallization of proteins occurs within a narrow range of slightly negative B22 
values. As negativity increases (i.e. attraction increased), so does the propensity of a 
protein solution to form an amorphous precipitate. Understanding the conditions 
under which crystallization occurs has long been the subject of interest for both the 
elucidation of protein structure by means of X-ray crystallography and as a method 
of protein purification (Giegé 2013). Some proteins can form crystals with more than 
one morphology which can coexist (Vekilov 2012; James, Quinn et al. 2015). In this 
case, the solubility of each crystal type differs. 
Liquid-liquid phase separation (LLPS), also known as coacervation or fluid-fluid 
phase separation, is a phase transition where, under a given set of conditions, a 
solution (which can be a simple liquid, a colloidal suspension, or a protein solution) 
separates into two liquid phases that can be macroscopically separated: a dense phase 
and a dilute phase (figure 1.12). The opacity associated with LLPS is due to 
variations in refractive index between the two phases (Malfois, Bonneté et al. 1996). 
At equilibrium, the chemical potential (consisting of an entropic component and a 
binding energy component) of the dense and dilute phases are equal (Vekilov 2010; 
Wang, Latypov et al. 2014). The phenomenon of LLPS occurs as a result of short-
ranged (less than a quarter of the protein diameter) attractive interactions. The range 
of hydration, hydrophobic and van der Waals forces is ~10 Å (Velev, Kaler et al. 
1998; Leckband and Israelachvili 2001) whereas salt bridges and electrostatic forces 
have a shorter range (Muschol and Rosenberger 1995; Velev, Kaler et al. 1998; 
McPherson and Cudney 2006). LLPS is metastable with respect to crystallization and 
can only be observed in protein solutions where the kinetics of nucleation required 
for aggregation or crystallization to proceed are sufficiently slow and the range of the 
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interaction is much smaller than the size of the protein (Vekilov and Chernov 2003). 
The metastability of the dense protein phase following LLPS in protein solutions 
arises due to the restriction of the spatial position of each protein in the condensed 
phase as result of its nearest neighbouring proteins. A protein in the condensed phase 
has fewer neighbours when compared to the solid phase and so it is not caged by 
surrounding proteins to the same extent as in the solid phase. This gives rise to a 
dense protein phase with a slightly lower entropy when compared to the solid phase 
which, in turn, results in a dense protein phase that is metastable with respect to 
crystallization (Wang, Latypov et al. 2014).  
 
Figure 1.12: Liquid-liquid phase separation of bovine γE crystallin showing dense protein droplets 
surrounded by the dilute protein (A) and complete liquid-liquid phase separation of thaumatin (B). 
Taken from Asherie 2004. 
Above certain volume fractions, native proteins in solution may condense to form a 
reversible gel (Vekilov 2010). Gelation is not a true equilibrium state and is instead a 
kinetically trapped state similar to the formation of colloidal glasses (Gunton, 
Shiryayev et al. 2007) Although the mechanisms governing gelation are poorly 
understood, several theories have attributed the mechanism to long-range attractive 
interactions (Noro, Kern et al. 1999; Sear 1999; Kulkarni, Dixit et al. 2003) or to 
formation of weak networks of protein molecules with limited lifetimes (Pan, 
Filobelo et al. 2009). 
1.7.3 Factors affecting the liquid-liquid phase separation 
temperature 
Temperature-induced LLPS of proteins was first measured for a solution of lysozyme 
in salt water (Ishimoto and Tanaka 1977). Protein solution conditions influence the 
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temperature at which liquid-liquid phase separation (Tph) occurs. The effect of 
varying salt concentration, salt type and pH on the Tph of lysozyme has been 
previously determined (Taratuta, Holschbach et al. 1990; Muschol and Rosenberger 
1997). The effect of adding another protein on Tph has also been determined for 
different protein mixtures  (Liu, Lomakin et al. 1995; Asherie, Pande et al. 1998; 
Thurston 2006; Wang, Lomakin et al. 2010; Banerjee, Pande et al. 2011; Wang, 
Lomakin et al. 2011; Quinn, Gnan et al. 2015). The impact point mutations on a 
protein surface have on Tph when compared to the native protein has also been 
determined for a number of mutant proteins (Pande, Annunziata et al. 2005; 
McManus, Lomakin et al. 2007).  
1.7.4 Protein phase diagrams 
Protein phase diagrams describe the physical state of a protein in two or three 
dimensions for a given set of parameters such as temperature, protein concentration 
(or volume fraction), pH or salt concentration. The phase diagram for a protein is 
determined by the range of interaction (Asherie, Lomakin et al. 1996; Rosenbaum, 
Zamora et al. 1996). A temperature-concentration (T,c) phase diagram (taken from 
Vekilov 2010) for lysozyme in pH 4.5 0.5 M sodium acetate with 4% salt is shown in 
figure 1.13. This phase diagram shows several regions of coexistence and stability, 
metastability and instability. A solubility line (or liquidus line) separates regions of 
monomer and monomer in equilibrium with a solid protein phase. Two solubility 
lines are shown in figure 1.13 because lysozyme can form two distinct crystal types: 
tetragonal and rhombohedral, each with its own solubility line (Muschol and 
Rosenberger 1997; Vekilov 2010). Of the protein phase transitions, LLPS is 
particularly important in determining colloidal stability (Wang, Latypov et al. 2014). 
There are two phase lines associated with LLPS; namely the liquid-liquid 
coexistence line (also known as the binodal) and the spinodal (figure 1.13). LLPS 
occurs between the binodal and spinodal by nucleation of protein droplets in the 
dense phase that grow until they reach equilibrium whereas spinodal decomposition 
occurs instantaneously below the spinodal without a nucleation barrier (Cahn and 
Hilliard 1958; Thomson, Schurtenberger et al. 1987; Dumetz, Chockla et al. 2008; 
Vekilov 2010). The critical point of a protein solution is the point at which the 
binodal and spinodal converge (Vekilov 2010). Normally, the critical point 
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represents the highest temperature that liquid coexistence is possible. However, for 
haemoglobin S (HbS), the critical point is the lowest temperature of liquid 
coexistence (Serrano, Galkin et al. 2001). The region where LLPS occurs for 
lysozyme (and indeed other proteins) is below the solubility line which is in contrast 
to the phase diagram for small molecules (Vekilov 2010). The position and the shape 
of the binodal is directly related to the range of attraction which must be significantly 
reduced i.e. much smaller than the size of the protein for LLPS to be metastable with 
respect to crystallization (Hagen and Frenkel 1994; Asherie, Lomakin et al. 1996; 
Lomakin, Asherie et al. 1996; Malfois, Bonneté et al. 1996). This in turn makes it 
directly related to the colloidal stability of a protein solution. 
 
Figure 1.13: Temperature, concentration (T,c) phase diagram for lysozyme in 0.5 M sodium acetate 
buffer pH4.5 with 4% salt showing two solubility lines for both types of crystal, liquid-liquid 
coexistence and spinodal curves, gelation line and the solution-crystal spinodal line.  
Taken from Vekilov 2010.  
1.8 Protein modifications  
1.8.1 Post translational modifications   
Covalent post translational modifications (PTMs) are chemical modifications of 
proteins that occur either in vivo or in vitro after their biosynthesis and serve to 
change the protein’s structure or function by means of covalent attachment of a 
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functional group or protein, proteolytic (or, less commonly, autocatalytic) cleavage 
or degradation (Walsh, Garneau-Tsodikova et al. 2005; Baslé, Joubert et al. 2010). 
Common naturally occurring PTMs include acetylation, acylation, ADP-ribosylation, 
amidation, γ-carboxylation, β-hydroxylation, disulphide bond formation, 
methylation, ubiquitylation, glycosylation, phosphorylation, proteolytic processing 
and sulphation (Whitford 2005; Walsh and Jefferis 2006). Out of the 22 
proteinogenic amino acids, 15 are subject to diversification via PTM (there are no 
known modifications of Leu, Ile, Val, Ala, Phe, Sec and Pyl) (Walsh, Garneau-
Tsodikova et al. 2005). In almost all cases, naturally occurring PTMs are crucial for 
the function and structure of proteins (Whitford 2005). 
1.8.2 Artificial chemical modification 
Given the diversity of structure and function of proteins as a result of naturally 
occurring PTMs, the ability to chemical modify proteins by artificial means is highly 
attractive (Baslé, Joubert et al. 2010). The artificial chemical modification of a 
protein surface (which will be referred to here simply as ‘chemical modification’) 
was first reported in 1904 and has, since then, been a mainstay in the study of 
proteins (Stephanopoulos and Francis 2011). Of the 22 proteinogenic amino acids, 
lysine (Lys) and cysteine (Cys) (figure 1.14) are the most commonly used sites for 
chemical modification (Sletten and Bertozzi 2009; Polakis 2016) owing to their 
inherent nucleophilic character (Baslé, Joubert et al. 2010; Spicer and Davis 2014; 
Boutureira and Bernardes 2015). Other amino acids can be chemically modified but 
can be more synthetically challenging to achieve (Sletten and Bertozzi 2009). 
 
Figure 1.14: Structures of lysine (A) and cysteine (B). 
Lysine is one of the most abundant amino acids in proteins and there are many 
established protocols to preferentially chemically modify the amine of its side chain 
which is typically the most nucleophilic amine on a protein surface (Sletten and 
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Bertozzi 2009; Spicer and Davis 2014; Boutureira and Bernardes 2015; Turecek, 
Bossard et al. 2016). Preferential modification of Lys requires the use of ‘harder’ 
nucleophiles such as activated esters, sulfonyl chlorides and isothiocyanates or 
modification can be achieved through reductive alkylation using aldehydes in the 
presence of cyanoborohydride (Spicer and Davis 2014). The abundance of Lys can 
lead to heterogeneous mixtures of modified protein which may be useful in some 
applications where multiple conjugates are required but undesirable in others such as 
the development of some biopharmaceutics where a more homogeneous mixture is 
preferred (Spicer and Davis 2014). Cys is regarded as the most important naturally 
occurring amino acid for chemical modification because, in addition to its highly 
nucleophilic nature (it is much more nucleophilic than Lys), it has a low abundance 
(<2%) which allows for chemical modification with a greater degree of specificity 
and, therefore, less heterogeneity (Chalker, Bernardes et al. 2009; Sletten and 
Bertozzi 2009; Spicer and Davis 2014). There are a number of electrophiles available 
for specific labelling of Cys residues such as α-halocarbonyls, iodoacetamides and 
maleimides, with maleimides prevailing as the most commercialised and widely used 
derivative for Cys modification as a result of their ease of use and straightforward 
synthesis (Spicer and Davis 2014). Indeed, a selenocysteine residue, which is more 
nucleophilic than Cys, can be inserted into a protein for highly specific modification 
also using maleimide derivatives (Hofer, Thomas et al. 2008).  
Tyrosine (Tyr) and tryptophan (Trp) (figure 1.15) are rarely found on the surface of a 
protein (due to their hydrophobic nature) which has made them the subject of focus 
as sites for chemical modification since single site modification is advantageous 
(Joshi, Whitaker et al. 2004; Baslé, Joubert et al. 2010). The modification of Tyr and 
Trp is generally performed using water-soluble transition metal catalysis (Antos and 
Francis 2006). Trp has the lowest natural abundance of all the canonical amino acids 
which can allow for Trp modification specificity provided the protein being modified 




Figure 1.15: Structures of tyrosine (A) and tryptophan (B) 
Chemical modification of histidine (His), arginine (Arg), glutamic acid (Glu) and 
aspartic acid (Asp) is also possible as each has a nucleophilic residue that can be 
used as a site for modification but their use is much rarer than modification of Lys, 
Cys, Tyr and Trp (Boutureira and Bernardes 2015). His (figure 1.16A) is a target for 
nucleophilic attack and is highly selective towards vinyl sulphone which allows for 
site specific labelling with molecules containing a vinyl sulphone group as an 
acetylating agent (del Castillo, Marales-Sanfrutos et al. 2014). While Arg (figure 
1.16B) has a similar abundance to Lys, it has a lower tendency to be found on the 
surface of the protein which makes it more favourable for site specific modification 
(Gauthier and Klok 2008). Specific modification of Arg involves the formation of a 
pyrimidine ring using two out of the three nitrogen atoms found in its side chain 
(Oya, Hattori et al. 1999). Although highly selective, modification of Arg requires a 
14 day reaction time, which may make it an unsuitable choice of site for some 
studies that require specificity as well as a short reaction time. Modification of the 
carboxylate groups in Glu (figure 1.16C) and Asp (1.16D) involves amidation using 
ethylenediamine (Díaz-Rodríguez and Davis 2011). However, ethylenediamine 
indiscriminately labels both Glu and Asp which make these sites unfavourable as 




Figure 1.16: Structures of histidine (A), arginine (B), glutamic acid (C) and aspartic acid (D) 
Antibody drug conjugates (ADCs) are a promising emergent biotherapeutic for 
targeted treatment of cancer that combine the specificity of an antibody with the 
potency of a small molecule (Agarwal and Bertozzi 2015; Akkapeddi, Azizi et al. 
2016; Diamantis and Banerji 2016; Polakis 2016). ADCs have three parts: a 
humanised antibody for an antigen uniquely expressed or overexpressed in cancer 
cells, a potent cytotoxic drug that can be tethered to the antibody and a stable linker 
between the two that prevents premature release of the cytotoxic drug and can also 





Figure 1.17: ADC structure and component requirements. Taken from Polakis 2016. 
There are currently two ADCs approved by the US Food and Drug Administration 
(FDA) available for cancer treatment: Kadcyla (approved in 2013) and Adcetris 
(approved in 2011) and over 40 currently undergoing clinical trials (Polakis 2016). 
Ado-trastuzumab emtansine (brand name Kadcyla) is manufactured by 
Roche/Genentech and used for the treatment of HER2 positive metastatic breast 
cancer and uses succinimidyl-4-[N-maleimidomethyl]- cyclohexane-1-carboxylate 
(SMCC) for Lys modification. Given the abundance of Lys residues, modification at 
this site gives a heterogeneous drug product with an average drug-to-antibody ratio 
(DAR) of between 3 and 3.5 (Akkapeddi, Azizi et al. 2016). Brentuximab vedotin 
(brand name Adcetris) is manufactured by Seattle Genetics/Millennium 
Pharmaceuticals and is used for the treatment of relapsed Hodgkin Lymphoma. 
Modification of Cys is achieved using N-hydroxysuccinimide (NHS) ester and 
produces a more heterogeneous drug product given the low abundance of Cys 
residues available for modification (Agarwal and Bertozzi 2015). 
1.8.3 Mutagenesis 
Mutagenesis also alters the surface chemistry of proteins and, as opposed to proteins 
that are modified after translation, mutant proteins are coded for by mutated codons, 
insertions and deletions in the DNA sequence (Carter 1986). Site-directed 
mutagenesis, was first successfully used 35 years ago to specifically alter the amino 
acid sequences of 2 proteins, namely tyrosyl–transfer RNA synthetase (TyrRS) and 
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beta-lactamase (Dalbadie-McFarland, Cohen et al. 1982; Irving, Harwood et al. 
1982; Winter, Fersht et al. 1982; Brannigan and Wilkinson 2002). Since then, it has 
become an invaluable tool in molecular biology that provides insight into the 
structure and function of proteins (Hsieh and Vaisvila 2013). For the purposes of site 
specificity during chemical modification, proteins can be mutated with either 
canonical (e.g. Cys) or non-canonical amino acids (Gauthier and Klok 2008; 
Stephanopoulos and Francis 2011). Naturally occurring mutants, such as those 
associated with sickle cell anaemia and congenital cataract, are discussed in more 
detail in sections 1.4.2 and 1.9.2 respectively.   
1.9 The eye lens 
1.9.1 Background 
The eye lens (figure 1.18) is an avascular tissue whose function is to focus light on 
the retina in order to see (Sharma and Santhoshkumar 2009). Crystallins, which were 
discovered nearly 125 years ago and are divided into two separate families (α and 
βγ), are the main structural proteins of the vertebrate lens and account for the vast 
majority (about 90%) of the water soluble proteins found in the eye lens (Andley 
2007; Graw 2009; Sharma and Santhoshkumar 2009).   
 
Figure 1.18: A representation of the cross-section of the lens indication the location of the nucleus. 
Taken from Sharma and Santhoshkumar 2009. 
These proteins remain soluble at high concentrations in excess of 450 mg ml
-1
 
(Hejtmancik 2008). While both crystallin families are structural proteins, α 
crystallins (consisting of αA and αB which are large polydisperse multimeric 
32 
 
subunits) account for 40% of the soluble lens proteins in humans and act as 
molecular chaperones to maintain lens transparency (Horwitz, Bova et al. 1999; 
Bloemendal, de Jong et al. 2004). Oligomeric β crystallins have four key Greek 
motifs organised into two domains and are divided into acidic β crystallins (βA1, 
βA2, βA3 and βA4) and basic β crystallins (βB1, βB2 and βB3) (Bloemendal, de 
Jong et al. 2004). Monomeric γ crystallins are also comprised of four Greek key 
motifs organised into two domains. The mammalian genome codes for seven γ 
crystallins (γA, γB, γC, γD, γE, γF and γS). In humans, γA, γB, γC, γD and γS are all 
expressed but only γC and γD are expressed in appreciable quantities, with γD 
having the most predominant expression (Andley 2007; Wistow 2012). The γ 
crystallins interact via short-ranged attractive interactions to contribute to lens 
transparency due to this short-ranged order (Benedek 1971; Delaye and Tardieu 
1983). Of all the proteins that undergo liquid-liquid phase separation, the γ 
crystallins are the most widely studied (Malfois, Bonneté et al. 1996; Muschol and 
Rosenberger 1997).  
Human γD-crystallin (HGD), formerly known as γIIIb (Liu, Lomakin et al. 1995), is 
an extremely stable (soluble at concentrations in excess of 400 mg ml
-1
), monomeric, 
globular protein consisting of 174 amino acids with a critical point at a volume 
fraction (ϕ) of approximately 0.21 and corresponding temperature of ~277 K in 0.1 
M sodium phosphate at pH 7.0 (Liu, Asherie et al. 1996; Lomakin, Asherie et al. 
1996; Wang, Lomakin et al. 2010). As a result of these short-ranged attractive 
interactions, it undergoes LLPS. It can also form crystals. Point mutations in the 
amino acid sequence of HGD have been linked to congenital cataracts (Basak, 
Bateman et al. 2003; Pande, Annunziata et al. 2005; Pande, Gillot et al. 2009; 
Banerjee, Pande et al. 2011; Ji, Jung et al. 2013). Modifications to the surface of 
HGD either by chemical modification or mutagenesis have been used to investigate 
the effect anisotropy has on determining the phase behaviour of proteins in solution 
(McManus, Lomakin et al. 2007; James, Quinn et al. 2015; Quinn, Gnan et al. 2015). 
1.9.2 Human γD-crystallin mutants 
A number of congenital cataract phenotypes are associated with several point 
mutations in the amino acid sequence of HGD and are briefly discussed below. 
Although mutations are known to occur in both the α and βγ crystallin families 
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(Wistow 2012), those occurring in the γ crystallin family, specifically mutations 
associated with human γD-crystallin (HGD) are the most relevant here.     
 Arg-58 to His (R58H) and Arg-36 to Ser (R36S) mutations lead to a loss of 
transparency due to a decrease in the solubility of the mutated protein relative to its 
native form and its increased propensity to form crystals (Pande, Pande et al. 2001). 
The formation of these crystals in the eye lens leads to increased light scattering due 
to variations in refractive index.  
Pro-23 to Thr (P23T) mutation also presents with a decrease in solubility relative to 
the native protein but form non-covalent self-associated aggregates with a retrograde 
temperature dependence that lead to blindness (Evans, Wyatt et al. 2004). Other 
mutations at and around this site (Pro-23 to Ser (P23S), Pro-23 to Val (P23V), 
P23TInsP24 and P23TAsn-24 to Lys (P23TN24K)) have been explored in a bid to 
better understand the mechanisms of aggregation associated with this mutation 
(Pande, Annunziata et al. 2005). P23S and P23V both led to the formation of 
aggregates that were more soluble than the naturally occurring P23T mutant but less 
soluble than the native form. Like the naturally occurring P23T mutant, the 
aggregates formed due to the P23V and P23S mutations also maintained an inverted 
temperature dependence. Interestingly, the P23TInsP24 and P23TN24K mutants 
restored protein solubility to native values (Pande, Annunziata et al. 2005).  
Like P23T, Arg-14 to Cys (R14C) leads to the formation of aggregates resulting in 
blindness. Unlike the P23T mutation, the R14C mutation results in disulphide cross-
linked oligomers as a result of presence of another Cys residue (Pande, Pande et al. 
2000). In the native protein, there is only one surface exposed Cys residue which can 
form only one disulphide bridge with another HGD protein. In the mutant protein, 
two Cys residues are available to form disulphide bridges and the mutant protein can 
form higher weight oligomers. 
A Trp-42 to Arg (W42R) mutation has been shown to have a reduced solubility with 
respect to the native form (Wang, Yu et al. 2011). The basis of the decreased 
solubility arises from a partial unfolding as a result of this mutation which mimics 
the photo-damaged HGD involved in age related cataract (Ji, Jung et al. 2013). 
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Like the point mutations mentioned previously, the Glu-107 to Ala (E107A) 
mutation is also responsible for a decrease in lens protein solubility but, unlike the 
above mutations, cataract is not caused due to an altered γ-γ interaction alone 
(Messina-Baas, Gonzalez-Huerta et al. 2006; Banerjee, Pande et al. 2011). Instead, 
light scattering arises due an increased net attraction between the negatively charged 
α-crystallins and the mutant γD-crystallin as a result of an increase in positive charge 
due to the replacement of a negative charged Glu with an uncharged Ala. 
1.10 Thesis motivation 
The motivation of the work presented in this thesis was to investigate how physical 
and chemical properties of a protein and its environment affect its phase behaviour. 
Phase behaviour is intrinsically linked with the solution stability of the protein. 
Understanding and optimising protein stability is of particular importance in the food 
and biopharmaceutical sectors.  
Proteins are inherently anisotropic macromolecules as a result of their unique surface 
chemistries. The sum of the attractive and repulsive interactions from the surface-
bound amino acid side chains give rise to a net interaction potential which affects a 
protein’s solution behaviour and can be altered by changing the surface properties of 
the protein. The environment surrounding a protein in solution also contributes to its 
phase behaviour. 
The first results chapter examines the effects of chemically modifying the surface of 
a protein with a (hydrophobic) small molecule fluorescent label. The second chapter 
continues in the vein of chemical modification of a protein’s surface but explores 
chemical modification using PEGylated biotin (which is hydrophilic). This chapter 
also investigates the phase behaviour of a mixture of a native and mutant protein that 
is known to contain a hydrophobic patch on its surface. The third chapter explores 
the impact the environment of the protein has on its phase behaviour. This is 
investigated in two ways; firstly, the impact different surfaces that are in contact with 
the protein solution have on protein phase behaviour are explored. Secondly, the 
impact of intracellular milieu on protein phase behaviour is examined. 
This thesis aims to show that protein phase behaviour is not only determined by the 
properties of the protein itself but is also dependent on its environment. 
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Chapter 2:  




2.1 Preparation of buffers and reagents 
2.1.1 Buffers  
Buffers were prepared using either ultrapure (Type 1, Milli-Q) or pure (Type 2, Elix) 
water and analytical or HPLC grade solvents and reagents. When required, buffer pH 
was adjusted using either a concentrated hydrochloric acid solution (HCl, Mw = 
36.46 g mol
-1
) (Fisher Scientific, UK) or a concentrated sodium hydroxide solution 
(NaOH, Mw = 40.00 g mol
-1
) (Fisher Scientific, UK), unless otherwise stated. To 
inhibit microbial growth, 0.02% (w/v) sodium azide (NaN3, Mw = 65.01 g mol
-1
) 
(Fisher Scientific, UK) was added to each buffer, unless otherwise stated. All buffers 
were filtered using either vacuum filtration through a 0.45 μm nylon membrane filter 
(Millipore, Ireland) or a 0.45 μm Millex-HV syringe driven filter (Millipore, Ireland) 
prior to use. Buffers were degassed under vacuum with stirring where necessary. 
Where filter sterilization was required, solutions were filtered through a 0.22 μm 
Millex-GV syringe driven filter (Millipore, Ireland).  
2.1.1.1 Sodium acetate  
 Sodium acetate buffer (0.275 M) was prepared either with or without salt at pH 4.5 
and pH 4.8 respectively. Sodium acetate buffer without salt at pH 4.5 was prepared 
using 16.50 g glacial acetic acid (CH3COOH, Mw = 60.05 g mol
-1
) (Fisher Scientific, 
UK) and 4.48 g NaOH (Fisher Scientific, UK) per litre of pure water. Sodium acetate 
buffer at pH 4.8 with salt was prepared using 19.02 g of sodium chloride (NaCl, Mw 
= 58.44 g mol
-1
) (Fisher Scientific, UK), 16.50 g CH3COOH and 6.70 g NaOH per 
litre of water. Caution was taken not to mix CH3COOH and NaOH directly.  
CH3COOH(l) + NaOH(s) → CH3COONa(aq) + H2O(l) 2.1 
CH3COOH(l) + NaOH(s) + NaCl(s) → CH3COONa(aq) + H2O(l) + NaCl(aq) 2.2 
2.1.1.2 Sodium phosphate  
 0.1 M sodium phosphate buffer was prepared using 14.20 g sodium phosphate 
dibasic heptahydrate (Na2HPO4.H2O, Mw = 141.96 g mol
-1
) (VWR, Belgium) and 





) (Fisher Scientific, UK) per litre of water. The pH was adjusted to 7.0 or 8.0 as 
required. 
1 M sodium phosphate buffer at pH 6.0 was prepared using 156.01 g NaH2PO4.2H2O 
and 149.2 g Na2HPO4.7H2O per litre of water.  
2.1.1.3 Sodium borate 
50 mM of sodium borate pH 8.5 was prepared using 12.37 g boric acid (H3BO3, Mw 
= 61.83 g mol
-1
) (Sigma Aldrich, USA) and 4.00 g NaOH per litre of water (2.3).  
 4H3BO3(s) + 2NaOH(s) → Na2B4O7(aq) + 7H2O(l) 2.3 
2.1.2 Buffers for fluorescent labelling 
2.1.2.1 Reducing buffer   
1 ml of reducing buffer was prepared by mixing 100 μl of 1 M sodium phosphate 
buffer at pH 6.0 and 5 μl of 0.5 M EDTA with 895 μl ultrapure water.   
2.1.2.2 Conjugation buffer  
Conjugation buffer was prepared using 20 μl of 0.5 M EDTA per 10 ml of 0.1 M 
sodium phosphate buffer at pH 7.0. 
2.1.3 Buffers and reagents for E. coli cell culture 
Where indicated, reagents for Escherichia coli (E. coli) cell culture were autoclaved 
at 121 °C and 0.212 MPa pressure for 20 minutes in a SX-500E TOMY autoclave 
(Seiko, Japan). 
2.1.3.1 Ampicillin stock solution 
 A 50 μg ml
-1
 solution of ampicillin sodium salt (C16H18N3NaO4S,  
Mw = 371.39 g mol
-1
) (Fisher Scientific, USA) was prepared in ultrapure water, filter 




2.1.3.2 LB preparation 
Lysogeny broth (LB) was prepared using 25 g of LB Miller powder (Fisher 
Scientific, USA) per litre of ultrapure water and autoclaved. Ampicillin was added to 
the cooled broth after autoclaving to give a final concentration of 100 µg ml
-1
. 
2.1.3.3 LB agar plates  
LB Agar plates were prepared using 37 g of LB Agar granules (Fisher Scientific, 
UK) per litre of ultrapure water which was then autoclaved on a liquid cycle. After 
autoclaving, agar was cooled to below 55 °C before adding ampicillin to a final 
concentration of 100 µg ml
-1
. Agar was poured into sterile 10 cm petri dishes and 
allowed to set before use. Plates were sealed with Parafilm (Bemis, USA) and stored 






 broth was prepared using 10 g NZ amine (Sigma Aldrich, USA), 5 g yeast 
extract (Oxoid, England) and 5 g NaCl per litre of ultrapure water. The pH of the 
broth was adjusted to 7.5 and the broth was autoclaved. After autoclaving, the broth 
was supplemented with 12.5 ml filter sterilised 1 M magnesium chloride hexahydrate 
(Fisher Scientific, USA) (MgCl2.6H2O, Mw = 203.30 g mol
-1
), 12.5 ml filter sterilised 
1 M magnesium sulphate heptahydrate (Fisher Scientific, USA) (MgSO4.7H2O, Mw 
= 246.45 g mol
-1




2.1.3.5 Lysis buffer 
Lysis buffer was prepared immediately before use by dissolving 0.0788 g (50 mM) 
tris(hydroxymethyl)aminomethane hydrochloride (Tris HCl, C4H11NO3, Mw = 
121.14 g mol
-1
) (Merck, Germany), 0.0146 g (25 mM) NaCl and 0.0074 g (2 mM) 
ethylenediaminetetraacetic acid (EDTA, C10H16N2O8, Mw = 292.23 g mol
-1
) (Fisher 
Scientific, USA) in 10 ml ultrapure water. 
2.1.4 Reagents for mammalian cell culture 
The reagents used for mammalian cell culture were prepared using sterile reagents 
and solvents in a Class II biological safety cabinet using aseptic technique. Where 
indicated, reagents for mammalian cell culture were autoclaved at 121 °C and 0.212 
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MPa pressure for 20 minutes in a SX-500E TOMY autoclave and filter sterilised 
using 0.22 μm Millex-GV syringe driven filter.  
2.1.4.1 Complete growth medium 
Complete growth medium (CGM) was prepared using HyClone Dulbecco’s modified 
Eagle’s medium (DMEM) (4 mM L-glutamine and 4.5 g L
-1
 glucose either with or 
without Phenol Red) (GE Healthcare Life Sciences, USA) supplemented with 10% 
(v/v) bovine calf serum (BCS) (Sigma Aldrich, USA), 1 mM sodium pyruvate 
(Sigma Aldrich, USA), 1.5 mg ml
-1
 sodium bicarbonate (autoclaved at 121 °C for 20 
minutes and filter sterilised) (Sigma Aldrich, Germany) and 2.5 ml penicillin (10,000 
units ml
-1
)-streptomycin (10 mg ml
-1
) (Sigma Aldrich, USA). CGM was stored at 4 
°C following preparation. 
2.1.4.2 Phosphate-buffered saline 
10 ml aliquots of 1X phosphate-buffered saline (PBS) were prepared in two ways; 1 
PBS tablet (Fisher Scientific, UK) was dissolved in 100 ml ultrapure water and 
autoclaved. Alternatively, 10X PBS (Sigma Aldrich, USA) was diluted to 1X PBS 
using ultrapure water and filtered. Aliquots of 1X PBS were stored at -20 °C 
following preparation.   
2.1.4.3 Trypsin-EDTA solution 
3 ml of 1X trypsin-EDTA was prepared by adding 300 μl 10X trypsin-EDTA (5.00 
g/l porcine trypsin, 2 g/l EDTA-4Na, 0.9% NaCl) (Sigma Aldrich, USA) to 2.7 ml 
1X PBS.  
2.1.4.4 Poly-D-lysine solution 
5 ml aliquots of 100 μg ml
-1
 solution of poly-D-lysine (PDL) were prepared using 5 
mg (70–150 kDa, lyophilised, γ-irradiated) poly-D-lysine hydrobromide (Sigma 
Aldrich, USA) per 50 ml autoclaved ultrapure water. After aliquoting, the PDL 
solution was stored at 4 °C.   
2.1.4.5 Cryopreservation medium   
Cryopreservation medium was prepared before use using 95% complete growth 
medium (CGM) and 5% dimethyl sulphoxide (DMSO) (Fisher Scientific, USA).    
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2.2 Bacterial cell culture 
2.2.1 HGD transformation in E. coli  
Human γD-crystallin (HGD) plasmid containing an ampicillin resistance gene and an 
isopropyl-β-D-thiogalactopyranoside (IPTG) promoter was transformed in BL21-
Gold(DE3) competent E. coli cells (Agilent, USA) as per manufacturer’s guidelines. 
Competent cells were thawed on ice and gently mixed. 100 μl of the cells were 
aliquoted into a pre-chilled 15 ml polypropylene centrifuge tube. 50 ng of HGD 
plasmid was added to the tube containing the competent cells and the contents 
swirled gently. The transformation reaction was incubated on ice for 30 minutes and 
then heat-pulsed at 42 °C for 20 seconds and incubated for a further 2 minutes on ice. 
0.9 ml pre-heated NZY
+
 broth was added to the transformation reaction and the 
mixture was incubated at 37 °C with shaking at 250 RPM for 1 hour in an Innova 42 
incubator shaker (New Brunswick Scientific, USA). The transformation reaction was 
plated on a LB agar plate containing 100 μg ml
-1
 ampicillin. The plate was incubated 
overnight at 37 °C. Stocks of transformed cells were prepared by inoculating 100 ml 
LB broth containing 100 μg ml
-1
 ampicillin with 1 colony picked from the streaked 
plate using a 1 μl inoculation loop and incubating overnight at 37 °C with shaking at 
225 RPM. Cells were transferred to Nalgene cryogenic vials (ThermoScientific, 
USA) and stored at -80 °C (New Brunswick Scientific, USA).  
2.2.2 Bacterial cell culture for recombinant protein production 
LB agar plates containing 100 μg ml
-1
 ampicillin were streaked with transformed E. 
coli from frozen stocks using 1 µl clear sterile disposable inoculation loops. Streaked 
plates were incubated at 37 °C overnight. A single colony was taken from the 
streaked plate using a clear disposable 1 μl inoculation loop and used to inoculate 
100 ml of LB broth containing 100 μg ml
-1
 ampicillin. The 100 ml culture was grown 
overnight in an incubator shaker at 37 °C with shaking at 225 RPM. The 100 ml 
culture was divided between 3 large cultures flasks containing 1.2 litres of sterilised 
LB broth containing 100 μg ml
-1
 of ampicillin. The large cultures were grown at 37 
°C with shaking at 225 RPM. When the optical density at 600 nm (OD600) was 
between 0.8 and 1.0, the cultures were induced using 1 ml of 1M IPTG (C9H18O5S, 
Mw = 238.3 g mol
-1
) (Fisher Scientific, Italy) per culture. The culture was incubated 
for a further 4 to 5 hours. The cultures were then centrifuged at 6,000 RPM for 8 
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minutes in 250 ml fluorinated Nalgene HDPE bottles using a carbon fiber rotor 
(ThermoScientific, USA) in a ThermoScientific Heraeus Multifuge 3SR+ centrifuge 
to pellet the cells. The supernatant was discarded after sterilisation using a 1 % 
Virkon solution (1 Rely+On Virkon tablet (Antec International Limited) per litre of 
water). The pelleted cells were stored at -80 °C.  
2.2.3 Bacterial cell lysis   
The pelleted E. coli cells were thawed in a water bath at 30 °C. 155 mg dithiothreitol 
(DTT, Mw = 154.35 g mol
-1
) (Fisher Scientific, Japan) and 1 Roche Protease 
Inhibitor Cocktail tablet (Roche Diagnostics, USA) were added to freshly prepared 
lysis buffer (10 mls) (section 2.1.3.5) and ~0.83 ml of the lysis buffer was added to 
each bottle containing the cell pellet. The cells and lysis buffer were mixed and 
vortexed to re-suspend the cell pellet. Cells were combined, vortexed briefly and 
incubated at room temperature for 2 hours. 160 μl of a 50 mg ml
-1
 lysozyme 
(Calbiochem, Canada) solution were added to the cell suspension. The cell 
suspension was vortexed and incubated for a further 30 minutes at room temperature. 
The cell suspension was then subjected to four freeze-thaw cycles using liquid 
nitrogen and a water bath at 30 °C. 2 ml of freshly prepared solution of 1 mg ml
-1
 
deoxyribonuclease (DNase I, Bovine Pancreas, Calbiochem, South Africa) and 1 ml 
of 1 M MgSO4 were mixed together and then added to the cell suspension following 
freeze-thaw. The cell suspension was incubated at room temperature for 30 minutes 
before adjusting the pH to ~4.5 using glacial acetic acid. The cell suspension was 
centrifuged at 8,500 RPM in a ThermoScientific Heraeus 3R+ Multifuge centrifuge 
to pellet the cell debris. The supernatant containing the protein was decanted and the 
cell pellet was stored at -80 °C for further extraction if required. The supernatant was 
filtered through a 0.45 μm Millex-HV syringe driven filter before purification.  
2.2.4 Site directed mutagenesis 
Site directed mutagenesis is a molecular biology method whereby the 
deoxyribonucleic acid (DNA) sequence at a specific site (or multiple sites) is 
intentionally changed via an amino acid insertion, deletion or substitution. The 
forward and reverse oligonucleotide primers were previously designed for the Arg-
36 to Ser (R36S) single mutation of HGD (Pande, Pande et al. 2001) and were 
synthesised by Life Technologies (Ireland). These primers were used to mutate a 
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previously mutated mammalian plasmid that coded for a single mutant of HGD 
containing a Pro-23 to Thr mutation (P23T).  
Forward Primer: 5ʹ-GCA ACT CGG CGA GCG TGG ACA GCG GC-3ʹ 
Reverse Primer:  5ʹ-GCC GCT GTC CAC GCT CGC CGA GTT GC-3ʹ 
Mutagenesis was performed using a QuikChange II site-directed mutagenesis kit 
(Stratagene, USA) as per manufacturer’s instructions. Each polymerase chain 
reaction (PCR) was prepared in 0.5 ml PCR tubes (Eppendorf, Germany) and 
brought to a total volume of 50 μl with ultrapure water using the quantities in table 
2.1: 
Table 2.1: PCR components and quantities for mutagenesis. 
Component Quantity 
10X reaction buffer 5.00 μl 
dsDNA template 50 ng 
Forward primer 125 ng 
Reverse primer 125 ng 
dNTP mix 1.00 μl 




The PCR tube was briefly vortexed and centrifuged. A 
3
Prime thermal cycler (Bibby 
Scientific, UK) was used for PCR and the temperature was cycled using the 
parameters outlined in table 2.2.  
Table 2.2: PCR cycling parameters for site-directed mutagenesis of EmGFP-P23T plasmid for 
EmGFP-P23TR36S expression in HEK293T/17 cells. 
Step Cycles Temperature (°C) Time (minutes) 
1 (Preheat Lid) 1 105 2 










The PCR tube was placed on ice for 2 minutes following temperature cycling. 1 μl 
Dpn I restriction enzyme was added to the amplification reaction to digest 
methylated DNA and mixed gently by pipetting. The reaction was centrifuged for 1 
minute and incubated at 37 °C for 1 hour to digest non-mutated supercoiled dsDNA. 
The plasmid was then transformed in E. coli and amplified, purified and sequence. 
2.2.5 P23TR36S transformation and amplification 
Plasmid DNA was transformed into XL1-Blue supercompetent cells (Agilent, USA) 
as per manufacturer’s instructions. Cells were thawed on ice and 50 μl thawed cells 
were added to a pre-chilled 15 ml polypropylene centrifuge tube. 1 μl of the Dpn I 
treated DNA (section 2.2.4) was added to the centrifuge tube. The tube was then heat 
pulsed at 42 °C for 45 seconds and then placed on ice for 2 minutes. 0.5 ml NZY
+
 
(section 2.1.3.4) pre-heated to 42 °C was added to the tube. The transformation 
reaction was incubated at 37 °C for 1 hour with shaking at 250 RPM. Following this, 
the transformation reaction was divided between 2 LB agar plates containing 100 μg 
ml
-1
 ampicillin and incubated overnight at 37 °C. 
4 ml LB containing 100 μg ml
-1
 ampicillin was inoculated using a single colony from 
each of the streaked plates. The inoculated starter culture was incubated at 37 °C 
with shaking at 300 RPM for 8 hours. 25 ml LB was then inoculated with 50 μl of 
the starter culture and grown overnight at 37 °C with shaking at 300 RPM. Cells 
containing the mutated plasmid DNA were harvested by centrifugation at 6000 g at  
4 °C for purification and sequencing.  
2.2.6 Plasmid purification and sequencing 
Plasmid DNA was purified from transformed cells using a QIAGEN Plasmid 
Purification Midi Kit (Qiagen GmbH, Germany) as per manufacturer’s guidelines. 
The concentration of the DNA was determined spectroscopically using a Molecular 
Devices SpectraMax M2e spectrometer (Molecular Devices, USA) (equation 2.4): 
 260( / ) 50 /Concentration g ml A df g ml     2.4 
where A260 is the absorbance at λ = 260 nm after baseline subtraction and df is the 
dilution factor. DNA purity was determined by calculating A260/A280 and A260/A230 
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ratios (after baseline subtraction) where a ratio of ~1.8 for A260/A280 and ~2.0 for 
A260/A230 is considered pure.  
Plasmid DNA was sequenced after purification with a T7 promoter primer using an 
automated capillary DNA sequencer (Medical Research Council Protein 
Phosphorylation and Ubiquitylation Unit, University of Dundee, Scotland). 
2.3 Analytical techniques for protein purification and protein purity 
determination 
2.3.1 Chromatography  
2.3.1.1 Background 
Chromatography is most commonly used as a means of purification and consists of a 
gas or liquid mobile phase in which an analyte is dispersed and a stationary phase 
with which an analyte interacts (Whitford 2005). The change in Gibbs free energy 
can be used to describe chromatographic processes (equation 2.5) (Hong, Koza et al. 
2012). 







 are the changes in free energy, enthalpy and entropy 
respectively, T is the absolute temperature, R is the gas constant and k is a partition 
coefficient. Changes in free energy are dominated by the enthalpy of adsorption for 
most chromatographic systems (Hong, Koza et al. 2012). 
Size exclusion chromatography (SEC), also known as gel filtration 
chromatography, is a chromatographic technique whereby analytes in a mixture are 
separated based on the physical interplay between the hydrodynamic radii of each of 
the individual components in the mixture with the pore size of the stationary phase 
(Whitford 2005). Molecules that have a relatively large hydrodynamic radius elute 
from the column quicker than smaller molecules and elution time increases with 
decreasing molecule size due to the ability of the smaller molecules to penetrate the 
interstitial spaces within the column packing. SEC is athermal and adsorption is 
ideally non-existent and so ΔH
0
 is zero and equation 2.5 now becomes equation 2.6 









  2.6 
where KD is the thermodynamic retention factor for SEC determined by the 







  2.7 
where VR is the retention volume, V0 is the interstitial volume and Vi is the intra-
particle volume. KD can range in value between 0 (where the analyte is fully 
excluded due to its size) to 1 where the interstitial space is fully accessible to the 
analyte. (Hong, Koza et al. 2012).  
Ion exchange chromatography (IEX) is a chromatographic technique that separates 
molecules, including proteins, from a mixture based on the difference in net charge 
of the individual molecules (Whitford 2005). The stationary phase is a medium with 
either a positively (anion exchange) or negatively (cation exchange) charged surface 
that reversibly binds with the molecule of interest. Proteins with the same net charge 
as the medium will not be bound and will elute during the wash step.   
There are four steps in performing IEX:  
1. Equilibration 
The column media is equilibrated with buffer with the aim of maximising the 
binding of the protein of interest to the column media.   
2. Sample application and wash  
The protein mixture is loaded and the column media rinsed to remove any 
unbound proteins.  
3. Elution 
The protein of interest is eluted by varying pH and ionic strength conditions. 
As the ionic strength increases, ions in the buffer compete with the charged 
side-chains of the protein for opposite charges on the IEX media and the 
protein of interest starts to elute.  
4. Regeneration 
The pH and ionic strength is increased further across a gradient to ensure that 
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no bound protein remains adsorbed onto the IEX media. The media can then 
be re-equilibrated, as in step 1.   
High performance liquid chromatography (HPLC) is an analytical and 
preparative chromatographic technique consisting of a liquid mobile phase and a 
solid stationary phase. The basic setup of the essential components of a HPLC 
system is shown in figure 2.1.  
 
 
Figure 2.1: Schematic of flow of operations and component setup in a HPLC system. 
The mobile phase is pumped through an online degasser before being pumped 
through the stationary phase (column) at high pressure. Samples for analysis are 
introduced manually via the injection port or via the autosampler. The interaction of 
the analyte/analytes with the stationary phase depends on the property of the 
stationary phase media, the mobile phase and the analyte itself. As the analyte elutes, 
it passes over a detector which, in turn, is connected to computer software that 
converts the signal to digital format for data analysis and processing before going to 
waste or a fraction collector.   
2.3.1.2 Instrumentation 
A XK 50/100 column (SEC) (GE Healthcare Bio-Sciences AB, Sweden) and a 
XK50/60 (IEX) column were both fitted with XK50 fast flow adapters (GE 
Healthcare Bio-Sciences AB, Sweden) and connected to an AKTAprime plus 
chromatography system (GE Healthcare Bio-Sciences AB, Sweden) comprising of a 
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pump, fraction collector, absorbance and conductivity monitors and valves for 
sample injection, gradient formation and flow diversion. Real-time data were viewed 
using PrimeView 5.0 software and recorded using PrimeView Evaluation software.  
The SEC column was packed with Sephacryl S-200 High Resolution media (GE 
Healthcare Bio-Sciences AB, Sweden), a hydrophilic cross-linked allyl dextran and 
N,N’-methylene bisacrylamide co-polymer. The hydrophilic nature of the co-polymer 
minimises non-specific adsorption while the small cross-linking maximises rigidity 
and chemical stability. The narrow particle size distribution increases the resolution 
of the eluting peaks within the size range 5–250 kDa. The size exclusion column 
media was cleaned between separations of different proteins or after five separations 
of the same protein using 0.2 M NaOH in pure water and re-equilibrated using 5 
column volumes of 0.275 M sodium acetate buffer at pH 4.5. The column was 
equilibrated between runs using 5 column volumes of 0.275 M sodium acetate buffer 
pH 4.5. 
The IEX column was packed with SP Sepharose Fast Flow media (GE Healthcare 
Bio-Sciences AB, Sweden), a hydrophilic ion exchange media composed of 6% 
cross-linked agarose beads, which minimise non-specific interactions and are highly 
chemically and physically robust, with sulphopropyl (SP) strong cation exchange 
groups attached to the matrix via ether linkages. The column was regenerated by 
washing with 1 M NaOH after each use and re-equilibrating with 5 column volumes 
of 0.275 M sodium acetate buffer at pH 4.5. 
HPLC analysis was carried out using a Shimadzu CBM-20A system controller 
attached to a Shidmadzu LC-20AT solvent delivery model, DGU-20A3 on-line 
degasser, SIL-20AHT autosampler and SPD-M20A UV/Vis photodiode array 
detector. Shimadzu LC Solution software was used for real-time and post-run data 
analysis. A Superdex 200 10/300 GL size exclusion column composed of cross-




2.3.1.3 Sample preparation and elution 
2.3.1.3.1 Size exclusion chromatography 
The filtered supernatant containing protein after bacterial cell lysis was loaded onto 
the Sephacryl S-200 XK 50/100 column at a flow rate of 2 ml min
-1
. An isocratic 
elution using 0.275 M sodium acetate buffer pH 4.5 as the mobile phase and the 
parameters in table 2.3 were used. Fractions were collected in 30 ml borosilicate test 
tubes using an automated fraction collector.  
Table 2.3: Programmed method for size exclusion chromatographic separation of HGD and P23V 











1 0 2 0 
2 400 2 20 
3 2300 2 20 
4 2300 0 0 
 
The SEC column was cleaned using 0.2 M NaOH and rinsed using 0.275 M sodium 
acetate buffer at pH 4.5 after 5 separations of the same protein or after each 
separation for different proteins. 
2.3.1.3.2 Ion exchange chromatography 
Fractions from the SEC step containing protein at the correct molecular weight were 
pooled and loaded onto the equilibrated IEX column at a flow rate of 10 ml min
-1
. 
Unbound protein was eluted after loading using 0.275 M sodium acetate buffer at pH 
4.5 at 10 ml min
-1
. A gradient method that increased both the salt concentration and 
pH of the mobile phase (table 2.4 or table 2.5) was used for protein elution and 





Table 2.4: Programmed method for ion exchange chromatographic separation of HGD and P23V 
















1 0 15 10 0 
2 1060 15 10 0 
3 1061 30 10 0 
4 1380 30 10 22 
5 2904 43 10 22 
6 3049 45 10 22 
7 3470 85 10 0 
 
Table 2.5: Programmed method for ion exchange chromatographic separation of P23VR58H double 















1 0 30 10 0 
2 600 30 10 0 
3 601 30 10 22 
4 2690 43 10 22 
 
The IEX column was re-equilibrated by cleaning with 1 M NaOH at a flow rate of 10 
ml min
-1
 and rinsing with 0.275 M sodium buffer at pH 4.5. 
2.3.1.3.3 High performance liquid chromatography 
Protein samples for HPLC analysis were prepared by dialysing protein against 0.1 M 
sodium phosphate at pH 7.0 using an Amicon Ultra-4 centrifugal filter with a 10,000 
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molecular weight cut off (MWCO) (Millipore, Ireland). Typically, a concentration of 
between 1–10 mg ml
-1
 was used. Protein samples were reduced using 20 mM DTT 
and filtered through a 0.22 μm Millex-GV syringe driven filter before adding to clear 
borosilicate glass HPLC autosampler vials (Chromacol, Germany) which were then 
sealed with a cap containing a rubber septum (ThermoScientific, USA). The 
parameters used for analysis are outlined in table 2.6.  
Table 2.6: Parameters for analysis using SE-HPLC using a Superdex 200 10/300 GL size exclusion 
column. 
Stationary Phase Superdex 200 10/300 GL 
Mobile Phase 0.1 M sodium phosphate, pH 7.0 
Flow Rate 0.75 ml min
-1
 
Pressure Limit 14 bar 
Analysis Time 60 min 
Sample Volume 20 μl 
 
Sample absorbance at a wavelength of 280 nm was measured and chromatograms 
were exported as ASCII files and analysed using OriginPro 9.1 data analysis 
software. 
2.3.1.3.3.1 Calibration curve: Molecular weight 
A calibration curve (figure 2.3) was constructed to determine the relationship 
between retention time (RT) and the log of the molecular weight of the protein using 
a Superdex 200 10/300 GL size exclusion column. The molecular weight range used 
was between 10 kDa and 300 kDa. Table 2.7 indicates the proteins analysed, their 
corresponding molecular weights, retention times and peak numbers. Gamma 
globulin, bovine serum albumin (BSA), chicken serum albumin and myoglobin were 
purchased from Sigma Aldrich (USA). Lysozyme was purchased from Calbiochem 
(Canada). 
Protein samples were prepared in 0.1 M sodium phosphate buffer at pH 7.0 at 
approximately 2 mg ml
-1
 and filtered through a Millex-GV 0.22 μm syringe filter 
prior to analysis. A Superdex 200 10/300 GL size exclusion column and a flow rate 
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of 0.75 ml min
-1
 were used for analysis. The mobile phase used was 0.1 M sodium 
phosphate buffer at pH 7.0. The chromatogram (figure 2.2) was reconstructed and 
analysed and the calibration curve (figure 2.3) plotted using OriginPro 9.1 data 
analysis software.  
Table 2.7: Proteins used for Superdex 200 10/300 GL size exclusion column calibration and their 
corresponding molecular weights (MW), peak numbers and retention times (RT). 







1 Gamma Globulin (dimer) 300 2.48 10.38 
2 Gamma Globulin 150 2.18 13.58 
3 BSA (dimer) 133.4 2.13 16.33 
4 BSA 66.7 1.82 18.92 
5 Chicken Serum Albumin 44.2 1.65 20.68 
6 Myoglobin 16.7 1.22 23.17 
7 Lysozyme 14.7 1.17 25.07 
 






































































Retention Time (minutes)  
Figure 2.3: Calibration curve for protein mixture showing log10 of protein molecular weight as a 
function of retention time. 
The calibration curve (figure 2.4) was fitted with a linear fit given in equation 2.8: 
  y = 3.50 – 0.09 x 2.8 
where y is the log base 10 of the protein molecular weight in kDa and x is the 
retention time in minutes. 
2.3.1.3.3.2 Calibration curve: Protein concentration 
A calibration curve (figure 2.4) was constructed to determine the relationship 
between HGD concentration and the area under the peak after size exclusion HPLC 
analysis using a Superdex 200 10/300 GL size exclusion column and the parameters 
in table 2.6. HGD concentration was determined spectroscopically using the Beer-
Lambert law (section 2.4.2.2). A concentration range of 1 to 10 mg ml
-1
 was used.  
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Figure 2.4: Calibration curve of peak area as a function of HGD concentration. 
 
All samples were prepared using 0.1 M sodium phosphate buffer at pH 7.0 with DTT 
at a final concentration of 20 mM since HGD forms a dimer in the absence of a 
reducing agent (figure 2.5) (Pande, Pande et al. 2000).  
All samples were filtered through a Millex-GV 0.22 μm syringe driven filter 
(Millipore, Ireland) before analysis. Samples were run using a flow rate of 0.75 ml 
min
-1
 and the mobile phase was 0.1 M sodium phosphate buffer at pH 7.0. 
Chromatograms were reproduced analysed and the calibration curve constructed 
using OriginPro 9.1 data analysis software. The linear relationship between peak area 
and protein concentration is given by equation 2.9: 
 y = 22499.98 + 47393.60 x 2.9 



































Figure 2.5: SE-HPLC chromatogram showing non-reduced (black) and reduced HGD (red) at 
approximately 2 mg ml
-1
. The minor peak (first peak) arises due to the presence of HGD dimer 
(~23%). When a reducing agent is used (20 mM DTT), only one peak is observed. 
2.3.2 Polyacrylamide gel electrophoresis 
2.3.2.1 Background 
Electrophoresis refers to the movement of particles within an electric field. 
Polyacrylamide gel electrophoresis (PAGE) is used for the separation and analysis of 
biomolecules (i.e. proteins and nucleic acids) and involves the migration of a 
biomolecule through a polyacrylamide gel network as a result of an electric field 
(Whitford 2005). Native PAGE separates biomolecules on the basis of net charge and 
size. Sodium dodecyl sulphate (SDS) PAGE separates proteins on the basis of their 
molecular weights alone (Weber, Pringle et al. 1972). After denaturation (e.g. heat 
denaturation), SDS will bind to the polypeptide chain of the protein (approximately 
1.4 g SDS per gram of protein) to mask the inherent charge of the protein 
(determined by its pI) and impart a net negative charge to the protein (Whitford 
2005). A reducing agent such as β-mercaptoethanol can be used to break disulphide 
bridges between cysteine residues (Whitford 2005).  
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2.3.2.2 Preparation of running and stacking gels 
12.6% running gels were prepared using a recipe outlined in table 2.8. Components 
were mixed together and then degassed for at least 15 minutes. All buffers and 
reagents were prepared using ultrapure water. Sodium dodecyl sulphate (SDS, 
NaC12H25SO4, Mw = 288.37 g mol
-1
) was purchased from Riedel-de Haën Sigma 
Aldrich (Germany). 30% Acrylamide/Bis (37.5:1) was purchased from BioRad 
(USA). 
Table 2.8: Components and volumes required for 12.6% running polyacrylamide gel preparation. 
Component Volume (ml) 
Ultrapure water 3.15 
1 M Tris-HCl pH 8.8 2.50 
10% (w/v) SDS 0.10 
Acrylamide/Bis (30%) 4.20 
 
50 μl of freshly prepared 10% (w/v) ammonium persulphate ((NH4)2S2O8, MW = 
228.18 g mol
-1
) (Fisher Scientific, UK) and 5 μl tetramethylethylenediamine 
(TEMED, C6H16N2, MW = 116.24 g mol
-1
) were added to the degassed mixture. Gels 
were cast using a casting frame and stand designed for use with a short glass plate 
and a spacer plate with a 1 mm spacer (all purchased from BioRad, USA). Tert-amyl 
alcohol (~200 μl) was added to the top of the gels to extrude any air bubbles. Gels 
were set for at least 30 minutes and rinsed with ultrapure water before casting the 
stacking gel. 4% stacking gels were prepared as per table 2.9. The components were 
mixed together and degassed for at least 15 minutes.  
Table 2.9: Components and volumes required for 4% stacking polyacrylamide gel preparation. 
Component Volume (ml) 
Ultrapure water 3.05 
0.5 M Tris-HCl pH 6.8 1.25 
10% (w/v) SDS 0.05 
Acrylamide/Bis (30%) 0.65 
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25 μl of freshly prepared 10% (w/v) ammonium persulphate and 5 μl TEMED were 
added to the degassed mixture. The stacking gel was set for at least 30 minutes 
before use.   
2.3.2.3 Preparation of sample buffer 
Stock sample buffer was prepared using the recipe outlined in table 2.10. Glycerol 
was purchased from Sigma Aldrich (USA). Bromophenol blue was purchased from 
Riedel-de Haën Sigma Aldrich (Germany). 
Table 2.10: Components and volumes required for stock sample buffer preparation. 
Component Volume (ml) 
Ultrapure water 4.8 
0.5 M Tris-HCl pH 6.8 1.2 
Glycerol 1.0 
10% (w/v) SDS 2.0 
0.1% (w/v) bromophenol blue 0.5 
 
Reducing sample buffer was prepared immediately before use using 475 μl of the 
stock sample buffer and 25 μl β-mercaptoethanol (Sigma Aldrich, Belgium). 
2.3.2.4 Preparation of molecular weight standards 
 SDS-PAGE Molecular Weight Standards, Low Range (figure 2.6) were purchased 
from BioRad (USA). 7 μl aliquots were prepared by diluting the standards 1:20 with 
the stock sample buffer and stored at -18 °C. Prepared standards were heated at ~95 
°C for approximately 5 minutes, cooled and briefly centrifuged before loading. 5 μl 




Figure 2.6: Low range molecular weight markers and their molecular weights run on a 12.6% SDS 
polyacrylamide gel stained with Coomassie R-250. 
2.3.2.5 Preparation of destaining solution 
Destaining solution was prepared by mixing ultrapure water, methanol (Sigma 
Aldrich, UK) and acetic acid respectively in a 60:30:10 (v/v) ratio. 
2.3.2.6 Preparation of protein samples for SDS-PAGE analysis 
Protein samples for SDS-PAGE analysis were prepared by dialysing protein against 
0.1 M sodium phosphate buffer at pH 7.0 in an Amicon-4 Ultra centrifugal device 
and then mixing with sample buffer. Samples were prepared to yield 2–10 μg of 
protein per well with each well having a maximum loading capacity of 30 μl. 
Samples were heated at ~95 °C for approximately 5 minutes, cooled and briefly 
centrifuged before loading.   
2.3.2.7 Running SDS-PAGE and analysis 
SDS-PAGE gels were run using a Mini-PROTEAN Tetra Cell electrophoresis 
system (BioRad, USA) connected to an external power source. 1X Tris/glycine/SDS 
running buffer was prepared by diluting 10X pre-mixed Tris/glycine/SDS buffer 
(BioRad, USA) with ultrapure water. Protein samples were carefully pipetted into the 
wells. Empty wells were filled with sample buffer. Gels were run at 200 V until the 
dye front was ~1 cm from the bottom of the gel. Gels were stained using Coomassie 
Brilliant Blue R-250 (BioRad, USA) for at least 1 hour, destained using destaining 
solution and stored in 5% (v/v) acetic acid. Gels were imaged using an Epson 
Perfection V300 Photo scanner and Epson Scan software.  
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2.4 Protein characterisation 
2.4.1 Mass spectrometry 
2.4.1.1 Background 
Mass spectrometry (MS) is a technique used for molecular weight determination 
based on the ratio of mass to charge (m/z) in a sample (Whitford 2005). There are 
several types of MS available but all include an ion source, an analyser and a 
detector and follow a basic operational setup whereby samples are loaded and 
ionised by the ion source (Whitford 2005). Ionised molecules are accelerated through 
an electric and/or magnetic field generated by the analyser which deflect the path 
based on their m/z ratio. The deflected ions are then detected by the detector which, 
in turn, is connected to computer software that converts the signal to digital format 
for data processing and analysis. Additional processes are sometimes used prior to or 
in tandem with MS for enhanced analysis. 
2.4.1.2 Sample preparation 
Protein samples for molecular weight confirmation were analysed using liquid 
chromatography electrospray ionisation quadrupole time of flight-MS 
(LC-ESI-Q-TOF-MS) analysis. Samples were prepared at a concentration of 0.5 mg 
ml
-1
 by exhaustively dialysing against 0.1 M sodium phosphate buffer at pH 7.0 in an 
Amicon-4 Ultra centrifugal filter and filtered through a 0.22 μm Millex-GV syringe 
driven filter prior to analysis. MS analysis was carried out in ‘FingerPrints’ 
Proteomics Facility, Post-Genomics and Molecular Interactions Centre, College of 
Life Sciences, University of Dundee, Scotland, UK.  
2.4.2 Spectroscopy 
2.4.2.1 Theory 
Frequency and wavelength are related to the speed of light as per equation 2.10: 
 
 
c   2.10 
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, λ is the wavelength in m and 
ν is the frequency in s
-1
 or Hz. The energy associated with a photon of light is related 
to frequency as per equation 2.11: 
 ( )cE h h

   2.11 
where E is the energy of the photon in J, h is Planck’s constant equal to 6.63 x 10
-34
 J 
s, ν is the frequency in s
-1 





λ is the wavelength in m.  
Spectroscopy is the measurement of the interaction of electromagnetic (EM) 
radiation with matter and can be used for analysing protein structure.  
2.4.2.2 UV/Vis absorbance spectroscopy 
Proteins absorb light in the UV/Vis region of the EM spectrum as a result of their 
aromatic side chains (mainly Tyr and Trp and, to lesser extent, Phe) and also due to 
the peptide bond. These amino acids absorb in the “near-UV” (i.e. 240–300 nm). 
Disulphide bonds also absorb light in this region at a wavelength of around 260 nm. 
The peptide bond between amino acid residues absorbs light in the far-UV 
wavelength region (i.e. 180–230 nm) (Schmid 2001). 
Protein concentration in mg ml
-1
 or M can be determined spectroscopically using the 
Beer-Lambert Law (equation 2.12). 
 A cl  2.12 
where A is the absorbance at λ = 280 nm, ε is the extinction coefficient (a term 









for a given protein, c is the concentration in mg ml
-1
 or M and l is the path-
length in cm.  
 An extinction coefficient of ε = 2.09 mg-1 ml cm-1 (Wang, Lomakin et al. 2010) or  




2.4.2.3 Second derivative UV/Vis absorbance spectroscopy 
2.4.2.3.1 Background 
Derivative spectroscopy was used to analyse the broad absorbance peak arising 
between 240 and 300 nm. Since this peak is a result of light absorbed by Phe (weakly 
absorbs at wavelengths of between 245 to 270 nm), Tyr (265 to 285 nm) and Trp  
(265 to 295 nm)  (Kueltzo, Ersoy et al. 2003), the second derivative of the 
absorbance spectrum can be used to extract data from the broad peak to provide 
information on each of the aromatic residues and, consequently, information about 
the secondary and the tertiary structure of the protein.  
Absorbance (A) is expressed as a function of wavelength (λ) (equation 2.13).  The 
first order derivative is given in equation 2.16 and the second order derivative is 
given in equation 2.15.   
Zero Order A = f (λ)  2.13 
First Order '( )dA fd


  2.14 
Second Order 
2





  2.15 
The signal-to-noise ratio (S/N) of the spectral data decrease with successive 
differentiations. To increase S/N without significantly distorting the spectral data 
after differentiation, the spectral data are smoothed using a Savitzky-Golay filter 
(polynomial order = 2, window size = 5). This method of averaging preserves the 
integrity of the data by performing a local polynomial regression to produce a 
smoothed value for each data point.  
2.4.2.3.2 Sample preparation and analysis 
Protein samples for second derivative UV/Vis spectroscopic analysis were prepared 
at a concentration of 0.1 mg ml
-1
 by exhaustively dialysing against 0.1 M sodium 
phosphate buffer at pH 7.0 in an Amicon-4 Ultra centrifugal filter and filtered 
through a 0.22 μm Millex-GV syringe driven filter prior to analysis. Samples were 
recorded using a Perkin Elmer Lambda 35 UV/Vis spectrometer and UV WinLab 
Scan Lambda 35 software. A scan rate of 240 nm min
-1
 in data intervals of 0.1 nm 
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for a wavelength range between 250–320 nm and was used for analysis. Spectra were 
plotted and analysed using OriginPro 9.1 data analysis software.  
2.4.2.4 Circular dichroism spectroscopy 
2.4.2.4.1 Background 
Circular dichroism (CD) is a spectroscopic method for assessing both the secondary 
and tertiary structures of a protein. CD refers to a differential in the absorption of 
clockwise (right-handed, R) and anticlockwise (left-handed, L) circularly polarised 
light by a chiral (optically active) molecule (Kelly, Jess et al. 2005). All amino acids 
with the exception of glycine are chiral molecules; thus, proteins are inherently 
optically active.   
Spectral data arising from CD are plotted as dichroism (also reported as ellipicity in 
degrees) as a function of wavelength. The near-UV CD spectrum ranges between 
320–260 nm and is representative of protein tertiary structure since the aromatic 
amino acids (i.e. Trp, Tyr and Phe) absorb in this region (Kelly and Price 2000; 
Kelly, Jess et al. 2005). Disulphide bonds also have weak absorption bands around 
260 nm (Kelly, Jess et al. 2005). The far-UV CD spectrum which ranges between 
240–180 nm corresponds to peptide bond absorption and provides information on 
protein secondary structure features (i.e. α-helices and β-sheets) (Kelly and Price 
2000; Kelly, Jess et al. 2005).  
2.4.2.4.2 Sample preparation and analysis 
Protein samples for near and far ultraviolet (UV) circular dichroism (CD) 
spectroscopic analysis were prepared at a concentration of 0.1 mg ml
-1
 by 
exhaustively dialysing against 0.1 M sodium phosphate buffer at pH 7.0 in an 
Amicon-4 Ultra centrifugal filter and filtered through a 0.22 μm Millex-GV syringe 
driven filter prior to analysis. Near- and far-UV CD spectra were recorded on a 
JASCO J-810 spectropolarimeter (Institute of Molecular, Cell and Systems Biology, 
College of Medical, Veterinary and Life Sciences, University of Glasgow, Scotland, 
UK) using 0.1 M sodium phosphate buffer at pH 7.0 as a reference. CD spectral data 
were plotted using OriginPro 9.1 data analysis software.  
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2.5 Chemical modification: Fluorescent labelling 
HGD was chemically modified at two different sites using two different dyes with 
similar molecular weights and photo-physical properties. HGD was also labelled 
using FITC which interacts with different amino acid side-groups on the protein 
surface. 
2.5.1 Lysine modification 
The ε-amino group of Lys-2, which is a primary amine, was chemically modified 




 405 Microscale Protein Labelling 
Kit (Eurogentec, USA)). The succinimidyl ester of the dye selectively reacts with the 
aliphatic amine in Lys to form a stable carboxamide bond (figure 2.7).   
 
Figure 2.7: Labelling the primary amine of Lys-2 with the succinimidyl ester of the dye. 
HGD (Mw = 20 608 Da) was dialysed against 0.1 M sodium phosphate buffer pH 7.0 
without sodium azide (since the fluorescent dye would react with the azide) and used 
at a concentration of 11 mg ml
-1
. The pH of the protein solution was adjusted for 
optimal Lys modification using supplied reaction buffer (Component B) of the kit at 
a 1:10 Component B:HGD ratio. 10 μl of dimethylsulphoxide (DMSO, C2H6SO, Mw 
= 78.13 g mol
-1
) (Component D) was added to a vial of dye and contents vortexed. 
~40 μl of HGD at 10 mg ml
-1
 was added to dye. The mixture was reacted for at least 
1 hour with gentle mixing. The excess dye was removed using a spin column 
(Component C) and the dyed protein collected in a collection tube (Component G). 
Further purification of the dye-protein conjugate was done using an Amicon Ultra-4 
centrifugal filter and exhaustively dialysing against 0.1 M sodium phosphate at pH 
7.0. Exhaustive dialysis was required to ensure no unbound dye remained in solution. 
The fluorescence intensity of the filtrate was analysed using a Molecular Devices 
Spectra Max spectrofluorometer and Soft Max software by exciting at λex = 404 nm 
and measuring emission at λem = 428 nm. The degree of substitution (DOS) 
(Equation 2.18) was calculated using the molar concentration of the dye (equation 
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2.16) and protein (equation 2.17). The labelled protein was stored at 4 °C. Molar 








  2.16. 
where Amax is the absorbance at λ = 404 nm and εfluor is the molar extinction 
coefficient for HiLyte Fluor
TM
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  2.17 
where Amax is the absorbance at λ = 404 nm and εHGD is the molar extinction 




. 0.85 is a correction factor for the dye 
to correct for the contribution of the dye to absorption at λ = 280 nm. The degree of 






  2.18 
2.5.2 Thiol modification 
The thiol group of Cys-110 was chemically modified using a fluorescent dye 
(DyLight 405 Maleimide) (ThermoScientific, USA). The maleimide group of the dye 
reacts predominantly with the reduced thiol group of a cysteine to form a stable 
thioether bond (figure 2.8). 
 
Figure 2.8: Fluorescent labelling of the thiol group of Cys-110 via conjugation with the maleimide 
group of the dye to form a thioether bond. 
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HGD was dialysed against reducing buffer (section 2.1.2.1) and concentrated to 10 
mg ml
-1
 before adding 1 ml of this to one vial (6 mg) of 2-Mercaptoethylamine.HCl 
(2-MEA, Pierce Biotechnology, Rockford, IL, USA). The contents of the vial were 
mixed by gentle inversion and incubated at 37 °C for 90 minutes. After cooling the 
reduced HGD and 2-MEA solution to room temperature, 2-MEA was removed using 
a Dextran Desalting Column (Pierce Biotechnology, USA). The fluorescent dye was 
dissolved in 100 μl dimethyl fumarate (DMF) (Romil, UK). The tube was then 
vortexed for 30 seconds and incubated at room temperature for 5 minutes. The dye 
solution was then gently pipetted to dissolve contents completely. 80 μl of the dye 
was added to the reduced HGD solution and mixed. The dye-protein mixture was 
incubated overnight at room temperature with gentle shaking. Unreacted dye was 
removed from the solution by exhaustive dialysis against 0.1 M sodium phosphate 
buffer at pH 7.0 using an Amicon Ultra-4 centrifugal filter. The fluorescent activity 
of the filtrate was analysed using a Molecular Devices Spectra Max spectrometer and 
Soft Max software by exciting at λex = 400 nm and measuring emission at λem = 420 
nm. The Degree of Substitution (DOS) (equation 2.20) was determined using the 
molar concentration of the protein (equation 2.19) as outlined below: 
Molar concentration of the protein: 
 






   2.19 
 max
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where A280 is the absorbance at λ = 280 nm, Amax is the absorbance at λ = 404 nm, 
0.564 is a correction factor for the dye, εHGD is the molar extinction coefficient for 




 and εfluor is the extinction coefficient of the DyLight 





2.5.3 Modification with FITC  
Fluorescein isothiocyanate (FITC, MW = 389.38 g mol
-1
, ThermoScientific, USA) 
can form stable conjugates with both primary and secondary amines and was used to 
non-selectively fluorescently label HGD (figure 2.9). FITC was dissolved in DMF at 
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a concentration of 10 mg ml
-1
. HGD was exhaustively dialysed against 50 mM 
sodium borate buffer at pH 8.5 (section 2.1.3) before conjugation. A 50 μl solution of 
FITC in DMF (10 mg ml
-1
) was added to 1 ml of HGD at 3 mg ml
-1
. Unreacted FITC 
was removed with by exhaustively dialysing against 0.1 M sodium phosphate buffer 
at pH 7.0. This was monitored by analysing the fluorescent activity of the filtrate 
using an excitation and emission wavelengths equal to 494 nm and 518 nm 
respectively. 
 
Figure 2.9: Labelling the primary (a) and secondary (b) amines in HGD with FITC  
to form a thiourea bond. 
The Degree of Substitution (DOS) (equation 2.22) was determined using the molar 
concentration of the protein (equation 2.21) as outlined below: 
Molar concentration of the protein: 
 


















where A280 is the absorbance at λ = 280 nm, Amax is the absorbance at λ = 494 nm, 
0.300 is a correction factor for the dye, εHGD is the molar extinction coefficient for 




 and εfluor is the extinction coefficient of FITC dye 





2.6 Chemical modification: Biotinylation 
2.6.1 Lysine modification 
The primary amine of Lys-2 in HGD was chemically modified with EZ-Link NHS-
PEG4-Biotin packaged in vials containing 2 mg of the label (Pierce Biotechnology, 
USA). The NHS ester moiety (N-Hydroxysuccinimde) attached to the PEGylated 
biotin reacts specifically with primary amines to form a stable carboxamide bond 
with release of the NHS (figure 2.10).  
 
Figure 2.10: Labelling the primary amine of Lys-2 with the succinimidyl ester of PEGylated biotin. 
HGD was dialysed against 0.1 M sodium phosphate at pH 8.0 without sodium azide. 
The biotin was dissolved immediately before use in 170 μl 0.1 M sodium phosphate 
buffer pH 7.0 (also without azide) and mixed with 1 ml of HGD at 10 mg ml
-1
. The 
reaction was incubated overnight at room temperature. Excess unreacted biotin was 
removed by exhaustively dialysing the modified HGD against 0.1 M sodium 
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phosphate buffer at pH 7.0. The degree of substitution was quantified using a 
Fluorescence Biotin Quantification Kit (Pierce Biotechnology, USA) (section 2.6.3). 
2.6.2. Thiol modification 
The thiol group of Cys-110 in HGD was chemically modified with EZ-Link-
Maleimide-PEG2-Biotin packaged in vials containing 2 mg of the label (Pierce 
Biotechnology, USA). The maleimide group of the PEGylated biotin reacts 
specifically with reduced thiol groups at pH 6.5–7.5 to form a stable thioether bond 
(figure 2.11).   
Figure 2.11: Labelling the thiol group of Cys-110 with the succinimidyl ester of the dye. 
HGD was dialysed against reducing buffer (section 2.1.2.1) and 1 ml of a 10 mg ml
-1
 
solution was added to one vial (6 mg) of 2-MEA. The contents of the vial were 
mixed by gentle inversion to dissolve and incubated at 37 °C for 90 minutes. The 
reduced HGD and 2-MEA solution was cooled to room temperature and the 2-MEA 
was removed using a Dextran Desalting Column. Biotin was dissolved immediately 
before use in 190 μl of a 0.1 M sodium phosphate buffer pH 7.0 and then added to 1 
ml of HGD at 10 mg ml
-1
. The reaction was incubated at room temperature 
overnight. Excess unreacted biotin was removed by exhaustively dialysing the 
modified HGD against 0.1 M sodium phosphate buffer at pH 7.0. The degree of 




2.6.3 Biotinylation efficiency determination 
The biotinylated protein was quantified using a Pierce Fluorescence Quantitation Kit 
(Pierce Biotechnology, USA) as per manufacturer’s guidelines. The standards were 
made up as per the following table using the 1 mM Biocytin Control (supplied) and 
the 1X PBS. By comparing the fluorescence intensity of the Biocytin Control with 
the fluorescence intensity of the biotinylated protein after assaying, it is possible to 
quantify the amount of biotinylated protein. 
Table 2.11: Biocytin standard preparation for biotin quantification. 
Vial 1X PBS volume  
(μl) 
Volume & Biocytin Source 
(μl) 





5 μl of Biocytin Control  
(Vial A) 
100 
B 20 80 μl Vial A 80 
C 40 60 μl Vial A 60 
D 60 40 μl Vial A 40 
E 80 20 μl Vial A 20 
F 90 10 μl Vial A 10 
G 95 5 μl Vial A 5 
H 100 0 μl Vial A 0 (Blank) 
  
The DyLight Reporter Working Reagent (DWR) (supplied) was prepared at a 1:14 
dilution by mixing 170 μl of the DWR with 2.38 ml 1X PBS. The standards and 
samples were analysed in triplicate by pipetting 10 μl of each standard and sample 
into a Nunc 96 black polypropylene MicroWell plate. 90 μl of DWR was added to 
each well containing the sample or the standard. The plate was covered and 
incubated at room temperature for 5 minutes. Fluorescence was analysed using 
excitation and emission wavelengths of 494 nm and 520 nm respectively. A standard 
curve was constructed of average relative fluorescence intensity as a function of 
Biocytin Control concentration within the linear range (10–60 pmol biocytin 10 μl
-1
) 





was calculated by substituting the average relative fluorescence intensity of 
the samples for y in the linear equation (y = mx + c, where y is the fluorescence 
intensity in AU, x is the Biocytin Control concentration in pmol 10 μl
-1
 and c is the y-
intercept). HGD concentration in pmol 10 μl
-1
 was calculated spectroscopically as 










  2.23 
2.7 Liquid-liquid phase separation measurements 
2.7.1 Protein sample preparation 
Protein samples were prepared for liquid-liquid phase separation (coexistence curve) 
measurement by dialysing protein against 0.1 M sodium phosphate buffer at pH 7.0 
and concentrating using an Amicon Ultra-4 centrifugal filter. Protein was then 
centrifuged at 15,000 RPM using a ThermoScientific Heraseus 3R+ temperature 
controlled centrifuge to pellet any large aggregates and the concentration of the 
supernatant was calculated. DTT was then added to a concentration of 20 mM. 
2.7.2 Liquid-liquid phase boundary measurement 
The liquid-liquid phase boundary (coexistence curve) for native HGD was measured 
using the same method as described previously (Broide et al., 1991, Asherie, 2004). 
A protein sample of known concentration was pipetted into a cuvette and placed in 
Perkin Elmer Lambda 35 UV/Vis spectrophotometer operated using UV Win Lab-
Timedrive Lambda 35 software. The percentage transmission (%T) of the sample 
was recorded at λ = 600 nm. The temperature of the system was controlled by an 
external thermostated water bath (ThermoScientific DC10-K10) and the temperature 
in the sample was monitored using an Omega HH509R thermocouple. As the protein 
solution was cooled, the temperature at which the intensity of transmitted light fell to 
half its initial value was taken as the clouding temperature (Tcloud). Once the 
transmitted intensity reached zero, the protein solution was warmed and the 
temperature at which the intensity of transmitted light returned to half of its initial 
value was defined as the clearing temperature (Tclear). The phase separation (Tph) 
temperatures were calculated as the average of Tcloud and Tclear. The error value for 
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each point is taken as plus or minus the half the difference between Tcloud and Tclear. 
Values for Tph (including error bars) were plotted as a function of protein 
concentrations. Coexistence curves were plotted using OriginPro 9.1 software.  
2.7.3 Chemically modified protein partitioning analysis 
A protein solution containing a mixture of modified and native protein at a known 
volume, concentration and modified protein fraction was centrifuged at 3,000 RPM 
in a ThermoScientific Heraseus 3R+ temperature controlled centrifuge at a 
temperature well below the phase separation temperature for 3 hours to 
macroscopically separate the dense and dilute protein phases. A volume of protein 
was pipetted from each phase and diluted appropriately to measure the protein and 
dye concentrations respectively. To quantify the protein modified with a fluorescent 
label in each phase, fluorescence intensity measurements were taken for protein in 
both phases; the relative proportions in each phase were then determined. For protein 
mixtures containing the protein modified with PEGylated biotin, the Pierce 
Fluorescence Biotin Quantitation kit was used as before to quantify the amount of 
labelled protein in each phase.   
2.8 Coverslip surface conditions for determining surface effect on 
protein aggregation 
The temperature induced assembly of a HGD double mutant (P23VR58H) was 
monitored in a chamber mounted on a microscope slide. A number of different 
surface treatments were used on the glass surface. Protein samples were prepared by 
dialysing against 0.1 M sodium phosphate buffer at pH 7.0 and concentrated using an 
Amicon Ultra-4 centrifugal filter. Care was taken when preparing the P23VR58H 
double mutant protein to keep the temperature at 4 °C to avoid any premature 
aggregate formation since P23VR58H mutants can form aggregates spontaneously at 
room temperature. P23VR58H was used at a concentration of 10 mg ml
-1
. DTT was 
added to protein sample to a final concentration of 20 mM. All samples were filtered 
using a 0.22 μm Millex-GV syringe driven filter prior to analysis and the protein 
sample was introduced to the chambers for imaging using a pipette. Chambers for 
monitoring assembly in solution were constructed using silicone spacers (cut using a 
cork borer of known outer diameter) and borosilicate coverslips (22 mm x 22 mm) 
(Menzel Glaser, Germany).  
71 
 
2.8.1 Piranha cleaning coverslip surface 
Piranha solution was prepared using equal parts 96% sulphuric acid (H2SO4, Mw = 
98.08 g mol
-1
) (Acros Organics, Belgium) and 30% hydrogen peroxide (H2O2, Mw = 
34.01 g mol
-1
) (Acros Organics, Germany) in a fumehood. 22 mm x 22 mm 
coverslips purchased from Fisher Scientific (UK) were placed in piranha solution for 
20 minutes. The coverslips were then rinsed by placing them in ultrapure water for 
20 minutes, then transferring to fresh ultrapure water for a further 20 minutes and 
then rinsed under a stream of ultrapure water for 30 seconds on each side. Coverslips 
were air dried overnight before use. 
2.8.2 Poly-D-lysine coated coverslips 
Dry coverslips cleaned with piranha solution were coated with a dilute (15 ng ml
-1
) 
solution of poly-D-lysine (PDL) (Sigma Aldrich, USA) by pipetting 300 μl PDL onto 
a glass coverslip (typically 22 mm x 22 mm) and incubating at room temperature for 
1 hour. Following this, the PDL solution was aspirated and the coated side was 
rinsed under a stream of ultrapure water for 30 seconds. Rinsed coverslips were air-
dried fully before use.  
2.8.3 PEGylating coverslips  
Coverslips were PEGylated using a modified version of a published protocol 
(Chandradoss, Haagsma et al. 2014). Coverslips were cleaned with piranha solution. 
Following cleaning, the coverslips were PEGylated as per the protocol. 
Methoxypolyethylene glycol succinimidyl carbonate ester (mPEG-NHS(SC)) 5,000 
and biotin PEG NHS 5,000 were purchased from Nanocs (USA). MS(PEG)4 was 
dissolved in DMSO and purchased from ThermoScientific (USA). 3-aminopropyl 
trimethoxysilane (APTES) was purchased from Sigma Aldrich (Belgium). Sodium 
bicarbonate (NaHCO3, Mw = 84.01 g mol
-1
) was purchased from Sigma Aldrich 
(Germany). The PEGylated coverslips were rinsed under a stream of ultrapure water 
for 30 seconds and air dried overnight before use.  
2.8.4 Silanising coverslips  
Dry coverslips cleaned with piranha solution were silanised using a protocol 
previously reported (Seed 2001). After cleaning with piranha solution, 200 μl of 99% 
dicholrodimethylsilane (Lancaster, England) was pipetted onto each coverslip. 
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Coverslips were then placed under vacuum in a dessicator for three hours. After this 
time, the silanised coverslips were washed thoroughly with detergent to remove 
residue, rinsed thoroughly with ultrapure water and air dried before use.  
2.8.5 Design and construction of chamber for aggregation study 
A frame was designed and drawn using SketchUp 2016 to house the chamber for 
monitoring aggregation. This was 3D printed using a Form 2 3D printer (Form Labs, 
USA) and a white photopolymer resin (which is rigid after curing).  
 
Figure 2.12: Plan (top) and cross-section (bottom) view of 3D printed holder. 
  Chambers for monitoring aggregation were assembled as follows: 
1. A coverslip was placed in the frame. If a functionalised coverslip was used, 
the functionalised side was placed facing up.  
2. A clean dry silicone spacer with a chamber of known dimensions (cut from 
silicone thermal pad) of desired thickness (0.5 mm or 1 mm) and chamber 
diameter (cut using a cork borer of known outer diameter) was placed on top 
and gently pressed to create a seal between the coverslip and spacer (figure 
2.13A). If the frame was not used, a small piece of Blu Tack (a pressure 
sensitive adhesive putty material) was placed in each corner of the coverslip 
to ensure that there was no slippage.  
3. The protein solution was added and another coverslip was placed on top 
(functionalised side facing down) and pressed gently to seal. A chamber to 
record temperature on the slide was assembled the same way but a narrow 
channel was cut in the silicone spacer first to accommodate a thermocouple 











Figure 2.13: Plan view of chamber for aggregation study (A) and temperature recording (B) and 
cross-section view of chamber with a top and bottom coverslip (C).  
2.9 Mammalian cell culture  
Mammalian cell culture was carried out under aseptic conditions using a SafeFAST 
Classic 212 biological safety cabinet (Faster S.r.l., Italy) and 70% ethanol as a 
disinfectant. HEK293T/17 cells (LGC, UK) were grown in a Memmert INCO 153 
CO2 incubator (Germany) under 5% CO2 and 90% relative humidity at 37 °C. 
2.9.1 Initiating cell culture from frozen stocks 
A cryogenic vial containing frozen cells was thawed in a water bath at 37 °C for ~2 
minutes before being transferred to a biological safety cabinet. The vial contents 
were transferred to a sterile 15 ml centrifuge tube containing 10 ml of pre-warmed 
complete growth medium (CGM). The tube was centrifuged at 125 g for 7 minutes to 
pellet cells. The supernatant was removed and cells were re-suspended in 7 ml pre-
warmed CGM before transferring to a T25 cell culture flask. CGM was replaced 
every 2–3 days with fresh CGM until cells reached ~90% confluency, after which the 
cells were subcultured (or passaged) (section 2.9.2).  
2.9.2 Subculturing cells 
Cells were subcultured (or passaged) when ~90% confluency was reached. The 
following protocol applies to a culture grown in a T25 cell culture flask. CGM was 
removed from the flask and cells were washed with 7 ml pre-warmed 1X PBS. After 
washing, the PBS was discarded and 3 ml 1X trypsin-EDTA solution (section 
2.1.4.3) was added to the flask to detach cells. The flask was incubated at 37 °C, 5% 
CO2 and 90% relative humidity for up to 10 minutes. After this time, 7 ml CGM was 
added to the flask. Cells were harvested by gently aspirating medium to dislodge 
cells from the wall of the flask. Cells were added to a sterile 15 ml centrifuge tube 
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and centrifuged at 125 g for 10 minutes. The supernatant was discarded and cells 
were re-suspended in CGM before counting and calculating cell viability. Cells were 





2.9.3 Cell counting and cell viability determination 
Cells were counted using a Bright-Line hemacytometer (Hausser Scientific, USA).  
Cell viability was assessed using Trypan Blue 0.4 % solution (Sigma Aldrich, USA). 
Viable cells do not absorb Trypan Blue and appear white. Dead cells appear blue as 
the dye can traverse the cell membrane.   
2.9.4 Cryopreservation of cells 
Cell stocks (1 ml aliquots) were prepared by seeding cells in T75 cell culture flasks 
(Corning, USA) and harvesting. Following centrifugation, cells were re-suspended in 
cryopreservation medium, aliquoted in Nalgene cryogenic vials (ThermoScientific, 
USA) and frozen at a density of 3 x 106 cells ml-1. The vials were frozen in a 
stepwise manner by cooling to 4 °C for 5 minutes, then to-20 °C for 1 hour followed 
by -80 °C for 1 hour before placing in a liquid nitrogen cryopreservation tank for 
long-term storage. 
2.9.5 Protein expression in HEK293T/17 cell line 
Emerald Green Fluorescent Protein (EmGFP), with a blasticidin resistant gene, was 
used as an expression control vector in HEK293T/17 mammalian cells. A 
mammalian expression vector containing the sequence of a fusion protein, EmGFP-
HGD, was designed and the vector was synthesized by GeneArt (ThermoFisher, 
GeneArt Division, Germany). The mammalian vector pc-DNA6.2_C-EmGFP-DEST 
was used and the HGD gene was inserted at the C-terminus. A double mutant of 
EmGFP-HGD (P23TR36S) was obtained by site directed mutagenesis of the HGD 
mammalian vector and expressed in the HEK 293T/17 cell line. Insertion of the 
correct mutation was confirmed by DNA sequencing. 
The insertion of genetic material into a mammalian cell by non-viral methods is 
known as transfection. HEK293T/17 mammalian cells were transfected with 
EmGFP-P23TR36S. Low passage cells (< 30 passages) that had not exceeded 90% 
confluency at any passage were transfected. Lipofectamine 2000 transfection reagent 
(Invitrogen, USA) is a cationic liposome based reagent and was used for transfecting 
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HEK293T/17 cells with the desired plasmid DNA. Nucleic acids are negatively 
charged at physiological pH and complex with the positively charged Lipofectamine 
2000 reagent, thus allowing uptake by the negatively charged cell membrane by 
overcoming electrostatic repulsion (Dalby, Cates et al. 2004).  
Cells for transfection were grown on cell culture coverslips that had either 4 or 8 
removable wells (Eppendorf, Germany). Coverslips were coated with PDL by adding 
either 0.5 ml (4 well) or 0.25 ml (8 well) PDL at 0.1 mg ml
-1
 to each well and 
incubating at room temperature for 2 hours. Wells were rinsed with sterile ultrapure 
water following coating and dried for at least 2 hours before introducing cells. Once 
a confluency of ~70% was reached, CGM in the wells was replaced with antibiotic 
and serum-free DMEM prior to transfection. Lipofectamine 2000 (5 μl 
Lipofectamine 2000 per 100 μl) and plasmid DNA (2.5 μg plasmid DNA per 100 μl) 
were separately mixed with serum-free DMEM and incubated at room temperature 
for 5 minutes. The DNA and Lipofectamine 2000 were then mixed to form the DNA-
liposome complex and incubated at room temperature for 20 minutes. 48 μl (for 4 
well) or 24 μl (for 8 well) of the DNA-liposome complex were added to the 
chambers containing the cells. After 4 hours, the medium containing the complex 
was exchanged for CGM. CGM was replenished every 2–3 days. 
2.10 Microscopy 
2.10.1 Background 
Microscopy is an invaluable tool for visualising objects at length-scales far beyond 
those perceptible by the human eye. There are three main branches of microscopy 
providing different levels of resolution: Optical microscopy (which uses transmitted 
light through a lens as a means of magnification), electron microscopy (which uses a 
beam of electrons to visualise specimens) and scanning probe microscopy (which 
uses a probe to scan the surface of the object being looked at). 
Optical microscopy has many distinct classes, such as bright field microscopy, phase 
contrast microscopy, polarization microscopy and fluorescence microscopy, all of 
which involve the visualisation of a specimen using transmitted light. Bright field 
microscopy is the simplest of these techniques and allows visualisation of a specimen 
simply by illumination. Phase contrast microscopy takes advantage of the difference 
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between the refractive indices of different visualised entities to provide higher 
contrast images than those generated using bright field microscopy. Fluorescence 
microscopy allows visualisation of specimens that are either intrinsically fluorescent 
or have a fluorescent molecule attached onto them. Fluorescence involves the 
absorption of light by an atom or molecule at one wavelength and emission of light at 
a longer wavelength (Herman 1998). A fluorescent microscope is designed to emit 
and detect photons of light for the purpose of providing spatial information to the 
user. Polarization microscopy is mainly used as a qualitative means of assessing the 
physical properties of a specimen and involves the transmission of plane polarized 
light through a birefringent material. 
2.10.2 Protein sample preparation and imaging 
The chamber containing the protein solution for monitoring aggregation (section 2.8) 
was heated to 30 °C using a heating stage and the temperature was monitored in a 
control chamber using an Omega HH509R thermocouple. The time at which the 
temperature of the chamber had equilibrated to the set temperature was taken as T0. 
Aggregates were monitored and imaged using phase contrast and polarisation 
microscopy using an Olympus BX61 upright microscope using 100X, 20X and 10X 
objective lenses. Images were analysed using Cell
F
 software.  
2.10.3 Preparation of transfected HEK293T/17 mammalian cells for 
imaging  
A set of transfected cells on PDL coated cell imaging coverslips (section 2.9.5) were 
imaged every 24 hours following transfection for a total of 96 hours. The medium 
was aspirated from the wells and the well removed before imaging. A sterile 
microscope slide was placed on top of the coverslip. Cells were imaged on a heating 
stage at 37 °C using an Olympus BX61 microscope and 100X oil-immersion or 10X 
objective lenses. Fluorescence microscopy (using an Olympus FITC fluorescent 
filter) and phase contrast microscopy were used to image cells. Images were recorded 
and processed using Cell
F
 imaging software.  
2.11 Model and simulation details 
A model was designed specifically to numerically describe the effects of chemically 
modifying HGD with a small molecule fluorescent label by Nicoletta Gnan, 
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Emanuela Zaccarelli and colleagues at the University of Rome, La Sapienza. This 
work was completed as part of a collaboration.. The model and simulation details 
outlined below is the exclusive work of our collaborators and are reproduced here 
from a publication that arose from this collaboration, which helps to explain the 
experimental work described in chapter 3 (Quinn, Gnan et al. 2015).  
2.11.1 Model for the unlabelled proteins 
Unlabelled HGD (‘U-type particles’) are modelled as patchy particles complemented 
with a square well (SW) potential. This is based on previously published models 
(Kern and Frenkel 2003; Liu, Kumar et al. 2007) that produce a coexistence curve 
with the same width as a curve experimentally produced for bovine gamma 
crystallin. Unlabelled proteins are represented as hard spheres of diameter σm 






SW ij SW m ij m SW m
if r
V r if r
otherwise











where ijr is the vector between the centres of particles i and j. The surface of the 
patchy particle has four non-overlapping randomly placed attractive patches (‘U-
patch’). This differs from the model outlined in Liu, Kumar et al. 2007 where the 
patches were arranged in a tetrahedral geometry on the surface of the particle. The 
resulting interaction potential between the patches is the product of the radial 
contribution modulated by an angular function:  
  , ˆ ˆ ˆ ˆ( , , )Uij SW U i j i j i jV V r G r r r   2.25 
where îr  and ˆjr   are the unit vectors from the centre of particle i(j) to the centre of 
the α(β) patch on the surface and the square well potential VSW,U has a width of δU,U 
and depth εU,U. The potential is modulated by function G and depends on the 
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Length and energy are given units of σm and εSW respectively. Temperature (T) is 
measured in units of εSW. Parameters for U-type particles are given in table 2.12 and 
are based on a previous model (Liu, Kumar et al. 2007). This model produces a curve 
of the correct width and critical volume fraction (ϕc = 0.21) for HGD. 
Table 2.12: Parameters of the interaction potential for unlabelled HGD,  
as given by Liu, Kumar et al. 2007. 
δU,U εU,U cos(θmax) δSW εSW 
0.05 5 0.95 0.5 1.0 
2.11.2 Model for the labelled proteins 
The small molecule fluorescent dye is modelled (L-particle) as having a fifth larger 
and more attractive patch (L-patch) to the U-type particle. The fifth patch is 
modelled as being attached to the U-type particle, as opposed to being a composite 
part of its surface, and thus can extend beyond the surface and, therefore, form bonds 
with more than one other particle. The fifth patch is forbidden from forming bonds 
with another L-patch.  
2.11.3 Evaluation of the critical points 
Umbrella sampling grand canonical Monte Carlo simulations (US-GCMC) and 
histogram reweighting were performed for accurate critical point and liquid-liquid 
coexistence curve evaluation of U-type particles (Ferrenberg and Swendsen 1988; 
Virnau and Müller 2004). At the critical point, the order parameter M has a 
probability distribution P(M) that follows the one typical of the Ising universality 
class (Nicolaides and Bruce 1988; Wilding 1997; Tsypin and Blöte 2000; Romano, 
Tartaglia et al. 2007). The parameter M = ρ + su is the linear combination of the 
number density ρ and the energy density u through the field mixing parameter s 
(Wilding 1997; Romano, Tartaglia et al. 2007; Rovigatti, Heras et al. 2013).   
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The critical point is located by tuning the temperature T and the chemical potential μ 
until the numerical joint distribution P(N, E: T, μ) projected over N shows the 
double-peaked shape that is typical of the Ising probability distribution P(M) which 
is indicative of the presence of large density fluctuations in the vicinity of the critical 
point within the system. A fitting procedure based on the histogram reweighting 
technique was implemented to transform the joint distribution P(N, E; T, μ), 
evaluated at T and μ, into P(N, E; T’, μ’), evaluated at T’ and μ’ to extract the best 
values for T’,  μ’ and s in order to find the P(M) that was closest to the Ising 
distribution (Ferrenberg and Swendsen 1988; Wilding 1997). This reweighting 
technique is also used to evaluate liquid-liquid coexistence curve. For temperatures 
lower than Tc, liquid-liquid coexistence densities are calculated by imposing the 
equality of the areas below the two peaks for the joint distribution P(N, E; T, μ) 
projected over N and centred on Nc = ρcL
3
 where ρc is the critical density and L is the 
length of the simulation box. 
The procedure for critical point evaluation in the binary mixture is similar to that for 
the pure system except a different order parameter is required.  
In this case, M = ρU + αρL where ρU(L) is the number density of the species U(L) and 
α is a mixing parameter (Rovigatti, Heras et al. 2013). As a result, the numerical joint 
distribution P(NU, NL, μU, μL) depends solely on the number of particles of the two 
species and their associated chemical potentials. Since there is no energy 
dependence, T cannot be varied when locating the critical points and so the critical 
temperature Tc is searched for for each μU and μL for a given concentration xL(U) to 
locate Tc. Thus, the specific Tc corresponding to the desired concentration of L-type 





Chapter 3:  
How fluorescent labelling alters the 




3.1 Introduction  
3.1.1 Background  
Chemical modification of proteins is a useful mechanism to label a protein for 
detection or to modify their behaviour and is currently used in a range of applications 
such as the modification of therapeutic biomolecules for improved stability and/or 
function, or in the production of novel materials in synthetic biology (Veronese 
2001; Walsh and Jefferis 2006; Sahoo 2012; Spicer and Davis 2014; Boutureira and 
Bernardes 2015). Fluorescent labelling of proteins is one of the most useful forms of 
protein chemical modification as it has allowed for the direct in situ visualisation of 
proteins. Advances in the development of specialised imaging techniques have led to 
a marked increase in resolution with microscopy and single molecule detection being 
used for studies involving protein distribution, translocation and interactions both in 
vivo and in vitro in addition to its use as a means to screen for the formation of 
protein crystals (Kasten 1999; Hillger, Nettels et al. 2007; Huang, Bates et al. 2009; 
Pusey, Barcena et al. 2015). Fluorescent labelling of proteins, coupled with either 
spectroscopy or microscopy can be used to understand the mechanisms underlying 
many biological processes such as inter/intra-cellular communication, genomics, 
protein condensation diseases and protein self-association during biotherapeutic 
production (Zhang, Campbell et al. 2002; Hillger, Nettels et al. 2007; Hawe, Sutter et 
al. 2008; Sahoo 2012). 
There are three main established strategies used to label fluorescent proteins: small 
molecule organic fluorescent labels that covalently attach to the protein of interest, 
fluorescent fusion proteins (such as GFP) that are co-expressed or fused to the 
protein of interest and quantum dots which are functionalised in order to form a 
biotin-avidin pair with the protein of interest (Tsien 1998; Zheng, Juette et al. 2014). 
Of these three established methods, fluorescent labelling via covalent attachment of a 
small molecule fluorescent dye is considered to be the most versatile (Zheng, Juette 
et al. 2014) given the relatively small sizes of the molecules used and well 




Figure 3.1: Relative size of a small molecule organic fluorescent dye (left), GFP (centre) and 
quantum dot (right) (taken from Zheng, Juette et al. 2014). 
Despite the advances being made with fluorescent imaging, little consideration has 
been given to the impact a fluorescent label has on protein solution behaviour. Yet, 
this is an important consideration when interpreting data obtained using labelled 
protein. Protein behaviour in solution is sensitive to changes in its environment, such 
as pH, and can also be considerably altered by changes to the surface of the protein, 
such as mutagenesis and specific binding of ions (Asherie 2004; Roosen-Runge, 
Zhang et al. 2014; James, Quinn et al. 2015; Li, Persson et al. 2015). It is therefore 
reasonable to expect some impact on protein solution behaviour due to a surface 
modification using a fluorescent label. Some studies have reported impacts that 
fluorescent labels can have on protein characteristics; FITC labelled BSA has been 
shown to possess an increased diffusion coefficient in addition to increased levels of 
irreversibly adsorbed proteins at the oil-water interface (Gajraj and Ofoli 2000). 
Chemically modified GFP exhibited a more acidic pI relative to its unlabelled 
counterpart (Richards, Stathakis et al. 1999). The varying effects of using different 
small molecule fluorophores on cellular function and adherence of leucocytes to 
endothelial cells has been investigated (De Clerck, Bridts et al. 1994). A study using 
monomerically labelled and mixtures of labelled and unlabelled group specific 
antigen (or ‘Gag’, a viral protein) showed the production of morphologically 
indistinguishable clusters at a lipid membrane (Gunzenhäuser, Wyss et al. 2014).  
Macromolecular interactions, including colloid and protein interactions, can be 
characterised using phase diagrams (Asherie, Lomakin et al. 1996; Sear 1999; 
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Asherie 2004; Möller, Grobelny et al. 2014). The net inter-protein interaction 
potential arises from both attractive and repulsive contributions from surface-
exposed amino acid side-chains (Lomakin, Asherie et al. 1999; James and McManus 
2012). Proteins are inherently anisotropic due to the variation in the side-chain 
chemistries of each surface-exposed amino acids and this anisotropy has been shown 
to have a direct impact on protein phase behaviour (Asherie, Lomakin et al. 1996; 
Bonneté, Finet et al. 1999; McManus, Lomakin et al. 2007; James, Quinn et al. 
2015). Liquid-liquid phase separation (LLPS) of a protein in a solution occurs for 
proteins interacting via short-ranged attractive interactions (Asherie, Lomakin et al. 
1996; Asherie 2004; Möller, Grobelny et al. 2014). The temperature at which LLPS 
occurs is sensitive to the strength of the net inter-protein attraction and can be used as 
a means of probing relative changes in inter-protein interactions as a result of altered 
protein chemistry, the introduction of a second protein type or changes in solution 
conditions (Broide, Tominc et al. 1996; Wang, Lomakin et al. 2010). As a result, 
LLPS is a phase transition that can be readily used as a means of assessing how 
fluorescent labelling affects the phase behaviour of a labelled protein relative to its 
unlabelled form.  
3.1.2 Aim of study   
The first aim of this study was to fluorescently label HGD protein using 
commercially available small molecule fluorescent labels to quantify the changes in 
phase behaviour of HGD after the addition of small amounts (≤ 1% total protein) of 
labelled protein. This was done by fluorescently labelling at two distinct sites (Lys-2 
and Cys-110, figure 3.2) on the protein surface (i.e. only one position at a time) in 
addition to using a dye with less labelling specificity. The changes in phase 
behaviour due to labelling were quantified by measuring the change in liquid-liquid 
phase separation temperature (Tph) after the addition of labelled protein. The second 





Figure 3.2: Topological rendering of HGD showing Lys-2 (green) and Cys-110 (red). 
3.2 Results  
HGD protein was produced recombinantly in E. coli and extracted and purified using 
SEC (figure 3.3) and IEX (figure 3.4). The purified protein was then characterised 
using SE-HPLC, SDS PAGE, in-tact mass spectrometry and circular dichroism 
spectroscopy. 






















Figure 3.3: Size exclusion chromatogram indicating the peak associated with HGD. 
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Figure 3.4: Ion exchange chromatogram after purifying fractions from the size exclusion step. The 
major peak contains HGD protein. Following purification, only fractions from the peak tail were 
pooled to maximise protein purity. 
SE-HPLC (figure 3.5) and reducing SDS-PAGE (figure 3.6) were used to determine 
protein purity. SE-HPLC produces one peak at 24.138 minutes. Using the calibration 
curve for this column under the same buffer conditions (section 2.3.1.3.3.1) indicates 
a molecular weight of ~21 kDa, a value consistent with the molecular weight of a 
HGD monomer found using intact ESI-MS (20 608 ±1 Da). 
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Figure3.5: SE-HPLC chromatogram for HGD prepared in 0.1 M sodium phosphate  
at pH 7.0with 20 mM DTT. 
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SDS-PAGE was also used to assess protein purity. A single clean band just below the 
21.5 kDa molecular weight marker indicated pure monomer protein (figure 3.6). 
 
Figure 3.6: 12.6% reducing SDS-PAGE gel showing a single band indicating the purity of HGD 
protein. 
3.2.1 Lysine modification 
HGD was labelled at the Lys-2 position using AnaTag HiLyte 405, a fluorescent dye 
with excitation and emission wavelengths of 404 and 428 nm respectively and a 
succinimidyl ester reactive moiety for primary amine specificity (section 2.5.1). In 
addition to the primary amine of the N-terminus group, HGD has only one other 
primary amine: a Lys in position 2 of the amino acid sequence. Careful pH control 
during labelling ensured that the ε-amino group (a primary amine) of Lys-2 was 
preferentially labelled since the pKa value of the α-amino group is different from that 
of the ε-amino group (Sélo, Négroni et al. 1996). This allowed for unambiguous 
labelling efficiency determination since a maximum of one dye molecule per protein 
was possible. After labelling, the modified HGD was used in mixtures with 
unmodified HGD at varying labelled protein fractions and the liquid-liquid 
coexistence curve for each composition was measured. Two spectroscopic 
techniques, circular dichroism (CD) and second derivative UV absorbance 
spectroscopy, were used to analyse if a structural change to the protein occurred as a 
result of fluorescent labelling. 
3.2.1.1 Phase diagram measurement 
Liquid-liquid phase boundaries were determined for mixtures of unlabelled HGD and 
amine modified HGD at varying labelled protein compositions ranging from xL = 
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0.002 – 0.01, where xL is the fraction of labelled protein (figure 3.7). The error bars 
shown indicate the temperatures recorded for Tcloud and Tclear. Fluorescently labelled 
proteins are generally used at low concentrations given the highly sensitive nature of 
fluorescence detection. Thus, the range of labelled protein compositions used here 
are comparable to those used in applications where fluorescent labelling is required.  
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Figure 3.7: Liquid-liquid coexistence curves for unlabelled HGD (black) and HGD fluorescently 
labelled at Lys-2 with labelled protein fractions of xL = 0.002 – 0.01 (green). Values for data points 
shown given in tables A1 and A2 in Appendix. 
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3.1 
where ϕ and ϕc represent the volume fraction and the critical volume fraction 
respectively, A is a parameter that determines the width of the coexistence curve, T 
and Tc are the temperature and critical temperature respectively (measured in Kelvin) 
and β is an exponent term for the three dimensional Ising model equal to 0.325 
(Broide, Berland et al. 1991). While ϕc was fixed in the estimation of Tc using 
equation 3.1, parameter A was varied. Values for Tc, ΔTc and A for each labelled 




Table 3.1: Estimated critical temperature (Tc), change in critical temperature (ΔTc) and width 
parameter (A) for each composition of HGD amine modified with HiLyte Fluor 405 at ϕc = 0.21. 
Fluorescently Labelled Protein Fraction  Tc (K) ΔTc (K) A 
xL = 0.00 277 - 2.6 
xL = 0.002 280 3 2.5 
xL = 0.006 287 10 2.2 
xL = 0.0075 297 20 1.8 
xL = 0.01 308 31 1.6 
3.2.1.2 Structural analysis 
Two complementary spectroscopic analytical methods, circular dichroism (CD) 
spectroscopy and second derivative UV absorbance spectroscopy, were used to 
assess if there was a structural change in the protein as a result of fluorescent 
labelling. Since unfolding can lead to exposure of hydrophobic amino acids in the 
protein’s interior and, consequently, an increase in the net attraction of the protein, it 
was essential to determine if a structural change was the cause of the increase in Tph.  
3.2.1.2.1 Circular dichroism spectroscopy 
Near- and far-UV CD spectroscopy were used to compare the tertiary and secondary 
structures of unlabelled HGD and fluorescently labelled HGD at the Lys-2 position. 
The spectroscopic data for near-UV CD (λ = 260 – 320 nm) arise as result of the 
aromatic amino acids, with Phe having a wavelength range of ~ 260 – 265 nm, Tyr 
having a wavelength range of ~275 – 285 nm and Tyr having a wavelength range of 
285 – 305 nm, although overlap between Tyr and Trp signals can occur (Kelly, Jess 
et al. 2005). Figure 3.8 shows the near-UV spectroscopic data for unlabelled (black) 
and amine modified (green) HGD. While the spectroscopic data for the wavelength 
ranges corresponding to Tyr and Trp are shown to be largely similar, there is a 
perturbation in the data for the wavelength region corresponding to Phe.  
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Figure 3.8: Near-UV CD spectra for unlabelled HGD (black) and amine modified HGD (green). 
There is a slight perturbation in the spectroscopic data for the wavelength range corresponding to 
Phe, indicating a localised change to the tertiary structure. 
Using Chimera software, it is possible to look at the location of amino acid residues 
found on the protein surface. On the surface of HGD, there is one Phe residue in 
proximity to Lys-2 in position 11 (figure. 3.9). An interaction between the 
fluorescent dye attached to Lys-2 and Phe at position 11 could lead to the largely 
localised change in the near-UV CD spectroscopic data of the amine modified HGD 
relative to the unlabelled HGD.  
 
Figure 3.9: Topological rendering of HGD showing Lys-2 in green and relative positions of Phe 
residues (blue).  
The far-UV CD spectroscopic data (for wavelengths of λ = 240 nm and below) arise 
due to the absorption of the peptide bond between proteins and is used to provide 
secondary structure information. From the data in figure 3.10, the secondary 
structures of unlabelled HGD and amine modified HGD are very similar. 
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 Amine Modified HGD
 
Figure 3.10: Far UV CD spectra for unlabelled HGD (black) and amine modified HGD (green) 
indicating very similar secondary structures.  
3.2.1.2.2 Second derivative UV absorbance spectroscopy 
As a complement to near-UV CD spectroscopic analysis of the unlabelled and amine 
modified HGD proteins, the second derivative of the UV-Vis absorption spectrum 
was analysed (figure. 3.11). The data indicate that a small change in the second 
derivate spectrum in the wavelength region corresponding to Phe (λ = 245 – 270 nm) 
can be seen. This observation is very consistent with the near UV CD data in the 
same wavelength region. The data for the wavelength regions corresponding to Trp 























Figure 3.11: Second derivative UV analysis of unlabelled HGD (black) and amine modified HGD 
(green). A perturbation exists in the wavelength region corresponding to Phe. This is a localised 
change given that the spectral data for higher wavelengths are very similar. 
3.2.2 Thiol modification 
HGD was also labelled at the Cys-110 position (section 2.5.2) using DyLight 405 
Maleimide, a fluorescent dye with excitation and emission wavelengths of 400 and 
420 nm respectively. These values are comparable to the excitation and emission 
wavelengths of the fluorescent dye used for amine modification of HGD at Lys-2. 
The maleimide reactive moiety ensures reduced thiol labelling specificity and reacts 
with a free thiol to form a stable thioether bond. Although HGD has six unpaired Cys 
residues, only one (in position 110) is surface exposed (Pande, Pande et al. 2000). 
Again, the sole availability of a single amino acid residue for labelling ensured 
unambiguous labelling efficiency determination since a maximum of one dye 
molecule per protein was possible. The labelled HGD was used in mixtures with 
unlabelled HGD at varying labelled protein compositions and the liquid-liquid 
coexistence curve for each composition was measured. Two spectroscopic 
techniques, CD spectroscopy and second derivative UV absorbance spectroscopy, 




3.2.2.1 Phase diagram measurement 
Liquid-liquid phase boundaries were determined for mixtures of unlabelled HGD and 
thiol modified HGD at varying labelled protein compositions ranging from  
xL = 0.0001 – 0.0002, where xL is the fraction of labelled protein (figure 3.12). Tph 
was measured as outlined in section 2.7.2 In this case, significantly lower volume 
fractions of labelled protein were used, since attempts to add higher concentrations 
led to precipitation of the protein.  
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Figure 3.12 Liquid-liquid coexistence curves for unlabelled HGD (black) and HGD fluorescently 
labelled at Cys-110 with labelled protein fractions of xL = 0.0001 and 0.0002 (red). The dashed line is 
a fit of the data when the critical volume fraction is equal to 0.21. Values for data points shown given 
in tables A1 and A3 in Appendix. 
 The liquid-liquid coexistence curves were fitted with equation 3.1 to estimate Tc for 
each labelled protein composition (table 3.3). Again, the value for ϕc (0.21) was 
fixed in the estimation of Tc for labelled proteins and parameter A was varied. 
Table 3.3: Estimated critical temperature (Tc), change in critical temperature (ΔTc) and width 
parameter (A) for each composition of HGD thiol modified with DyLight 405Maleimide at ϕc = 0.21. 
Fluorescently Labelled Protein Fraction Tc (K) ΔTc (K) A 
xL = 0.0000 277 - 2.6 
xL = 0.0001 291 14 2.1 
xL = 0.0002 301 24 1.9 
93 
 
3.2.2.2 Structural analysis 
Near- and far-UV CD spectroscopy and second derivative UV absorbance 
spectroscopy were used to determine if a structural change as a result of fluorescently 
labelling Cys-110 contributed to the increased net attraction measured 
experimentally. 
3.2.2.2.1 Circular dichroism spectroscopy 
Near- and far-UV CD spectroscopy were used for tertiary and secondary structure 
comparative analyses respectively. Figure 3.13 (near-UV) and figure 3.14 (far-UV) 
indicate no significant change in either the tertiary or secondary structures of the 
thiol labelled protein relative to the unlabelled protein and, hence, indicate that 
protein unfolding did not contribute to the increase in Tph.  
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Figure 3.13: Near-UV CD spectra for unlabelled HGD (black) and thiol modified HGD (red) 
indicating very similar tertiary structures.  
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 Thiol Modified HGD
 
Figure 3.14: Far-UV CD spectra for unlabelled HGD (black) and thiol modified HGD (red) 
indicating very similar secondary structures.  
3.2.2.2.2 Second derivative UV spectroscopic analysis 
Second derivative UV spectroscopic analysis was again used as a complement to 
near-UV CD spectroscopy. The spectroscopic data (figure 3.15) also indicate no 
significant change in the data for thiol labelled protein relative to the unlabelled 
protein and, hence, indicate no significant change in the tertiary structure. These data 
are consistent with the data for near-UV CD which also indicated that there was no 
change in the tertiary structure of the protein. 


















Figure 3.15: Second derivative UV analysis of unlabelled HGD (black) and thiol modified HGD (red) 
indicating that the tertiary structures of the labelled and unlabelled protein are very similar. 
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3.2.3 Size exclusion HPLC analysis  
SE-HPLC was carried out on a mixture of unlabelled and amine modified HGD 
(xL=0.01) under reducing conditions to determine if higher molecular weight 
oligomers were present since this can contribute an increase in Tph and, thus, the net 
attraction of the protein (Pande, Lomakin et al. 1995; Asherie, Pande et al. 1998; 
Pande, Pande et al. 2000).  Asherie, Pande et al. (1998) showed that Tph at the critical 
point, increased from ~278 K for a monomer only solution of γIIIb-crystallin (bovine 
equivalent of HGD) to 305 K for a dimer only solution of γIIIb-crystallin. Pande, 
Pande et al. 2000 showed that a mixture monomer, dimer and higher molecular 
weight oligomers of the R14C single mutant of HGD also led to an increase in Tph of 
~20 K. 
Figure 3.16 indicates that there are no detectable peaks at lower retention times thus 
indicating an absence of higher molecular weight oligomers in the solution 
containing the labelled protein. Unreduced HGD has a naturally occurring dimer, due 
to the formation of a disulphide bridge between two monomers that can easily be 
detected by HPLC at low concentration. Where a dimer between fluorescently 
labelled monomers occurs, we would expect that to be formed with a relatively large 
binding energy due to the hydrophobic nature of the label itself and the potential for 
π – π interactions between the dye molecules to occur upon dimer formation. Hence, 
it should also be possible to detect protein dimers mediated by the fluorescent dye 
molecules attached to the protein by HPLC if present. A single peak for the 
fluorescently labelled protein is detected by HPLC, and when compared with the un-
reduced un-labelled HGD, suggests that no detectable concentration of higher 
molecular weight oligomers are present in solution and the presence of low 
molecular weight oligomers are unlikely to be the source of the increase in  Tph.  
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Figure 3.16: SE-HPLC chromatogram for unreduced, unlabelled HGD (black) and a mixture of 
amine modified HGD and unlabelled HGD (xL=0.01) (green). 
3.2.4 Fluorescently labelled protein partitioning 
To determine if the fluorescently labelled protein preferentially partitioned into one 
phase over another, a solution of known volume (90 μl) containing a mixture of 
unlabelled HGD and HGD fluorescently labelled at the Lys-2 position at a known 
labelled protein fraction (xL = 0.002) was cooled to and centrifuged at 0 °C to fully 
separate the dilute and dense phases (section 2.7.3). A fixed volume was carefully 
taken from each phase and diluted to measure the volume fraction and fluorescence 
intensity in each phase. Using these measurements, the dilute and dense phase 
protein volume fractions were calculated to be ϕ = 0.074 and ϕ = 0.35 respectively; 
these values were plotted on the liquid-liquid coexistence curve for HGD with a 
labelled protein fraction of xL = 0.002. The labelled protein fraction after complete 
phase separation was calculated to be xL = 0.0012 in the dilute phase and xL = 0.0025 
in the dense phase. This is consistent with previously published data where in a 
mixture of two proteins, the protein with the stronger net attraction preferentially 
partitions into the dense phase (Wang, Lomakin et al. 2010). 
97 
 
























Volume Fraction ()  
Figure 3.17: Liquid-liquid coexistence curves for unlabelled HGD (black) and HGD fluorescently 
labelled at Lys-2 with labelled protein fraction of xL = 0.002 (green). The diamonds indicate the 
volume fractions of the dilute and dense phases following separation and the tie-line connects these 
two points. The circles indicate the critical volume fraction for each protein composition.  
 
3.2.5 FITC labelling 
3.2.5.1 Background 
FITC is a widely used derivative of fluorescein with an isothiocyanate group that has 
excitation and emission peak maxima at 495 nm and 514 nm respectively. FITC does 
not possess the same degree of specificity as fluorophores with either a maleimide or 
NHS reactive moiety and will interact with various different side-chain groups. 
However, in general, only interactions with primary and secondary amines yield 
stable products. FITC labelling was used as a means of determining if the 
observations using site (primary amine and thiol) specific dyes were related to the 
specific chemistries of those dyes or if the increase in attraction is a more general 
phenomenon for widely used dyes.  
3.2.5.2 Phase diagram measurement 
A mixture of HGD and HGD fluorescently labelled with FITC in an aqueous solution 
(0.1 M sodium phosphate buffer at pH 7.0) was prepared as outlined in section 2.5.3 
to a concentration of 100 mg ml
-1
 (ϕ = 0.071) to  measure part of the ascending limb 
of its liquid-liquid coexistence curve (figure 3.18). The composition of HGD labelled 
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with FITC (xL) used as a fraction of total protein was xL = 0.0002. Tph was measured 
and the coexistence curve fitted with equation 3.1. Estimated values for Tc, ΔTc and 
A are given in table 3.3. Once again, a value of ϕc=0.21 was fixed. 


























Figure 3.18: Liquid-liquid coexistence curves for unlabelled HGD (circles) and HGD fluorescently 
labelled with FITC at a labelled protein fraction of xL = 0.0002 (orange). Values for data points 
shown given in tables A1 and A4 in Appendix. 
A substantial increase in Tph (~20 K) was observed under these conditions in addition 
to a narrowing of the liquid-liquid coexistence curve (as indicated by a decrease in 
parameter A). This is to be expected given the diminished labelling specificity 
associated with FITC and is consistent with the data for both Lys and Cys 
modifications of HGD whereby fluorescently labelling HGD led to an increase in the 
phase separation temperature of the protein mixture relative to the unlabelled as well 
as a decrease in the width of the coexistence curve. 
Table 3.3: Estimated critical temperature (Tc), change in critical temperature (ΔTc) and width 
parameter (A) for each composition of HGD modified with FITC at ϕc = 0.21. 
Fluorescently Labelled Protein Fraction  Tc (K) ΔTc (K) A 
xL = 0.0000 277 - 2.6 




3.2.6 Modelling the phase behaviour of a fluorescently labelled 
protein in a mixture 
A patchy particle model was designed specifically to numerically investigate if the 
experimental results, could be captured using a patchy particle model (as described in 
section 2.11) (Quinn, Gnan et al. 2015). This work was done by Nicoletta Gnan and 
Emanuela Zaccarelli and colleagues at the University of Rome, La Sapienza as part 
of a collaboration. The unlabelled protein (designated ‘U particle’) was based on a 
previous model used to describe the coexistence curve of bovine γ-crystallin using 
Kern-Frenkel patchy particles exhibiting a square-well (SW) attraction (Kern and 
Frenkel 2003; Liu, Kumar et al. 2007). The surface of the U particle has four 
randomly placed non-overlapping attractive sites (‘U patch’); In using randomly 
placed attractive patches, it was possible to correctly reproduce the coexistence curve 
(i.e. correct width and ϕc) for HGD (Quinn, Gnan et al. 2015).   
The labelled protein (designated ‘L particle’) was modelled as for the U particle with 
four attractive sites but had a fifth wider and more attractive site (‘L patch’) on its 
surface to mimic the fluorescent label. This was based on the assumption that a small 
molecule fluorescent label (e.g. FITC, figure 3.19 (left)) has a molecular weight that 
is larger than any of the aromatic amino acids (i.e. Phe, Trp and Tyr, figure 3.19 
(right)) and is significantly more hydrophobic as a result of having several aromatic 
groups in its structure.  
 
Figure 3.19: Structure of FITC (left) and structures of the aromatic amino acid residues  
Phe, Trp and Tyr (right). 
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Since the L patch is attached to the surface as opposed to being a composite part of 
the L particle structure, it extends beyond the surface and can readily interact with 
multiple U patches of both U and L particles (figure 3.20). The possibility of an 
interaction with another L patch was prohibited since this would lead to the 
formation of L particle clusters, an eventuality that was excluded experimentally 
(section 3.2.1.3) – at least within the composition range investigated. 
 
Figure 3.20: Patchy particles used for modelling unlabelled HGD (‘U particle’). Unlabelled HGD 
has four patches (‘U patch’). Fluorescently labelled HGD (‘L particle’) has four patches as for the U 
particle and a fifth larger patch (‘L patch’ shown in green) representing the fluorescent label (Quinn, 
Gnan et al. 2015). 
The model devised in support of the experimental data (equations 2.25 and 2.26 and 
table 2.12 in 2.11) was numerically compared to the data for unlabelled HGD to 
ensure that the width of the curve and the critical volume fraction was correctly 
captured. Figure 3.21 shows good agreement between the experimental data (purple) 





Figure 3.21: Comparison between the experimental liquid-liquid coexistence curve of unlabelled 
HGD protein (purple) and two different numerical models (blue and green). Blue circles are data 
points for the U particle (a Kern-Frenkel patchy particle model with four randomly placed attractive 
patches on the surface complemented with a SW attraction representing HGD). The dark blue line is a 
fit of these data. The thick green dashed line is a liquid-liquid coexistence curve for γ-crystallins from 
a previously published simple SW model  (Lomakin, Asherie et al. 1996) in which the isotropic 
attraction correctly describes the critical volume fraction and temperature but fails in describing the 
correct width of the liquid-liquid coexistence curve. Taken from Quinn, Gnan, et al. 2015. 
 
Unlabelled protein-labelled protein interactions were modelled by varying the 
parameters (attraction strength (εL,U), angular width in radians ((θmax)L) and patch 
width (δL,U)) that characterised the L patch. The combinations of these values, as 
well as their corresponding Tc and ϕc (with respect to the critical temperature of the 
unlabelled system Tc/T
U








Table 3.4: L patch parameters and corresponding Tc and ϕc values for different labelled protein 
compositions (xL). Reproduced from Quinn, Gnan et al. 2015. 






























































































Figures 3.22 and 3.23 show the resulting fits to the Ising probability distribution for 
the estimation of the critical points for unlabelled particles and binary mixtures 
containing labelled particles at a composition of xL ~ 0.02. 
 
Figure 3.22: Best fit of numerical data (circles) to the Ising order parameter distribution P (M = ρU + 
su) (solid line) for a monodisperse system of U particles where s = 0.028 and L = 5 for simulation 





Figure 3.23: Best fit of numerical data (circles, triangles and diamonds) for a binary mixture of U 
type and L type particles with a labelled particle composition of xL = 0.02 with varying L patch 
interaction strength (εL,U/ εU,U). The order parameter is given by M = ρU + αρL where α = 0.001. 
Simulation box L =5. Angular width ((θmax)L) = 0.723 and width (δL,U) = 0.175. Taken from Quinn, 
Gnan et al. 2015. 
The majority of simulations for the binary mixture were carried out with a wide 
angular width relative to the angular width of the U particles to allow for multiple 
bonding. The volume available in which to form bonds with other particles 
(“bonding volume”) depends on both the angular width and the interaction width. 
The patch can be involved in more than one bond whenever the condition in equation 














Since the bonding angle is already considerably wide, an increase in the interaction 
width does not lead to a significant increase in critical temperature and a further 
increase in bond angle would create overlaps with other patches on the particle’s 
surface. In addition, if the L patch is overly attractive, bonds with other particles 
become irreversible thus rendering estimation of the critical point impossible. This 
occurs at εL,U/ εU,U = 1.5 (where bond angle equals 0.723 and patch width equals 
0.175). Consequently, the range of bonding energies that are directly relevant to the 
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experimental results (where the energetic contribution arising from the fluorescent 
molecule is estimated to be 3–4 times larger than a typical protein-protein 
interaction) cannot be directly probed. Thus, extrapolation of the critical temperature 
for higher bonding energies is required for comparison with experimental results. 
The values of the extrapolated bond energies using a labelled protein composition of 
xL ~ 0.02 is shown in figure 3.24.  
 
Figure 3.24: Evolution of the critical temperature of the mixture of labelled and unlabelled particles 
(normalised to the critical temperature of the unlabelled system T
U
c) as a function of the bond energy 
between a U-patch and a L-patch εL,U. The fraction of labelled particles is xL ~ 0.02. The darker area 
in the plot corresponds to the range of interaction energies comparable to experiments. Inset: critical 
volume fraction ϕc as a function of εL,U. Taken from Quinn, Gnan et al. 2015. 
The significant increase in critical temperature of the mixture as a result of adding a 
very small amount of L particles (i.e. xL = 0.02) qualitatively agrees with the 
experimental data which showed that the addition of a small amount of fluorescently 
labelled protein resulted in an increase in the critical temperature. A shift in the 
critical volume fraction relative to the unlabelled system is also observed. However, 
the extrapolated data show that for a bonding energy of ~4, the critical volume 
fraction only shifts to 0.23. In the experimental data, a point on the descending arm 
of liquid-liquid coexistence curve for a mixture of unlabelled protein and amine 
labelled protein at xL = 0.002 has been determined (section 3.2.1.4). This value is 
consistent with a critical volume fraction equal to 0.21 (the critical volume fraction 
for the unlabelled protein).  
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The relative concentrations of L particles in each phase (dilute and dense phases) 
have also been examined. L particles were found to be present in the dense phase 
alone. This observation is also consistent with the experimental data where the 
majority (~2:1) of labelled protein partitioned into the dense phase following total 
liquid-liquid phase separation.  
3.3 Conclusion  
HGD was labelled using three different small molecule fluorescent dyes: Ana Tag 
HiLyte 405 fluorescent dye was used for specifically labelling HGD in the Lys-2 
position; DyLight 405 Maleimide fluorescent dye was used for specifically labelling 
HGD at the Cys-110 position; FITC was used to non-specifically fluorescently label 
HGD. Using fluorescent dyes for labelling specific amino acids (i.e. Lys and Cys) 
and carefully controlling reaction conditions, it was possible to label HGD with a 
maximum of 1 dye molecule per protein ensuring that the labelling efficiency was 
calculated accurately. Each labelled protein was used in mixtures of various labelled 
protein fractions and the liquid-liquid phase boundaries were measured for each. 
Labelled protein fractions as low as xL = 0.0001 were sufficient to increase liquid-
liquid phase separation temperature (Tph) significantly (ΔTc ~ 14 K) (and indicated an 
increase in the net attraction of the solution relative to a solution containing HGD 
alone). Tph was affected by not only the varying chemistries of the fluorescent label 
but also by the position labelled.  
A specifically designed patchy particle model in which unlabelled HGD is 
represented as a particle containing four attractive sites and labelled HGD is 
represented as for the unlabelled particle but with the addition of a fifth larger and 
more attractive site was used to numerically assess the experimental observations. 
This model proved to be qualitatively consistent with the experimental data for 
amine labelled HGD and approximately conserved the critical points estimated in the 
experimental system.   
The data outlined here present several important observations. Anecdotally, it is 
known that fluorescent labelling can diminish protein solubility. This has led to the 
derivatization and development of small molecule fluorescent labels with hydrophilic 
moieties to impart increased solubility. Here, it has been shown that the origin of the 
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decreased solubility as a result of fluorescent labelling is not directly due to the 
formation of aggregates (however, a reduced solubility would lead to aggregate 
formation downstream) or a significant structural change but is due to an increased 
net inter-protein attraction as a result of an increased number of attractive sites on the 
surface of the protein. It has also been shown that the effect of labelling is also highly 
dependent on the site used for labelling due the inherent anisotropic nature of 
protein. While this result is not unsurprising, the low labelled protein compositions 
required to induce such a significant change in the liquid-liquid phase separation 
temperature are somewhat unexpected. 
Fluorescence methods are widely used as a means of understanding protein 
behaviour. This study quantitatively assessed the impact different labelling 
methodologies have on the solution behaviour and, therefore, stability of 
fluorescently labelled proteins. From this study, it is clear that fluorescently labelled 
proteins are best used in small quantities. Consequently, studies requiring the use of 
fluorescently labelled proteins must take into account these important effects so as to 
avoid a misinterpretation of data as a result of an increase in the net inter-protein 
attraction. 
In a broader sense, the results presented here serve to provide an insight into the role 





Chapter 4:  
Chemical modification of human γD-








Using a combination of experiments and coarse grained simulations, we have 
demonstrated that fluorescently labelling HGD using small molecule fluorophores 
increased the temperature at which LLPS occurs (Tph) due to an increase in net-
attraction between all proteins in the system. Small molecule fluorophores are 
significantly larger and inherently more hydrophobic in nature (given their aromatic 
structures) than any naturally occurring amino acid. It was, therefore, unsurprising 
that chemical modification using fluorophores led to a significant change in Tph for 
solutions of varying composition of fluorescently labelled protein.  
In this chapter, Tph has been experimentally measured across a range of volume 
fractions for different types of modified HGD in mixtures with unmodified HGD. 
First, two separate amino acids on the surface of HGD, Lys-2 and Cys-110, have 
been chemically modified using PEGylated biotin. Second, a single mutant of HGD 
that replaces a proline with a valine at position 23 (P23V) has been used in a mixture 
with HGD.  
PEGylated biotin was used to chemically modify sites 2 and 110 of HGD. Biotin is a 
vitamin (also known as Vitamin H, Vitamin B7, or Coenzyme R) with a valeric acid 
side-chain that can be derivatized to enhance its functionality (figure 4.1). It is a 
relatively small molecule with a molecular weight of 244.3 g mol
-1 
compared to the 
molecular weight of HGD which is approximately 21 kDa. The interaction of biotin 
with the larger biotin-binding protein avidin (67 – 68 kDa) and other biotin-binding 
proteins streptavidin and NeutrAvidin is the strongest known non-covalent 
interaction (Kd = 10
-15
 M for biotin-avidin) and this interaction is often exploited for 
protein purification and detection.  
 
Figure 4.1: Structure of biotin showing valeric acid (highlighted in red). 
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While biotin itself is water-soluble, its derivitization with a PEG linker (figure 4.2) is 
intended to enhance the hydrophilicity of the biotin molecule by increasing the 
solvation shell around the molecule.      
 
Figure 4.2: Structure of ethylene glycol.  
The P23T single mutant of HGD is associated with a number of cataract phenotypes 
and forms amorphous aggregates at low concentrations (1–2 mg ml
-1
 at room 
temperature) with an inverted temperature dependence at physiological pH (Nandrot, 
Slingsby et al. 2003; Shentu, Yao et al. 2003; Mackay, Andley et al. 2004; Pande, 
Annunziata et al. 2005). Two other mutations at site 23 (P23S and P23V) have also 
demonstrated a decreased  solubility (to different extents) with an inverted 
temperature dependence (Pande, Annunziata et al. 2005). The dramatically altered 
solubility associated with P23T, P23S and P23V mutants is due to an increase in the 
surface hydrophobicity of the mutant protein relative to the native HGD as a result of 
the addition of an attractive “sticky” patch to the protein’s surface (Pande, Ghosh et 
al. 2010). Previously, the effect of the P23V mutation on the liquid-liquid phase 
boundary was investigated (Pande, Annunziata et al. 2005; McManus, Lomakin et al. 
2007). The P23V single mutant is the only mutant of the three mutants discussed that 
can be concentrated to a concentration range where LLPS can be measured since its 
(retrograde) solubility is higher than both P23S and P23T (McManus, Lomakin et al. 
2007). These studies found that the liquid-liquid phase boundary for P23V was 
indistinguishable from the liquid-liquid phase boundary for HGD despite the 
remarkable change in the mutant’s solubility relative to the native protein. It was 
determined that this observation was directly related to the highly anisotropic nature 
of the protein where its net attraction was spatially averaged in the liquid phase but 
fully engaged in the solid phase (McManus, Lomakin et al. 2007). The mutation of 
HGD of a Pro to a Val at site 23 is analogous to the chemical modification of HGD 
using small molecule fluorescent labels in the sense that both give rise to the addition 
of an attractive patch on the surface of the protein (albeit at different positions on the 
protein surface). Banerjee, Pande et al. (2010) showed that there was no change in 
Tph for the E107A single mutant of HGD relative to native HGD. Like P23V, E107A 
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has very similar tertiary and secondary structures to HGD. However, when E107A 
was used in a mixture with α-crystallin, there was a notable increase in Tph, the value 
of which was dependent on the fraction of α-crystallin present in the mixture. It is, 
therefore, reasonable to ask if the net protein-protein attraction for the P23V mutant 
(which adds an attractive, hydrophobic patch to its surface) that was averaged out in 
the liquid phase for a single protein system (i.e. P23V alone) remains averaged out in 
a binary protein system (i.e. in mixtures with native protein). 
4.1.2 Aim of study 
The aim of this study was to experimentally measure Tph across a range of volume 
fractions for different types of modified HGD. First, two separate amino acids on the 
surface of HGD, Lys-2 and Cys-110, were chemically modified using PEGylated 
biotin and used in mixtures with HGD. Second, the P23V single mutant of HGD was 
used in a mixture with HGD.  
In modifying HGD at different sites, it was possible to demonstrate that the effect of 
surface modification, be it by chemical modification or mutagenesis, depends not 
only on the physicochemical properties of the modifier but also on the site of the 
modification.  
4.2 Results 
Two forms of modified HGD were used to investigate the phase behaviour of 
mixtures of modified and unmodified protein: HGD chemically modified with 
PEGylated biotin and the P23V mutant of HGD. HGD for chemical modification was 
produced recombinantly in E. coli and chemically modified after purification using 
PEGylated biotin with reactive moieties for residue specific modification. The 
chemically modified sites (shown in figure 4.3) used in this study were Lys-2 and 
Cys-110. A single mutant form of HGD containing a mutation of Proline (Pro, P) at 
position 23 to a Valine (Val, V) (P23V) (achieved by site-directed mutagenesis) was 




Figure 4.3: Topological rendering of HGD showing the locations of modified sites, Lys-2 (blue), Cys-
110, and P23V (orange). 
The liquid-liquid phase separation (LLPS) temperature (Tph) was used to quantify the 
change in net-interaction potential between proteins for mixtures of modified and 
unmodified proteins. 
4.2.1 Production and purification of P23Vsingle mutant protein 
HGD was expressed, extracted, purified and characterised as detailed in chapter 3. 
The purity of each batch produced was confirmed by SE-HPLC and SDS PAGE. The 
P23V single mutant protein of HGD was produced recombinantly in E. coli and 
extracted and purified using SEC (figure 4.4) and IEX (figure 4.5) Characterisation 
of the purified product included SE-HPLC, SDS PAGE, mass spectrometry and 
circular dichroism. SE-HPLC (figure 4.6) and SDS-PAGE (figure 4.7) confirmed the 
product purity. 





















Figure 4.4: Size exclusion chromatogram indicating the peak associated with P23V. 
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Figure 4.5: Ion exchange chromatogram after purifying fractions from the size exclusion step. The 
major peak contains the P23V mutant of HGD. Following purification, only fractions from the peak 
tail were pooled to ensure protein purity. 
The SE-HPLC chromatogram for P23V shows one peak at 24 minutes (figure 4.6). 
Using the calibration curve for this column under similar buffer conditions, this 
indicates a molecular weight of ~21 kDa, a value consistent with the previously 
published molecular weight of a P23V monomer (20 608 ±1 Da) (Pande, Annunziata 
et al. 2005). 
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Figure 4.6: SE-HPLC chromatogram for P23V single mutant of HGD prepared in 0.1 M sodium 
phosphate at pH 7.0 with 20 mM DTT. 
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SDS-PAGE was also used to assess protein purity. A clean band just below the 21.5 
kDa molecular weight marker indicates pure monomer protein (figure 4.7). 
 
Figure 4.7: 12.6% reducing SDS-PAGE gel showing a single band indicating the purity of P23V 
single mutant protein. 
4.2.2 Biotinylated HGD  
4.2.2.1. Phase diagram measurement  
HGD was chemically modified using two forms of PEGylated biotin for separate 
modification of a primary amine at Lys-2 and a thiol at Cys-110. The ascending 
limbs of the liquid-liquid coexistence curves using two modified protein 
compositions (xm) were measured for both Lys-2 (figure 4.8) and Cys-110 
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Figure 4.8: Liquid-liquid coexistence curves for unlabelled HGD (black circles) and HGD chemically 
modified with PEGylated biotin at Lys-2 with modified protein fractions of xm = 0.62 (light blue 
triangles) and xm = 0.86 (cornflour blue squares). Values for data points shown given in tables A1 
and A5 in Appendix. 





























 Figure 4.9: Liquid-liquid coexistence curves for unlabelled HGD (black circles) and HGD 
chemically modified with PEGylated biotin at Cys-110 with modified protein fractions of xm = 0.47 
(light pink pentagons) and xm = 0.89 (dark pink triangles). Values for data points shown given in 
tables A1 and A6 in Appendix. 
The data for unmodified HGD and each composition of modified protein was fitted 
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 5.1 
where ϕ and ϕc are the volume fraction and critical volume fraction respectively 
(where the partial specific volume, ν, of HGD and its modified forms is taken to be 




), A is a parameter related to the width of the coexistence 
curve, T and Tc are the phase separation temperature and critical temperature 
respectively and β is an exponent term for the three-dimensional Ising model equal to 
0.325. The critical volume fraction, ϕc, was taken to equal 0.21, a value consistent 
with ϕc for all gamma crystallins (Liu, Asherie et al. 1996). The estimated values for 
Tc, ΔTc and A are given in table 5.1 for each composition of chemically modified 
protein.  
Table 4.1: Values for estimated changes in critical temperature to the nearest K (ΔTc) with respect to 
unmodified HGD using equation 1 for each binary protein mixture in aqueous solution 
Modified Protein  Tc (K) ΔTc (K) A 
Unmodified HGD (xm = 0.00) 277 - 2.6 
HGD amine modified with PEG4-Biotin (xm = 0.62) 278 1 2.6 
HGD amine modified with PEG4-Biotin (xm = 0.86) 279 2 2.6 
HGD thiol modified with PEG2-Biotin (xm = 0.47) 283 6 2.6 
HGD thiol modified with PEG2-Biotin (xm = 0.89) 287 10 2.6 
 
The data clearly indicate that there is a greater change in Tph after modifying the thiol 
at site 110 than modifying the primary amine at site 2. This observation is  consistent 
with the published data that are presented in Chapter 3 of this thesis where HGD was 
chemically modified at Lys-2 and Cys-110 using small molecule fluorescent dyes 
(Quinn, Gnan et al. 2015). When fluorescently labelled protein was in mixtures with 
unlabelled HGD at protein compositions between 0.0001 and 0.01 (partial data 
shown in figure 4.10), an increase in Tph with increases in the proportion of modified 
protein were observed. The proportion of labelled protein that was required to 
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increase Tph was substantially lower for protein modified at the Cys position (by a 
factor of ~50).  
The range of the protein-protein interaction is related to the width of the liquid-liquid 
coexistence curve where a decrease in coexistence curve width is indicative of an 
increase in the interaction range of the protein (Lomakin, Asherie et al. 1996; Chen, 
Vekilov et al. 2004). While there is very little change in Tph for HGD modified with 
PEGylated biotin at the amine position, there is a substantial increase in Tph with 
increasing proportions of HGD modified with PEGylated biotin at the thiol position. 
However, there is no change in the width of the coexistence curve for HGD modified 
with PEGylated biotin (parameter A in equation 4.1, see table 4.1). This would 
suggest that the increased net attraction as indicated by the increase in Tph is not 
accompanied by an increase in the range of the attraction. Figure 4.10 shows partial 
coexistence curves for HGD in mixtures with fluorescently labelled HGD modified 
at the amine position (NH) and thiol position (SH) where an increase in Tph was 
accompanied by a decrease in curve width. This is in contrast to the coexistence 
curves for HGD modified with PEGylated biotin. There was also a substantial 
difference in the fraction of modified protein required to induce a change in Tph of 
similar magnitude (xm=0.0001 for fluorescently labelled HGD versus xm=0.89 for 
HGD chemically modified with PEGylated biotin). Hence there are notable 
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Figure 4.10: Liquid-liquid coexistence curves for HGD (black) and HGD chemically modified via 
fluorescent labelling of a primary amine (green) (A), and a thiol (red) (B). 
Electrostatic inter-protein interactions between charged groups on the protein’s 
surface contribute to its solubility (Cooper 2011). The pI of HGD (pI = 7.2 ± 0.1 
(Banerjee, Pande et al. 2011)) is almost at physiological pH and is very close to the 
working pH used in the data presented here. Lysine (along with histidine and 
arginine) is one of three positively charged amino acid residues at neutral pH (pH 
7.0). The modification of Lys-2 by covalent attachment of the PEGylated biotin thus 
removes one positive charge from the protein surface and results in a protein with a 
net negative charge. This change in charge may be a contributing factor as to why the 
increase in net attraction (as indicated by the lower change in Tph) is not as 
substantial as the increase in Tph for HGD modified at Cys-110 with PEGylated 
biotin. Since the structures of the small molecule fluorescent dyes previously used 
for specific labelling of HGD are proprietary, it is not possible to comment on how 
this affected the electrostatic contribution of the net interaction potential. FITC, 
which has a partial negative charge at neutral pH, can modify both primary and 
secondary amines. As a result, HGD labelled with FITC will carry a net negative 
charge which should contribute to its solution stability. A mixture of HGD and HGD 
fluorescently labelled with FITC (xL = 0.0002) led to an increase in Tph of 20 K. This 
would suggest that the net negative charge of FITC labelled HGD did not contribute 
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as significantly to the net protein interaction potential as the increase in surface 
hydrophobicity as a result of FITC labelling. 
4.2.2.2 Modified protein partitioning 
A binary protein solution of known volume fraction containing HGD and HGD 
chemically modified at Cys-110 with a modified protein composition of xm = 0.89 
was cooled (-4 °C) to induce liquid-liquid phase separation and the liquid phases 
were macroscopically separated by centrifugation at -4 °C into the dilute and dense 
protein phases (figure 4.12). The volume fraction and modified protein composition 
of each phase was determined. The dilute phase was determined to have a modified 
protein composition xm equal to 0.80, while in the dense phase xm equalled 0.87 
indicating that the protein fraction of HGD in the dilute and dense phases was 0.20 
and 0.13 respectively. The propensity of the less attractive unmodified HGD to 
preferentially partition into the dilute phase is consistent with previously published 
data (Wang, Lomakin et al. 2010) and is directly related to the relative strengths of 
the inter-protein attractions, i.e. HGD-HGD, HGD-modified-HGD and modified 
HGD-modified HGD interactions, with the more attractive protein (i.e. modified 
HGD) preferentially partitioning into the dense liquid phase. This observation is also 
consistent with our previous data using fluorescently labelled HGD where the 
majority of the labelled protein (i.e. the more attractive protein) partitioned into the 




























Volume Fraction ()  
Figure 4.12: Liquid-liquid coexistence curves for unmodified HGD (black) and a binary protein 
mixture in aqueous solution containing 89% (of total protein) PEG2-Biotin modified HGD at Cys-110 
. The triangles indicate the volume fractions for the dilute phase (ϕ = 0.06) and concentrated phase (ϕ 
= 0.38) after liquid-liquid phase separation. The dashed line is a tie-line and connects the pair of 
volume fractions after phase separation. The percentage of biotinylated protein was determined to be 
80% in the dilute phase and 87% in the concentrated phase. 
4.2.2.3 Structural analysis 
A structural or conformational change as a result of unfolding can cause an increase 
in the net attraction of a protein due to the exposure of hydrophobic residues. To 
determine if this was the case for both the amine and thiol modified proteins, near 
and far ultraviolet (UV) circular dichroism (CD) spectroscopy and second derivative 
UV spectroscopy were used to assess the impact of chemically modifying HGD with 
PEGylated biotin on its respective tertiary and secondary structures. 
4.2.2.3.1 Circular dichroism spectroscopy 
Far-UV CD spectral data for amine modified (4.13) and thiol modified (figure 4.14) 
HGD indicates that there was no significant change in the secondary structure of the 
biotin modified protein relative to the unmodified protein.  
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Figure 4.13: Far UV CD spectra for unlabelled HGD (black) and amine modified HGD (blue) 
indicating very similar secondary structures.  
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Figure 4.14: Far-UV CD spectra for unlabelled HGD (black) and thiol modified HGD (pink) 
indicating very similar secondary structures.  
Near-UV CD spectral data for amine modified (4.15) and thiol modified (figure 4.16) 
HGD indicates that there was no significant change in the tertiary structure of the 
modified proteins relative to the unmodified protein.  
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Figure 4.14: Near-UV CD spectra for unlabelled HGD (black) and amine modified HGD (green). 
There is a slight perturbation in the spectral data for the wavelength range corresponding to Phe 
indicating a localised change to the tertiary structure. 
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Figure 4.16: Near-UV CD spectra for unlabelled HGD (black) and thiol modified HGD (pink) 
indicating very similar tertiary structures.  
Near and far UV CD spectral data has already been published for the P23V single 
mutant of HGD (Pande, Annunziata et al. 2005). These data indicated very similar 
spectra for both near and far UV wavelengths. Again, this is indicative of a minimal 
impact on tertiary and secondary structures as a result of a modification to the 
surface of HGD and thus that a structural or conformational change is not responsible 




4.2.2.3.2 Second derivative UV spectroscopy 
Second derivative UV spectroscopic analysis was used as a complement to near-UV 
CD spectroscopy for tertiary structure analysis. The spectroscopic data for amine 
modified (figure 4.17) and thiol modified (figure 4.18) HGD indicate no significant 
change in the modified protein’s tertiary structure relative to unmodified HGD. This 
is consistent with the spectral data obtained using near-UV CD. 
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Figure 4.17: Second derivative UV analysis of unlabelled HGD (black) and amine modified HGD 
(blue). 
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4.2.3 HGDP23V mixture; Effect on liquid phase diagram 
A partial liquid-liquid phase boundary was measured for a 50:50 mixture of HGD 
and P23V to determine the effect of the mutation in a mixture with the native protein 
in terms of its net interaction potential (figure 4.19).  
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Figure 4.19: Liquid-liquid coexistence curve for unmodified HGD (black) and a binary protein 
mixture in aqueous solution containing 50% (of total protein) P23V mutant of HGD (orange) showing 
the phase separation temperature across a range of volume fractions for HGD in a 50% mixture with 
P23V. Values for data points shown given in tables A1 and A7 in Appendix. 
There is no apparent change in the LLPS temperature for a mixture of P23V and 
HGD relative to phase separation temperature of HGD (or, indeed, P23V) alone 
(figure 4.19). These data would suggest that, even when used in a mixture, the effect 
of the mutation at site 23 remains averaged in the liquid phase.  
4.3 Conclusion 
HGD was modified in two ways: by chemical modification of two different amino 
acid residues (Lys-2 and Cys-110) using PEGylated biotin and by mutagenesis to 
replace a Pro at site 23 with a Val. These modified proteins were then used in 
mixtures with unmodified HGD to assess what impact, if any, the presence of the 
modified protein had on solution behaviour relative to solutions containing 
unmodified protein alone. Both mixtures containing a chemically modified protein 
(i.e. Lys modified HGD and Cys modified HGD) showed an increase in the net 
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attraction of the system (as indicated by an increase in Tph) relative to the unmodified 
protein, albeit to different extents; Mixtures containing HGD amine modified at Lys-
2 with modified protein compositions of xm = 0.62 and 0.86 both showed a very 
slight increase in Tph (≤~2 K) while mixtures containing HGD thiol modified at Cys-
110 with modified protein compositions of xm = 0.47 and 0.89 showed a more 
significant increase (≤~10 K). These results are qualitatively consistent with the 
results presented in the previous chapter using HGD fluorescently labelled with a 
small molecule fluorescent label which showed that the protein modified at the Cys-
110 position resulted in a much greater increase in Tph than the protein modified at 
Lys-2. In this study, the width of the liquid-liquid coexistence curve measured for 
each protein mixture containing chemically modified and unmodified protein was 
unchanged. This is in contrast with the data presented in the previous chapter using 
small molecule fluorescent dyes, where a decrease in curve width was observed - 
indicative of an increase in the range of the attraction. Complete phase separation of 
a sample containing thiol modified HGD indicated that, as expected, the majority of 
the chemically modified protein (that had a higher net attraction than the unmodified 
protein) preferentially partitioned into the dense protein phase. This observation is 
consistent with previous studies using HGD and other proteins with a higher net 
attraction. Near and far UV CD data indicated that the increase in Tph of solutions 
containing the chemically modified proteins is not as a result of a significant 
structural change in either the secondary or tertiary structure of the modified protein. 
These results are also consistent with the data presented in the previous chapter using 
small molecule fluorescent dyes.  
In this chapter, it is also shown that a single mutant protein (P23V) that contains a 
more hydrophobic amino acid than its native form does not change the LLPS phase 
transition temperature when used in a 50:50 mixture with the native protein.  This 
further demonstrates how both the modification and its position on the protein 
surface can impact the way in which changes to a phase boundary can manifest.  
The results presented here show that the effect of modifying the surface of a protein 
on its solution behaviour is not only highly dependent on the physicochemical 
properties of the modifier used but also on the site of the modification. This study 
has direct industrial applicability given the widespread use of surface modifications, 
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Chapter 5:  
The self-assembly of double mutants 













Protein self-assembly is dependent on both the intrinsic characteristics of the protein 
and on its environment (Whitesides and Boncheva 2002). Using a combination of 
chemical modification and mutagenesis, we have shown that changes to the surface 
of a protein affect its phase behaviour (James, Quinn et al. 2015; Quinn, Gnan et al. 
2015). For HGD, a number of single and double mutations are known to influence 
the phase behaviour of the protein. The McManus group have identified several 
different double mutant proteins for HGD with interesting phase behaviour (James, 
Quinn et al. 2015). In this chapter, some aspects of the phase behaviour for two of 
these double mutants, P23VR58H and P23TR36S were investigated in more detail. 
Protein condensation is always characterised by the creation of an interface between 
a new dense phase and the solution phase (Buell 2017). A discontinuity in the 
concentration of solutes in a bulk solution makes the formation of this interface 
energetically unfavourable and nucleation occurs when fluctuations in energy can 
overcome this energy barrier (Vekilov 2010; Karthika, Radhakrishnan et al. 2016). 
This process is known as homogeneous nucleation. The formation of a nucleus can 
also occur via the introduction of another interface into the system, a process known 
as heterogeneous nucleation (Buell 2017). As a result of the different routes to 
nucleation, the formation of condensed phases is divided into two processes: 
nucleation and growth (Buell 2017).  
Because nucleation rarely occurs in the bulk solution alone (and is, therefore, rarely 
homogeneous), the interaction of the protein solution with interfaces must be taken 
into account. Heterogeneous nucleation can influence phase behaviour in different 
ways such as by introducing variations in local protein concentration as a result of 
adsorption and by introducing a decrease in interfacial energy as a result of 
adsorption which in turn drives growth (Buell 2017). 
When proteins in solution are exposed to a solid surface, they tend to accumulate at 
the solid/liquid interface (Haynes and Norde 1994). This is due to a lower free 
energy associated with the interface than the bulk material which, in turn, drives 
thermodynamic stabilization via adsorption (Nakanishi, Sakiyama et al. 2001). This 
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interfacial adsorption of proteins has implications for industries such as 
biotechnology, food and medical devices and can be both favourable (e.g. in 
chromatographic processes) and unfavourable (e.g. adsorption to medical devices) 
depending on the application (Nakanishi, Sakiyama et al. 2001; Anand, Sharma et al. 
2010). Solid/liquid interfacial adsorption of proteins is influenced by the chemical 
properties of the protein itself (e.g. pI and surface patchiness), the solution conditions 
(e.g. ionic strength and pH) and the characteristics of the surface with which the 
protein solution is in contact (e.g. roughness and polarity) (Anand, Sharma et al. 
2010; Ouberai, Xu et al. 2014). Surface passivation is commonly used to diminish 
non-specific protein binding to glass surfaces and involves creating a hydrophilic 
surface via PEGylation or non-covalent protein blocking (Hua, Young Han et al. 
2014; Hai, Yifan et al. 2015). Surface modifications that impart a net charge or 
change the polarity of the surface have been developed to alter the extent of protein 
adsorption (Thevenot, Hu et al. 2008). Generally, hydrophilic surfaces are considered 
to be more resistant to protein adsorption than hydrophobic surfaces (Ostuni, 
Chapman et al. 2001; Wu 2009).  
The Pro-23 to Tyr (P23T) single mutant of HGD is associated with congenital 
cataract and leads to the formation of reversible amorphous aggregates with low 
solubility and an inverse temperature dependence under physiological pH and 
temperature (Nandrot, Slingsby et al. 2003; Shentu, Yao et al. 2003; Mackay, Andley 
et al. 2004; Pande, Annunziata et al. 2005). Pro-23 to Val (P23V), which is not a 
naturally occurring mutant of HGD, is far more soluble than P23T yet maintains an 
inverse temperature dependence (Pande, Annunziata et al. 2005; McManus, Lomakin 
et al. 2007). The Arg-58 to His mutation of HGD is also associated with congenital 
cataract and forms crystals with a normal temperature dependence under 
physiological conditions. Previously, a double mutant (P23VR58H) of HGD was 
created that incorporated both mutations (James, Quinn et al. 2015). For the double 
mutant, the solubility line lies between the solubility lines for P23V and R58H and 
the aggregates it forms are consistently spherical in shape (James, Quinn et al. 2015). 
One particularly interesting feature of the growing spherical assemblies for this 
protein is a very consistent aggregate size as the particles grow. Work done by Susan 
James demonstrated that the rate of growth was concentration dependent (figure 5.1) 
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(James 2015). Furthermore, for assemblies grown in bulk solution, at some point, 
protein crystals begin to grow on the surface.  
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Figure5.1: Growth of P23VR58H double mutant aggregates for different concentrations. Reproduced 
from James 2015.   
When these experiments were replicated in significantly reduced volumes (~80 μl 
versus ~360 μl in the original experiments), it became apparent that surface effects 
were dominating protein phase behaviour. In a bid to minimise this interfacial 
interaction, the nucleation and growth of the P23VR58H double mutant was 
investigated for a number of different surfaces. 
Intracellular self-assembly of proteins is a feature of normal biological function as 
well as being implicated in the pathogenesis of protein condensation diseases such as 
sickle cell anaemia and cataract (Eaton and Hofrichter 1990; Brangwynne 2011; 
Shiels and Hejtmancik 2013). While protein studies carried out in vitro in simple 
aqueous solution are of huge importance to furthering our understanding of the 
mechanisms driving protein aggregation, they do not account for the highly complex 
and crowded intracellular environment and the effects of this environment on protein 
behaviour (Kuznetsova, Turoverov et al. 2014; Danielsson, Mu et al. 2015). The 
intracellular environment is an extremely crowded milieu consisting of proteins, 
nucleic acids, polysaccharides, etc. (Kuznetsova, Turoverov et al. 2014). Given the 
heterogeneity of the intracellular environment and the influence of heterogeneity on 
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protein nucleation and growth of the P23VR58H double mutant, we wanted to 
investigate the nucleation and growth of a protein expressed in a mammalian cell 
line. Protein concentration is an important variable when considering intracellular 
protein phase transitions (Brangwynne 2013). As a result, a double mutant of HGD 
with a low solubility at physiological pH and temperature was selected: P23TR36S. 
Like R58H,  the Arg-36 to serine (R36S) single mutant of HGD is also responsible 
for congenital cataract and also has a significantly lower solubility than wild-type 
HGD that leads to the formation of crystals with normal temperature dependence 
(Kmoch, Brynda et al. 2000; Pande, Pande et al. 2001). Though position 36 is not a 
crystal contact in the native protein, it becomes one in the mutant protein (Kmoch, 
Brynda et al. 2000; Basak, Bateman et al. 2003). The equilibrium solubility lines for 
R36S and R58H are similar, but crystallization of the R36S mutant occurs more 
rapidly than the R58H mutation (Pande, Pande et al. 2001). The phase behaviour of 
P23TR36S was previously investigated in 0.1 M sodium phosphate buffer at pH 7.0 
with 20 mM DTT (James, Quinn et al. 2015). This double mutant was shown to 
produce rhombic crystals with an inverted temperature dependence at physiological 
temperature. Because of this interesting phase behaviour at low concentrations and 
physiological temperature, it was selected for expression in a mammalian cell line.    
5.1.2 Aim of this study 
The aim of this chapter was to study the influence of environment on nucleation and 
growth of protein aggregates. Previous studies on the P23VR58H double mutant of 
HGD were carried out in large volumes. The work presented here was carried out at 
smaller volumes which served to amplify the surface effects on nucleation. To 
minimise the interaction of the protein with the surface, a number of different surface 
modifications were explored and their influence on the nucleation and growth of this 
double mutant was investigated. In addition, the effects of heterogeneity on the 
nucleation and growth of a different double mutant of HGD (P23TR36S) were 
investigated by expressing this protein in a mammalian cell line. 
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5.2 Results  
5.2.1 The growth of P23VR58H aggregates in bulk and in small 
volumes 
5.2.1.1 Production and characterisation of P23VR58H double 
mutant protein  
The primers for the P23VR58H double mutant protein of HGD were designed 
previously and transformed in E. coli (James, Quinn et al. 2015). The P23VR58H 
double mutant protein of HGD was produced recombinantly in E. coli and extracted 
and purified using SEC (figure 5.2) and IEX (figure 5.3) SE-HPLC (figure 5.4) and 
SDS-PAGE (figure 5.5) confirmed the product purity. 
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Figure 5.3: Ion exchange chromatogram after purifying fractions from the size exclusion step. The 
major peak contains P23VR58H double mutant of HGD protein. Following purification, only 
fractions from the peak tail were pooled. 
SDS-PAGE (figure 5.3) and SE-HPLC (figure 5.4) and were used to confirm protein 
purity. The chromatogram for P23VR58H produced using SE-HPLC shows one peak 
at 24 minutes (figure 5.3). Using the calibration curve for this column under similar 
buffer conditions indicates a molecular weight of ~21 kDa, a value consistent with 
the published molecular weight of a P23VR58H monomer (20,589 ±1 Da) (James, 
Quinn et al. 2015). 
 
Figure 5.4: 12.6% reducing SDS-PAGE gel showing a single band indicating the purity of 
P23VR58H double mutant protein. 
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Figure 5.5: SE-HPLC chromatogram for P23VR58H double mutant of HGD prepared in 0.1 M 
sodium phosphate at pH 7.0 with 20 mM DTT. 
5.2.1.2 Nucleation and growth of P23VR58H 
The previous studies on P23VR58H protein aggregation were carried out using large 
volumes (~360 μl). When smaller volumes were used to conduct the same 
measurements (≤ ~80 μl), it became apparent that surface effects influenced the 
nucleation and growth of P23VR58H aggregates to a greater extent. We attempted to 
minimise this interaction by altering the surface in contact with the protein solution. 
To maintain a degree of consistency with the earlier work done, each study was 
carried out at 30 °C using a protein concentration of 10 mg ml
-1
 in 0.1 M sodium 
phosphate buffer, pH 7.0 with 20 mM DTT. The surface treatments employed for 








Table 5.1: Chamber variables for monitoring growth of P23VR58H double mutant protein 
aggregates. 
Surface Height (mm) Diameter (mm) Volume (μl) 
Unclean, uncoated 1.00 10.04 80 
Piranha cleaned, 
uncoated 
1.00 10.04 80 
Piranha cleaned, 
poly-D-lysine coated 
1.00 10.04 80 
Piranha cleaned, 
PEGylated 
1.00 10.04 80 
Piranha cleaned, 
silanised 
1.00 10.04 80 
Piranha cleaned, 
uncoated 
0.50 10.04 40 
 
Initially, uncleaned, uncoated coverslips were used to monitor the formation of 
P23VR58H aggregates in smaller volumes. The aggregates formed using these 
coverslips were found to form inconsistently and exhibited a polydisperse size 
distribution (figure 5.6). The polydispersity observed under these chamber conditions 
is not unexpected given that manufacturing artefacts (e.g. grease and particulates) 
were not removed and would hence provide multiple interfaces for heterogeneous 
nucleation to proceed which would influence the growth of aggregates to different 
extents. 
 
Figure 5.6: Phase contrast microscopy images taken after 29 hours of P23VR58H aggregates formed 
in a chamber constructed using uncleaned, uncoated coverslips (d x h = 10.04 mm x 1 mm). 
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We then attempted to minimise the interaction of the protein with the glass surface of 
the coverslip using several different surface treatments and hence promote 
homogeneous nucleation in the bulk. Piranha solution is a highly corrosive mixture 
of sulphuric acid and hydrogen peroxide used for the removal of organic matter from 
glass surfaces. The purpose of cleaning the coverslips with piranha solution was to 
create a negatively charged, hydrophilic surface which would limit the adsorption 
and subsequent nucleation of P23VR58H at the surface.  
Aggregates formed in this chamber were more uniform in size than in the chamber 
formed using uncleaned, uncoated coverslips (figure 5.7). Silica and silicate glass 
surfaces acquire a negative charge in an aqueous environment due to the dissociation 
of the terminal silanol groups (Israelachvili 1992; Behrens and Grier 2001). This 
acquired charge could have also contributed to minimising interfacial adsorption via 
electrostatic interactions. As a result, this uniformity in the nucleation and growth of 
P23VR58H aggregates is not unexpected. 
Figure 5.7: Phase contrast microscopy images taken after 29 hours of P23VR58H aggregates formed 
in a chamber constructed using piranha cleaned, uncoated coverslips (d x h = 10.04 mm x 1 mm). 
Surface passivation using natural or synthetic proteins has been used to limit the 
adsorption of protein to a surface. Poly-lysine, which has two commonly sold 
enantiomers, namely poly-D-lysine (PDL) and poly-L-lysine (PLL), is a synthetic 
positively charged polymer often used in mammalian cell culture to promote cell 
adherence via electrostatic interactions (Mazia, Schatten et al. 1975) and in 
immunoassays to promote antibody binding (Stearns, Zhou et al. 2016). It has also 
been used in very low concentrations to coat plates used for fluorescence correlation 
spectroscopy measurements to minimise peptide interactions with the glass surface 
(Mittag, Milani et al. 2014). In a next step, coverslips were coated with PDL after 
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cleaning with piranha solution. The aggregates formed in this chamber formed at 
different rates and exhibited a polydisperse size distribution (figure 5.8). This is most 
likely due to a heterogeneity introduced by the quality of the surface coating which 
may have resulted in variations in the adsorption of PDL and, consequently, 
variations in the interaction of P23VR58H with the PDL coating which led to 
heterogeneous nucleation.  
 
Figure 5.8: Phase contrast microscopy images taken after 29 hours of P23VR58H aggregates formed 
in a chamber constructed using poly-D-lysine coated coverslips (d x h = 10.04 mm x 1 mm).  
Coating with polyethylene glycol (PEG), which is a hydrophilic polymer, is 
considered the most effective way of passivating glass surfaces (Elbert and Hubbell 
1996; Kingshott and Griesser 1999). Coverslips were PEGylated after piranha 
cleaning. Figure 5.9 shows the aggregates formed in chambers constructed using 
PEGylated coverslips. While significantly better than for PDL coated surfaces, 
aggregates formed in PEGylated chambers showed variations in the size distribution, 
again suggesting that some surface induced heterogeneous nucleation was occurring. 
Again, this is most likely indicative of variations in the quality of the surface coating 
where patches of the PEGylated surface would have interacted differently than on 
un-PEGylated patches which would result in variations in the nucleation and growth 
of the protein. 
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Figure 5.9: Phase contrast microscopy images taken after 29 hours of P23VR58H aggregates formed 
in a chamber constructed using PEGylated coverslips (d x h = 10.04 mm x 1 mm).  
We also investigated how the creation of a hydrophobic surface would influence the 
interaction of the protein solution with the solid interface. Glassware can be silanised 
to increase its hydrophobicity and is achieved by functionalising the silanol groups 
on the glass surface with reactive silane (figure 5.10) (Seed 2001).  
Figure 5.10: Silanisation of glassware using dichlorodimethylsilane 
Figure 5.11 shows the aggregates formed in chambers constructed with silanised 
coverslips. The uniformity in size of the aggregates formed in this chamber suggests 
that the hydrophobic surface used served to minimise the surface interaction of the 
protein and hence ensured that more nucleation occurred in bulk solution, rather than 
at the surface interface. 
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Figure 5.11: Phase contrast microscopy images taken after 29 hours of P23VR58H aggregates 
formed in a chamber constructed using piranha cleaned, silanised coverslips  
(d x h = 10.04 mm x 1 mm). 
Thus far, piranha cleaned chambers produced the most monodisperse protein 
aggregates. The chambers used up to this point were ~80 μl in volume. To see if 
surface effects could be minimised by introducing a charged hydrophilic surface with 
even smaller volumes, we decreased the volume further by decreasing the chamber 
height. Figure 5.12 shows aggregates formed uniformly in this chamber suggesting 
that the interaction with the charged, hydrophilic surface was minimised using 
piranha cleaning (i.e. no further heterogeneity was introduced by increasing the 
surface to volume ratio).  
Figure 5.12 Phase contrast microscopy images taken after 29 hours of P23VR58H aggregates formed 
in a chamber constructed using piranha cleaned, silanised coverslips (d x h = 10.04 mm x 0.5 mm).  
5.2.1.3 Kinetics of aggregate growth  
Surface conditions that minimised interfacial protein interactions and thus gave rise 
to aggregates with similar rates of nucleation were analysed by measuring the early 
stage growth. The kinetics of P23VR58H growth were monitored for the following 
conditions where surfaces appeared to promote more homogeneous nucleation in the 
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bulk: piranha cleaned, uncoated chambers (d x h = 10.04 mm x 1 mm), piranha 
cleaned, uncoated chambers (d x h = 10.04 mm x 0.5 mm) and piranha cleaned, 
silanised chambers (d x h = 10.04 mm x 1 mm). Average aggregate diameter was 
plotted as a function of time (T) for each condition (figure 5.13). T0 was taken as the 
time the chamber was equilibrated to 30 °C. 
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Figure 5.13: Growth of aggregates between T0 and T = 500 minutes. 
While the initial growth rate was apparently unaffected by the surface treatment used 
(figure 5.14; table 5.2), the final size of the aggregates formed was rather different 
for different surface treatments. Aggregates stop growing once equilibrium between 
the aggregate and the monomer solution is established (James, Quinn et. al 2015). 
Since the monomer in the bulk is depleted as aggregate growth progresses, the final 
size will be determined by the number of nuclei initially formed. However, the total 
volume occupied by the aggregates formed at a particular timepoint for each surface 
treatment is very similar, even for different particle sizes. 
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Figure 5.14: Growth of aggregates between T0 and T = 60 minutes. 
























The growth rates of the aggregates, as indicated by the slopes, are very similar for the 
conditions monitored. We wanted to compare the growth rates for different 
conditions listed above with growth rates for the concentrations of P23VR58H 
determined from the earlier measurements in larger volumes. To do this, the particle 
growth for each concentration of P23VR58H used in the earlier work (James 2015) 
was analysed in the same way (figure 5.15). The growth rates determined from this 
linear fit are given in table 5.3.  
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Figure 5.15: Growth of P23VR58H aggregates for different concentrations of P23VR58H.  


























(1)   -9.970 
(2) -11.415 
  
The data presented in table 5.2 and 5.3 suggest that the growth rate of P23VR58H at 
10 mg ml
-1
 is similar regardless of the surface to volume ratio when the coverslips 
are treated by either cleaning in piranha solution or by silanising the surface – 
indicating that these methods are sufficient to allow nucleation and growth to be 
measured in smaller volumes. The negative intercept shown in table 5.3 is an artefact 
of an induction period. 
The next question is to consider the mechanism by which particle growth proceeds. 
Ostwald ripening occurs in the late stages of a first order phase transition in systems 
where there is competitive growth between clusters which drives the larger clusters 
to “consume” smaller clusters to minimise the interfacial free energy (Streets and 
Quake 2010). The rate of growth of the diameter associated with Ostwald ripening 
shows a power-law time dependence equal to t
1/3
. For our data, the power law time 
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dependence is approximately t
1/3
, however we do not see any differential in the 
particle sizes that would normally be associated with Ostwald ripening (at least on 
the length scales of our measurements), and it is more likely that particle growth 
occurs via monomer addition from the bulk after the initial nucleation event. 
However, measurements at earlier time points will be required to confirm this. 
The majority of nucleation and growth that occurs in protein solutions occurs via 
heterogeneous nucleation (Buell 2017). However, this is generally associated with 
heterogeneous particle sizes when nucleation is a low probability event. In this case, 
nucleation and growth occurs as a result of a first order phase transition, which offers 
the possibility that homogeneous nucleation may occur. In small volume systems, 
where more heterogeneous nucleation is expected due to the large surface area of 
glass, polydispersity in the particle sizes is observed. However, when the glass 
surface is treated to minimise the surface induced nucleation, monodisperse particle 
sizes grow. This seems consistent with a homogeneous nucleation process, but 
further work will be required to confirm this. 
5.2.2 P23TR36S expression in a HEK293T/17 mammalian cells 
Given how strongly heterogeneous surfaces influenced the phase behaviour of the 
P23VR58H double mutant, as a next step we examined the expression of a protein 
that forms condensed phases at low concentrations at physiological temperature, 
namely P23TR36S. Plasmid DNA coding for this double mutant was used for 
transfection of a mammalian cell line (HEK293T/17) to determine if the propensity 
of this double mutant to form crystalline solids at physiological temperature is 
conserved when expressed in a mammalian cell line.  
Plasmid DNA that coded for the HGD-EmGFP fusion protein and designed for 
propagation in E. coli (with optimal expression in mammalian cells) was synthesised 
by GeneArt (ThermoScientific, Germany). The P23TR36S double mutant was 
obtained by site directed mutagenesis of HGD plasmid DNA (section 2.2.4). The 
incorporation of these mutations was confirmed by sequencing which shows the 





Figure 5.16: Sequence of P23TR36S plasmid DNA aligned with wild type HGD using BLAST (NCBI).  
Transfection of HEK293T/17 cells was achieved using Lipofectamine 2000 in either 
4 or 8 well cell imaging chambers coated with PDL to promote cell adherence 
(section 2.9.5). Transfection efficiency was typically ~70% (figure 5.17). 
 
Figure 5.17: Phase contrast (A) and fluorescence (B) microscopy images of HEK293T/17 cells after 
transfection with EmGFP-P23TR36S plasmid DNA. Scale bar = 200 μm. 
Previously, EmGFP, HGD fused with EmGFP (EmGFP-HGD) and the P23T single 
mutant of HGD fused with EmGFP (EmGFP-P23T) were expressed in a mammalian 
cell line (HEK293T/17) to monitor expression and self-assembly of these proteins 
inside a more biologically relevant environment (Migas, Quinn et al. 2017). EmGFP 
and EmGFP-HGD were both evenly distributed within the cytoplasm and no protein 
condensation was observed (figure 5.18a&b). However, HEK293T/17 cells 
expressing EmGFP-P23T fusion protein were shown to have regions of greater 




Figure 5.18: Phase contrast and fluorescence microscopy images of HEK293T/17 cells expressing 
EmGFP (a), EmGFP-HGD (b), and EmGFP-P23T (c–f). Scale bar = 10 μm. Taken from Migas, 
Quinn et al. 2017. 
Using the same approach, HEK293T/17 cells were used to express EmGFP fused 
with P23TR36S (EmGFP-P23TR36S) to investigate the effect the intracellular 
environment had on the phase behaviour of this double mutant protein. 
Phase contrast and fluorescence microscopy images were taken of transiently 
transfected cells every 24 hours after transfection to monitor aggregation within cells 
for a total 96 hours (4 days) (figures 5.19–5.22). This was to determine if there was 
any correlation between aggregate size and time. Regions of increased fluorescence 
intensity are indicative of the formation of a condensed protein state within the cell. 
An increase in fluorescence intensity does not always correspond to an increase in 
the difference between refractive indices of the condensed state and the intracellular 





Figure 5.19: Phase contrast (A–C) and corresponding fluorescence microscopy (D–F) images of 
HEK293T/17 mammalian cells expressing P23TR36S double mutant of HGD taken 1 day post 
transfection. Scale bar = 20 μm. 
 
Figure 5.20: Phase contrast (A–C) and corresponding fluorescence microscopy (D–F) images of 
HEK293T/17 mammalian cells expressing P23TR36S double mutant of HGD taken 2 days post 




Figure 5.21: Phase contrast (A–C) and corresponding fluorescence microscopy (D–F) images of 
HEK293T/17 mammalian cells expressing P23TR36S double mutant of HGD taken 3 days post 
transfection. Scale bar = 20 μm. 
 
Figure 5.22: Phase contrast (A–C) and corresponding fluorescence microscopy (D–F) images of 
HEK293T/17 mammalian cells expressing P23TR36S double mutant of HGD taken 4 days post 
transfection. Scale bar = 20 μm. 
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5.2.2.2 Summary of time resolved study on HEK293T/17 cells 
transfected with P23TR36S 
Figure 5.23 shows the normalised frequency of the size distributions of aggregates 
formed in cells from days 1 to 4 after transfection and table 5.4 indicates the 
aggregate statistics from 1 to 4 days following transfection of HEK293T/17 with 
P23TR36S. As expected, due to the heterogeneous intracellular environment, there 
was variation in the size distribution of aggregates formed in cells. The majority of 
aggregates formed in cells between 1 and 4 days after transfection were between 1 
and 2 μm in size. The largest aggregates were seen in cells, 2 days after transfection. 
After this time, an increased amount of cell debris was seen in the culture wells 
indicating cell death. Cells respond to stresses to either ensure the cell’s survival or 
eliminate damaged cells (Fulda, Gorman et al. 2010). Apoptosis refers to 
programmed cell death while necrosis refers to unregulated cell death (Elmore 2007). 
Necrosis can occur in response to cellular stress and is morphologically characterised 
by a swelling in the cell volume and organelles which in turn lead to cell rupture 
(Fulda, Gorman et al. 2010). Since the expression of P23TR36S and its subsequent 
self-assembly within the cell is not a normal feature of biological function, this may 



























































































 1 day post transfection
 2 days post transfection
 3 days post transfection
 4 days post transfection
 
Figure 5.23: Collated histograms representing the size ranges of the aggregates formed in 
HEK293T/17 cells 1, 2, 3 and 4 days post transfection.  
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1 day  51 2.66 1.40 0.62 6.54 
2 days 87 2.14 1.60 0.42 10.08 
3 days  93 2.73 1.75 0.42 7.69 
4 days  59 2.11 1.17 0.42 6.86 
5.3 Conclusion 
Two double mutants of HGD (P23VR58H and P23TR36S) were used to investigate 
how environmental conditions influence the nucleation and growth of protein 
condensed phases. These double mutants were used since they are known to form 
condensed phases with specific morphologies at certain temperatures and 
concentrations.  
The kinetics of the P23VR58H double mutant of HGD, which forms spherical 
aggregates in 0.1 M sodium phosphate at pH 7.0, were previously investigated in 
large volumes. Here, the aggregation of P23VR58H has been analysed in smaller 
volumes where surface effects on nucleation and growth of aggregates are more 
prevalent. Different surface functionalisation strategies were explored as a means of 
minimising the surface effects on aggregation and to promote homogeneous 
nucleation. The growth rates for P23VR58H aggregates were then monitored for the 
conditions where nucleation proceeded uniformly and resulted in a monodisperse 
size distribution of aggregates which was consistent with a homogeneous nucleation 
process. These growth rates were compared to growth rates for previous aggregation 
studies done using P23VR58H in larger volumes. The growth rates in both volumes 
at concentrations of 10 mg ml
-1
 were very similar.  
The P23TR36S double mutant, which forms rhombic crystals at low concentrations 
and physiological temperature in 0.1 M sodium phosphate buffer at pH 7.0, was 
fused with EmGFP and expressed in a mammalian cell line to investigate the 
influence of the intracellular environment on protein nucleation and growth. Cells 
transfected with the double mutant were imaged every 24 hours following 
transfection to monitor EmGFP-P23TR36S aggregation. The intracellular 
environment did not affect the propensity of the double mutant to form a condensed 
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state. Unsurprisingly, the heterogeneous intracellular environment gave rise to 
condensed states of different sizes. The morphology of these condensed states was 
different to that observed under 0.1 M sodium phosphate pH 7.0 with 20 mM DTT 





Summary and final conclusions 
This work focusses on different factors that influence protein phase behaviour. This 
was explored via modifications (both chemical modification and mutagenesis) to the 
surface of human γD-crystallin (HGD) and also by exploring the impact of 
environment on nucleation and growth of condensed protein phases.  
Chemical modification of HGD by fluorescent labelling of specific amino acids 
(Lys-2 and Cys-110) on the surface of HGD with a (hydrophobic) small molecule 
fluorescent label was examined using both experiments and simulations. This study 
found that very low modified protein compositions (as low as xm = 0.0001) were 
sufficient to increase Tph significantly (~14 K) and that both the position and type of 
fluorescent dye used influenced Tph. A numerical model was designed to explain the 
experimental observations revealed that the increase in LLPS in the presence of 
modified protein was due to a new increase in attraction in the system.  
PEGylated biotin (hydrophilic) was also used to modify HGD at both the Cys and 
Lys positions on the protein surface. There was little change in Tph relative to 
unmodified HGD when the modification was performed at the Lys position. 
However, Tph increased significantly for thiol modified protein at a similar modified 
protein composition (~10 K). Neither modification had any impact on the structure of 
the protein relative to unmodified HGD.  
Finally, the nucleation and growth of protein aggregates in solution and in cells was 
probed using double mutants of HGD. For solution based measurements at smaller 
volumes, surface effects led to polydisperse aggregate formation. To suppress 
surface effects, different surface treatments were investigated. The chemical nature 
of the surface treatment did not cause significant differences in the kinetics of 
aggregation but the quality of the surface modification did. Aggregate growth in cells 
was demonstrated for the P23TR36S mutant of HGD. Heterogeneous aggregates of 
GFP labelled protein were observed in cells for up to 4 days. The particles sizes 
observed were predominantly 1-2 µm in size. Some larger particle sizes were 
observed but these were very few in number and significant cell death was associated 
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This appendix provides data tables for phase diagrams presented in Chapters 3 and 4. 




























































































































































































































































































Table A4: Data table for phase diagram in figure 3.18. 
Modification Modified Protein 
Fraction (xm) 
















































































































Table A6: Data table for phase diagram in figure 4.9. 
Modification Modified Protein 
Fraction (xm) 

















































































Table A7: Data table for phase diagram in figure 4.19. 
Modification Modified Protein 
Fraction (xm) 






P23V single mutant of 
HGD 
0.5 
0.06807 
0.0644 
0.06037 
0.05635 
0.05232 
0.0483 
0.04428 
273.15 
273 
272.65 
272.35 
272.15 
271.7 
271.05 
0.8 
0.55 
0.6 
0.5 
0.6 
0.45 
0.5 
 
 
